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ABSTRACT 
 
Rubber tree (Hevea brasiliensis Muell.) is the world’s major source of natural rubber and a 
major non-oil, agricultural export commodity in the producing countries in Africa. However, it 
is highly susceptible to specific mistletoes of the Loranthaceae family. Phragmanthera capitata 
(Sprengel) Balle is the major mistletoe parasitizing the rubber tree plantations in Africa and 
hence, alongside with other mistletoes, has attracted indiscriminate destruction from plantation 
owners. Indiscriminate destruction of plants could be as a result of ignorance of the importance 
or benefit(s) of the plants and this could lead to their extinction if not checked. Hence, there is 
the need for scientific documentation of plants and their uses because, from the 
pharmacological perception, the destruction of a plant could result in the permanent loss of a 
potential drug. Therefore, this study was aimed at documenting and evaluating the 
pharmacological potentials of P. capitata collected from rubber tree. 
Fresh leaves were gently rinsed with water and dried. Dried leaves were pulverised and kept at 
4
o
C when not in use. Pulverised leaves were extracted with acetone, methanol, ethanol and 
water and concentrated to give the respective solvent crude extracts used in most of the assays. 
From the extraction, Methanol had the highest yield of 21.5%, water had 10.8% and acetone 
was 6.87% while ethanol had the lowest yield of 4.3%.  Standard spectrophotometry assays on 
the extracts were used to quantify some major phytochemicals of pharmacological interest and 
also to determine the antioxidant potentials of the sample. The result revealed high amounts of 
phenols (175.53 ± 0.32 mg GAE/g to 218.62 ± 3.38 mg GAE/g), flavonoids (197.06 ± 3.80 mg 
QE/mg to 679.82 ± 6.26 mg QE/g) and proanthocyanidins (128.83 ± 1.69 mg CE/g to 645.68 ± 
6.35 mg CE/g) with the acetone extract having the highest amount of the phytochemicals while 
the aqueous extract had the least. The results of the antioxidant assays revealed that the sample 
had high radical scavenging potentials with comparable inhibitory concentrations to standard 
antioxidant drugs. 
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The proximate and mineral analysis on the pulverised sample showed that it is rich in 
carbohydrate with a composition of 57.73 ± 0.33 g/100 g. Protein, fat and fibre compositions 
were 12.50 ± 0.50 g/100 g, 3.34 ± 0.18 g/100 g and 11.66 ± 0.54 g/100g. The total energy 
composition was 310.97 ± 2.30 Kcal/100 g. The mineral composition revealed high potassium 
level of 1047.83 ± 34 mg/100g. Calcium (6.22.58 ± 0.01 mg/100g), magnesium (361.15 ± 0.01 
mg/100 g) and phosphorous (115.40 ± 0.01 mg/100 g) were also present in appreciable 
amounts. The toxicity of the four extracts was assayed using brine shrimp. The LC50 in all the 
solvent extracts was greater than 1 mg/mL which according to Meyer’s index and other indexes 
signify “no toxicity” for crude plant extracts. 
Antimicrobial activity of the extracts was done using the minimal inhibitory concentration 
(MIC) assay against 10 bacteria (Enterococcus faecalis, Staphylococcus aureus, Bacillus 
subtilis, Bacillus cereus, Streptococcus pyogenes, Vibrio cholera, Klebsiella pneumonia, 
Pseudomonas aeruginosa, Salmonella typhi and Escherichia coli) and 4 fungi (Trichophyton 
mucoides, Trichophyton tonsurans, Candida albicans and Aspergillus niger) of human 
pathogenic strains. The MIC of the antibacterial assay ranged from 1.25 mg/mL to 5 mg/mL for 
the organic extracts while no activity was observed in the aqueous extract at the highest 
concentration tested. However, the aqueous extract had a great inhibitory activity on all four of 
the tested fungi with a MIC of ≤ 0.3125 mg/mL to 1.25 mg/mL while only two fungi 
(Trichophyton Tonsurans and Aspergillus niger) were susceptible to the organic extracts. The 
MIC of the TB causative pathogen, Mycobacterium tuberculosis (H37Rv) strain ranged from 25 
μg/mL (acetone and aqueous extracts) to 50 μg/mL in the ethanol extract while it was > 50 
μg/mL (highest concentration tested) in the methanol extract. 
This study revealed that the sample has the potential in phytotherapy against oxidative stresses 
(inflammations) caused by free radicals. It could also be a useful herb in combating diseases 
caused by pathogenic organisms. The high anti-Mycobacterium tuberculosis activity observed 
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in this study suggests it could be a plant with high promise in the fight against tuberculosis. The 
toxicity evaluation signifies it is safe for further plant-based pharmaceutical explorations. This 
study also validated some reported ethnopharmacological uses of this plant and call for its 
protection from indiscriminate destruction in rubber plantations and other crop 
gardens/plantations in the world.  
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Background 
Historically, plants have played a pivotal role as natural sources of novel compounds with 
potentials for the development of safe, effective and affordable drugs (Iwalokun et al., 2011). 
The genesis of the use of medicinal plants by man was instinctive as it is in the case with 
animals (Stojanoski, 1999). The widespread use of herbal remedies and their preparations in 
healthcare have been traced to the occurrence of natural products with medicinal properties 
(Parekh, 2007). In every culture and in every age, there are different theories of diseases and 
different systems employed in medicine, but botanical remedies are universal (Parekh, 2007). 
Until the advent of synthetic drugs, plants had been the source of treatment and prophylaxis 
(Kelly, 2009). Nonetheless, the decreasing efficacy and the increasing contraindications of 
synthetic drugs have made the usage of natural drugs a cynosure again (Petrovska, 2012). 
However, the rise in the global disease burden in recent times has resulted in a simultaneous 
increase in the lack of adequate affordable healthcare mostly in impoverished regions of the 
world. The use of plants as medicine has been the major hope for affordable healthcare in these 
regions and in the fight against the alarming rise in the global disease burden. The evaluation 
and proper documentation of potential plant species with medicinal values cannot be 
overemphasised; hence, this study was born on this premise. 
Herbal Medicine 
During the last decade, the use of herbal medicine has expanded globally and has gained 
popularity. It has not only been used for the primary healthcare of the poor in developing 
countries but has also been used in countries where conventional medicine is predominant in 
the national healthcare systems (WHO, 2000).  About 70% of the world’s population depends 
on medicinal plants for their primary healthcare. Among the 250,000 estimated plants species in 
the world, an equivalent of about 35 to 75% species have been used worldwide and about 14 to 
28% has been used as medicaments (Mamedov, 2012; Padulosi et al., 2002; Akerele, 1992; 
Farnsworth and Soejarto, 1991). Recently, more than 50 major therapeutic drugs in the global 
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markets originated from tropical plants (Mamedov, 2012; Padula et al., 1999). Chemical and 
biological diversity observed in plants is a potential reservoir to a limitless renewable source of 
new drugs development (Mamedov, 2012).  
The use of herbal medicine or phytotherapy was derived from the accumulation of botanical 
wisdom by indigenous people (Mamedov, 2012; Shankar and Liao, 2004; Sumner, 2000). In 
fact, drugs derived from plants that are currently prescribed in the developed countries were 
discovered by using the ethnobotanical approach of studying the uses of traditional herbs 
(Balick and Cox, 1997; Farnsworth, 1992).  
According to the World Health Organization (2003), herbal medicine has gained a documented 
popularity in all parts of the developing world and also gaining rapid acceptance in the 
developed countries. Over 50% of the population in Europe, North America and other 
developed nations of the world have used herbal therapy at least for once. About 60% of the 
Hong Kong population has used the services of a herbalist. Herbal preparations have accounted 
for 30 to 50% of the total medicinal consumption in China. 75% of the people living with 
HIV/AIDS in San Francisco, London and South Africa have used herbal therapy. In Canada and 
Germany, 70% and 90% of the respective populations have used herbal medicine at some point 
in their lives. From 1995 to 2000, the number of medical doctors who had gone for special 
training in the use of natural remedy medicine almost doubled to 10,800 in Germany (WHO, 
2003). In France and Australia, 49% and 46% of the respective population use herbal Medicine 
(Abdullahi, 2011). Reports from the United States have revealed that about 158 million adult 
population use complementary medicine. About 17 billion USD was spent on herbal remedies 
in 2000 in the United States and 230 million USD spent annually on alternative medicine in the 
United Kingdom. The global herbal medicine market currently stands at over 60 billion USD 
annually and the trend is steadily increasing (WHO, 2003). 
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Herbal Medicine in Africa 
Africa is considered as the cradle of mankind and blessed with a vast biological and cultural 
diversity. Africa is believed to be the oldest and most assorted of all the healing systems 
(Mahomoodally, 2013; Gurib-Fakim, 2006). Prior to the colonial era and the advent of orthodox 
medicine by the Europeans, millions of Africans have relied solely on herbal medicine as the 
only available healthcare system in both rural and urban communities (Abdullahi, 2011; 
Romero-Daza, 2002). The difficulty or inability in accessing modern healthcare which may be 
due to cost or inadequate health service providers and the lack of effective Western medical 
treatment for some ailments like malaria and HIV/AIDS which although are worldwide 
diseases, but with Africa having the worst hit, might have triggered the continued interest in 
herbal therapy in African healthcare system (Mahomoodally, 2013). 
Africa is endowed with an enormous diversity of about 40,000 to 45,000 plants species of 
which about 5,000 have been exploited in the African Traditional Medicine system 
(Mahomoodally, 2013). Research has shown that African medicinal plants accumulate 
important secondary metabolites to be able to withstand the sun’s ultraviolent rays typical of the 
tropics and also to ward off different pathogenic attacks. Hence, these plants show more ability 
to amass chemoprotective biocompounds to survive in this harsh environment than species from 
the northern hemisphere. Abegaz et al. (2004) study on different species of Dorstenia showed 
that only species from the tropical rainforest in Central Africa had more biological activities 
than related ones from outside the tropics (Mahomoodally, 2013; Manach et al., 2004; 
Farnsworth et al., 1985).  
Although there had been simultaneous and contradictory attitudes or feelings to herbal medicine 
in Africa (Abdullahi, 2011; Bello, 2006; Feierman, 2002), herbalism is still practised even in 
modern-day Africa after aeons of its existence without much-reported cases of adverse effects 
(Okigbo and Mmeka, 2006). According to the WHO (2003) report, up to 80% of the African 
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population relies on herbal medicine for primary healthcare. In Ghana, Mali, Zambia and 
Nigeria, the first choice of treatment for about 60% of children with high fever as a result of 
malaria is the use of herbal remedies at home. According to Carpentier et al. (1995), there is an 
increasing demand for herbal therapy in Africa for the management of rheumatic and 
neurological complaints. About 27 million black South Africans use herbal medicines for a 
variety of ailments (Abdullahi, 2011). Convulsion also known as “degedege” in Tanzania has 
been extensively managed and treated with plant products and over 70% of Ghanaians rely on 
phytotherapy (Abdullahi, 2011; Makundi et al., 2006; Roberts, 2001). In Nigeria, some patients 
suffering from hypertension had integrated herbs into their conventional treatments (Amira and 
Okubadejo, 2007). 
Aside from the inadequate technical specifications and quality control standards which have 
fraught the use of herbal medicinal system in Africa, there is also a pressing concern for the 
rapid loss of natural habitats of some medicinal plant species as a result of anthropogenic 
activities and the fast erosion of traditional knowledge (Gurib-Fakim and Mahomoodally, 2013; 
Mahomoodally, 2013). The highest rate of deforestation is observed in the African continent 
and in spite of her endowed biodiversity, the continent has only a few drugs commercialised 
globally to her credit (Chintamunnee and Mahomoodally, 2012; Atawodi, 2005). Hence, there 
is the need for scientific validation, documentation and sustainable exploitation of African 
medicinal plants. One of the various group of plants which has been exploited for their 
medicinal values for centuries in Europe but had suffered a dearth of medicinal exploration in 
Africa is the Mistletoe. 
Mistletoe 
The term “mistletoe” is not strictly a taxonomic term. It donates a group of polyphyletic 
shrubby parasitic flowering plants in the order, Santalales. They attach to the aerial stem or 
branches of shrubs and trees (Mathiasen et al., 2008; Nickrent, 2002). Molecular phylogenetic 
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studies have revealed that mistletoes evolved from their root parasitic ancestors on five different 
occasions and have also independently evolved in five separate families viz: Viscaceae, 
Amphorogynaceae, Santalaceae, Loranthaceae and Misodendraceae. Presently, mistletoes are 
represented by 88 genera and about 1600 species (Table 1). Loranthaceae (over 900 species) 
and Viscaceae (about 550 species) are the most abundant and diverse mistletoe families 
(Nickrent, 2011; Nickrent et al., 2010).  
Table 1: Mistletoes: number of genera and species 
S/N Families Number of Genera Number of species 
1 Misodendraceae 1 10 
2 Loranthaceae 73 990 
3 Santalaceae
a
 3 11 
4 Amphorogynaceae
b
 4 37 
5 Viscaceae 7 550 
 Total 88 1598 
a
Traditionally classified as Eremolepidaceae. 
b
Traditionally considered as part of Santalaceae (Nickrent, 2011). 
 
 
Folkloric and Ethnopharmacological uses of mistletoes 
Mistletoes from the earliest times has been one of the magical, mysterious, sacred and revered 
plants in the European folklore. It was believed to bestow life and fertility and acts as protection 
against poison and as an aphrodisiac (http://www.theholidayspot.com/christmas 
/history/mistletoe.htm). The custom of using mistletoe to decorate homes at Christmas and 
other festive periods is a survival of the European beliefs and traditions. Branches are cut and 
hung from the ceilings to ward off evil spirits. In some other countries, they are placed over 
houses and stable doors to prevent the entrance of witches. There was also a belief that 
mistletoe could be used as a fire extinguisher (Olawale, 2012).  
Almost all cultures and continents at some point in their history have used mistletoes in folk 
medicine. The use of mistletoes for holiday affection is only a minor example of the various 
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ways in which they have been used throughout history and in different regions. In the last 
century, awareness of the medical potential of mistletoe has resurged as its efficacy in treating 
cancers has been investigated (Evans, 2005). It is seen in folklore medicine as a panacea and 
has been used in various forms to treat cancers, infertility, menopausal symptoms, epilepsy, 
smallpox, ulcer, nervous tension, asthma, headache, hypertension and dermatitis etc (Ameer et 
al., 2015; Zainuddin and Sul’ain, 2015; Dibong et al., 2009). 
According to Adesina et al. (2013), the ethnomedicinal applications of mistletoes had for a long 
time been in the hands of very few herbal practitioners. They claimed it is used to counter 
sorcery and has magical powers to treat mental disorders, urogenital problems, sterility and 
rheumatism related pains. Presently in Europe, mistletoe is mostly used for the treatment and 
management of cancer, physical and mental conditions. It is either used alone or in combination 
with other drugs or medication for cancer therapy. Some HIV/AIDS Non-Governmental 
Organisations have reported that mistletoe therapy restores immune systems (National Cancer 
Institute, 2016; Ogunmefun et al., 2015a and b). In Germany, mistletoe extracts are used for 
traditional oncology therapy. It has also found application for the treatment of skin diseases and 
prostate cancer in the Palestine traditional medicine system (Ogunmefun et al., 2015b). 
Ken’ichi et al. (2006) reported that species of Loranthaceae made into tea were believed to heal 
bone fractures and body pains. In Southwestern Ethiopia, leaves of Tapinanthus globiferous is 
mixed with cold water and taken orally for the treatment of “Tanachaa” (tumor) (Yineger and 
Yewhalaw, 2007); in Cameroon, the fresh leaves are macerated with an equal amount of the 
root bark of Boswella odorata in 5L of local beer and a glassful taken two times a day for about 
2 weeks for the treatment of syphilis (Noumi and Eloumou, 2011). The fresh twigs of 
Tapinanthus globiferus also called “Hadhal” in Saudi Arabia has been used in all kinds of 
livestock to treat their fever and also to remove their placentals after parturition (Adesina et al., 
2013; Sher and Alyemeni, 2011). 
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In South Africa, Viscum capensis is sold as a “Cape Mistletoe Tea” for the treatment of asthma, 
bronchitis and irregular menstruation (Afrinatural Holdings, 2012) and the Woodrose formed 
from the association of the mistletoe in the genera, Erianthemum and Pedistylis (Loranthaceae) 
are detached, polished and sold as curios (Mathiasen et al., 2008). In Nigeria, Loranthus 
micranthus has been widely used as ethnomedicine for the treatment of hypertension, diabetes, 
schizophrenia and as an immune system booster (Osadebe and Omeje, 2009). The National 
Health Product Services (NAHEPS) Limited in southern Nigeria has produced a tea from 
mistletoe which is sold as “NAHEPS Tea”; it is believed that this tea promotes good health by 
enhancing the body natural immune system (Adesina et al., 2013). Some of these 
ethnomedicinal uses have already been supported and acclaimed by several investigations 
(Osadebe and Omeje, 2009; Griggs, 1991; Nwude and Ibrahim, 1980). 
Different products of mistletoe with the trade names; Helixor, Iscador, Eurixor, Isorel, Iscucin, 
Plenosol and abnoba VISCUM have been sold across the European market for the treatment of 
infertility, epilepsy, hypertension and arthritis (National Cancer Institute, 2016; Adesina et al., 
2013; Kienle and Kiene, 2007).  
Studies have demonstrated that composition and biological activities of mistletoe are dependent 
on harvesting period, host tree species (National Cancer Institute, 2016; Adesina et al., 2013; 
Scheer et al., 1992) and geographical locations. Leaves of a particular mistletoe are usually 
prepared alone as medicaments but at some instances, leaves of a particular mistletoe 
differentiated by their host are prepared together as a mixture. This is because the bioactivity of 
mistletoe is chiefly dependent on the host species as certain host species confer some activities 
on the mistletoe for the cure of a particular ailment than others (Ogunmefun et al., 2015a; 
Adesina et al., 2013; Burkill, 1985). 
 10 
 
Ecology of mistletoe 
Mistletoe is often considered a pest that kills trees and devalues natural habitats, but recently, it 
has been recognised as an ecological keystone species; an organism with a disproportionately 
pervasive influence over its community (Wikipedia, 2015; Watson, 2001). A broad array of 
animals, insects and even fungi depends on mistletoe for food; consuming the leaves, young 
shoots, flowers and fruits. This interaction helps in transferring pollen between host plants and 
also helps in dispersing the sticky seeds of the mistletoe (Wikipedia, 2015) 
A study of mistletoe in junipers concluded that more juniper berries sprout in stands where 
mistletoe is present, as the mistletoe attracts berry-eating birds that also feed on juniper berries 
(Milius, 2002). The dense evergreen “witches' brooms” formed by the dwarf 
mistletoes (Arceuthobium species) of western North America is an excellent habitat for roosting 
and nesting of the northern spotted owl and the marbled murrelet (Wikipedia, 2015). In 
Colorado, a pine forest with mistletoe had a greater diversity of bird species and a high 
population of elk and deer than pine forests without mistletoe stands (Bennetts et al., 1996). 
Such interactions lead to dramatic influences on diversity, as areas with greater mistletoe 
densities support higher diversities of animals. March and Watson (2007) reported the ability of 
mistletoe to replenish the host and the surrounding organisms with nutrients through litterfall. 
The report is based on the fact that mistletoe litter contains a high proportion of many elements 
most especially phosphorus and potassium.  Thus, rather than being a pest, mistletoe can have a 
positive effect on biodiversity, providing high-quality food and habitat for a broad range of 
animals in forests and woodlands worldwide. Also, their vast network of interactions with other 
organisms can be utilised as sensitive indicators of community structure integrity and 
ecosystem health (Wikipedia, 2015; Mathiasen et al., 2008). 
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The African mistletoe — Loranthaceae 
Loranthaceae and Viscaceae are the major families of the mistletoe. Both families were initially 
classified as subfamilies of Loranthaceae but are now considered to have originated separately. 
Loranthaceae is monophyletic and by far the widest distributed family in the Order, Santalales. 
They are widely distributed from the tropics to the temperate regions (Nickrent, 2011; 
Mathiasen et al., 2008; Polhill and Wiens, 1999) excluding the extremely cold zones.  
Most African mistletoe belongs to the Loranthaceae family. Seven genera of the Loranthaceae: 
Helixanthera, Berhautia, Englerina, Globimetula, Agelanthus, Tapinanthus and 
Phragmanthera are recognised in Western Africa (Adesina et al., 2013; Burkill, 1985). These 
genera are hemiparasitic on a wide variety of economic, cultivated and non-cultivated shrub or 
trees which include; Vitellaria paradoxa, Azadirachta indica, Theobroma cacao, (Adesina et 
al., 2013), Kola acuminata, Baphia nitida, Persia americana, Irvingia gabonensis, Citrus 
simensis, Pentacletrama crophylla, Treculiarafricana, Ficus exasperata (Osadebe et al., 2012; 
Ali et al., 2005), Accacia karroo, Ziziphus mucronata, Ehretia rigida (Okubamicheal et al., 
2001; Dean et al., 1994) and Hevea brasiliensis etc (Begho et al., 2007). 
Phytochemistry of some African Loranthaceae 
Extensive phytochemical evaluations of Loranthus micranthus extracts demonstrated the 
presence of various phytoconstituents and compounds. Crude leaf methanolic extract of L. 
micranthus harvested from P. americana was found to possess terpenoids, steroids, oils, 
proteins, resins, flavonoids, tannins, saponins, alkaloids, reducing sugar, acidic compounds, 
glycosides and carbohydrates (Osadebe et al., 2010). Lohézic-Le et al. (2002), study on L. 
ferrugineus as cited by Ameer et al. (2015), revealed the presence of flavonoids and a high 
amount of condensed tannins. The study also reported the isolation of three natural flavonol 
compounds from the ethyl acetate fraction in addition to the isolation of a flavonol glycoside, 
4”-O-acetylquercitrin. 
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Iwalokun et al. (2011) investigated the phytochemicals of n-butanol, chloroform, ethyl acetate, 
and water fractions of the methanolic extract of L. micranthus leaves of Kolanut tree (K. 
acuminata). Moderate and high levels of steroids and terpenoids were detected in the n-butanol 
fraction, while a moderate level of phenols and tannins were reported in the chloroform 
fraction. Reducing sugars and tannins were detected in all the fractions they studied. Flavonoids 
and saponins were only present in the ethyl acetate and water fractions respectively. They 
reported that terpenoids were present in low to moderate levels in the chloroform and water 
fractions, while they were not detected in the ethyl acetate fraction. Phytochemical studies of L. 
micranthus leaves harvested from six different host trees: P. americana, K. acuminate, B. 
nitida, P. macrophylla, A. indica and I. gabonensis, revealed that alkaloids are more in the 
extracts of K. acuminata, P. americana, and I. gabonensis. 
The effect of seasonal variation on the phytoconstituents of the African mistletoe, L. micranthus 
was evident in a study on the petroleum ether leaf extract of L. micranthus parasitic on P. 
americana harvested in January, April, July, and November. The results showed the presence of 
alkaloids only in the April and July extracts (Osadebe et al., 2007). In Africa, pharmacological 
investigation of mistletoe is very scanty as most of the attention is channelled on crop 
protection: how to reduce the devastating effect of mistletoe on the host (Dibong et al., 2009) 
and its possible eradication from existence if possible. 
Phragmanthera capitata (Sprengel) Balle 
The genus, Phragmanthera, comprises 33 species (http://www.theplantlist.org/browse/A/ 
Loranthaceae/Phragmanthera/) which include Phragmanthera capitata (Sprengel) Balle. It 
belongs to the Kingdom: Plantae (plants); Subkingdom: Tracheobionta (vascular plants); 
Superdivision: Spermatophyta (seed plants); Division: Magnoliophyta (flowering plants); Class: 
Magnoliopsida (Dicotyledons); Subclass: Rosidae; Order: Santalales; Family: Loranthaceae; 
Genus: Phragmanthera Tiegh.; Species: Phragmanthera capitata.  
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Phragmanthera capitata is a woody aerial hemiparasitic shrub of about 2 m long. The leaves 
are entire, short-stalked and opposite with pack of yellow corolla with reddish-pink tips that 
look like a matchstick. The berries are green when young and red when ripe (Figure 1). It is 
found in secondary jungles and bush savannas in the tropical regions of Africa. These regions 
include; South Tropical  Africa of Angola, through the West Tropical Regions of Benin, Cote 
D'Ivoire, Ghana, Guinea, Liberia, Sierra Leone, Togo, Nigeria and the West-Central Tropical 
Regions of Burundi, Cameroon, Central African Republic, DR Congo, Equatorial Guinea, 
Gabon, Rwanda (Ogunmefun et al., 2013; Polhill and Wiens, 1999, 1998). It is parasitic on a 
number of hosts which include Theobroma cacao, Cola nida and acuminate, Irvingia 
gabonensis, Citrus maxima, Manikarazapota, Persia americana, Psidium guajava, Coffea spp 
and Heavea brasiliensis etc (Ogunmefun et al., 2015a and b, 2013; Adesina et al., 2013; 
Dibong et al., 2010, 2009; EngoneObiang et al., 2009). 
Figure 1: Phragmanthera capitata (Sprengel) Balle showing the leaves, inflorescence (flowers) 
and seeds. Pic by Franklin Ohikhena 
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Ethnomedicinal uses of Phragmanthera capitata 
A survey on the uses of P. capitata by Dibong et al. (2009) in Cameroon reported that the 
leaves prepared as an infusion or marc are used for the management and treatment of over 22 
diseases in the Logbessou region of North Douala. These ailments include; nerve attacks, 
convulsion, chronic muscular pains, diabetes, respiratory disorders, rheumatism, epilepsy, 
dizziness, uterine haemorrhage, hypertension, hypotension, back pains, kidney pains, 
menopause, headache, heart palpitation, general purifications, irregular menstruation and nose 
bleeding. Another ethnobotanical survey of P. capitata conducted in Nigeria also reported its 
usage for the treatment and management of insomnia, infertility, hypertension and diabetes etc. 
These surveys information were gathered from traditional and herbal practitioners in the 
countries sampled (Ogunmefun et al., 2015b, 2013). Some in-vitro and in-vivo works have be 
conducted to validate some of its ethnopharmacology uses. Ogunmefum et al. (2015a) reported 
the antimicrobial activity of P. capitata parasitic on Theobroma cacao and Cola nitida. Though 
antimicrobial activities were shown, they were very weak as the study reported minimal 
inhibitory concentration (MIC) values of 100 mg/mL to 200 mg/mL. The work also showed 
that host plants play significant roles in the phytoconstituents and/or activities of P. capitata.  
The leaves of P. capitata have been reported to reduce the levels of plasma inorganic 
phosphatase, haemoglobin, muscle glycogen and blood sugar (Fasanu and Oyedapo, 2008). 
Takem et al. (2014) reported the anti-secretory, gastroprotective and anti-ulcer activities of 
aqueous extract of P. capitata harvested from Avocado in albino rats. As with most mistletoe, 
distinction in biological activities of a specific species is made between host plants and not 
always necessary between the mistletoe. Hence, the host species and even locations are very 
important in the investigation of the ethnopharmacological activities of P. capitata. 
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Rubber tree (Hevea brasiliensis Muell) and Phragmanthera capitata 
Rubber tree (Hevea brasiliensis Muell. Arg.) (Figure 2) that is grown primarily for its latex 
(milky colloidal aqueous dispersion of rubber particles), is the world’s major source of natural 
rubber. In Gabon, it was first introduced during the World War II to supply rubber for the 
Allied countries during the war. Its production stopped immediately after the war and was 
reintroduced in the 1980s to help diversify the Gabon economy which was over-reliant on crude 
oil (EngoneObiang et al., 2009). The plant was introduced into Nigeria in 1895 and is now 
widely cultivated on more than 200,000 ha of land in the rain forest belt in the South of the 
country, with smallholders accounting for over 70% of the planted area (Shaib et al., 1997). In 
Nigeria, natural rubber is a major non-oil, agricultural export commodity (Esekhade et al., 
2003). However, the rubber tree now cultivated in most tropical nations of the world is 
susceptible to various specific parasitic plants belonging to the Loranthaceae family. For 
example, in China by Taxillus chinensis and Dendrophthoe pentandra (Zhiwei et al., 1995) and 
in most African plantations like Cameroon (Dibong et al., 2010), Gabon (EngoneObiang et al., 
2009) and Nigeria (Akinlabi et al., 2005; Gill and Oyinbe, 1990) by Phragmanthera capitata 
(EngoneObiang et al., 2009). 
 
 
 
 
 
 
Figure 2: (A) Rubber plantation showing healthy and (B) infected with P. capitata stands.  
Pic by Franklin Ohikhena 
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Begho et al. (2007) reported that the species of mistletoe observed on rubber trees in Nigeria 
were the yellow-flowered Phragmanthera capitata (present in all plots examined) and 
Agelanthus brunneus (which was scarcely seen). They also reported Phragmanthera as the only 
phanerogamic parasite on rubber trees in Rubber Research Institute of Nigeria plantations. In 
the reports of EngoneObiang et al. (2009), data collected in the area of Mitzic, Gabon, in the 
industrial and smallholding plantations of rubber trees, showed Loranthaceae were very 
common and that among them, Phragmanthera capitata was by far the most widespread (95%). 
Studies carried out by various researchers on rubber plantations infected with mistletoe in 
Rubber Research Institute of Nigeria, Iyanomo, revealed that there is no significant effect on 
the quality of natural rubber latex from such mistletoe-infected trees. The report also went 
further to recommend that lattices from mistletoe-infected trees should not be commercially 
inferior to latex from uninfected trees (Akinlabi et al., 2005). In other studies, some plantations 
with severe mistletoe infestation gave higher latex yield by volume of latex (cm
3
) and dry 
weight (g) of cup lump (Ogbebor et al., 2007). The findings of EngoneObiang and Salle (2006), 
suggested that there is no need for the eradication of P. capitata parasitizing rubber trees as 
there was no statistical difference in the latex yield and that the parasite most often times 
parasitizes the larger trees which can accommodate it.  
Justification for this research work 
Generally, mistletoe is seen as notorious, noxious and a devastating parasite in 
gardens/plantations which poses serious loss to economically valuable tree crops like cocoa,  
kola nut, coffee, rubber tree and some medicinal plants whether growing in the wild forests, 
gardens or orchards etc (Adesina et al., 2013). They tend to reduce the value of the cultivated 
plants in amounts more than the thresholds the host can accommodate by drawing water and 
nutrients from them. Hence, the first action that comes to mind is to eradicate them as soon as 
they appear. 
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In Nigeria and other rubber growing nations of Africa and the world in general with the 
mistletoe scourge, expensive, laborious and time-consuming programmes are been used and 
sort after for its eradication without any consideration to the other benefits it may possibly 
confer. The known method of removing mistletoe from host trees is by pruning (cutting off 
completely) the infected part(s) (Dibong et al., 2010) thereby losing important physiological 
host plant parts in the process. This practice could lead to low biomass accumulation by the host 
and create an avenue for the introduction of other pests and diseases. If this trend of destroying 
mistletoe continues, there is the chance of losing the function(s) they play in our ecosystem. 
This could also lead to their extinction as already evident in the report of the International 
Union for the Conservation of Nature (IUCN) that some species of both Loranthaceae and 
Viscaceae are on the RED LIST of Threatened Species and calling for conservation (IUCN, 
2015). 
This study is born from the premise that although P. capitata is a hemiparasite of rubber 
plantation and other economic crops, it could also serve other purposes: it is believed that when 
the host leaves falls during the drier seasons, mistletoe could act as a photosynthetic organ 
providing some nutrition to the host (Mathiasen et al., 2008). Also, when rubber tree is treated 
with ethephon and other chemicals to stimulate latex production, the presence of P. capitata 
could steadily improve the rubber tree metabolism to increase latex yield (EngoneObiang and 
Salle, 2006).  It also can play an ecologically important association with rubber trees; aiding 
pollination when birds that feed on the berries help in transferring pollens from one flower to 
another or within flowers. It also has importance in cultural and traditional medicine. Hence, if 
these values can be channelled with well-documented proof of their phytotherapeutic 
importance, it can be used sustainably with proper harvesting from rubber trees. This will aid in 
maintaining a synergistic relationship with the host plants while providing its ecological, 
cultural and medicinal functions to man and the environment. In no doubt, this will serve in 
maintaining a threshold which the rubber tree can accommodate without much pronounced 
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negative effect(s). This study, therefore, tends to scientifically investigate the various medicinal 
values of P. capitata harvested from rubber trees as no attention has been given to this aspect 
other than its negative effects on rubber plantations.  
Overall aim of the study 
The aim of this study was to evaluate, validate and document the pharmacological importance 
of Phragmanthera capitata that is parasitic on rubber trees and how these values could be used 
as an alternate source of medicine.  
Specific objectives of this study 
1. To quantitatively evaluate the phytochemical constituents and to screen for the free radical 
scavenging/antioxidant potentials of the mistletoe. 
2. To evaluate the nutritive and mineral value(s) of the mistletoe. 
3. To extract and identify the compounds in the essential oils of the mistletoe using GCMS. 
4. To investigate the possible toxicity of the mistletoe using Brine Shrimp. 
5. To evaluate the antibacterial and antifungal potentials of the mistletoe. 
6. To screen for the anti-Mycobacterium tuberculosis potential of the mistletoe in the fight 
against tuberculosis. 
7. To investigate the anti-diabetic properties of the mistletoe 
 
Structure of the thesis 
This thesis is composed of discrete chapters that have been published, accepted or under review 
or prepared for manuscript in different peer-reviewed accredited journals.  
Chapter 1 is the introduction and literature review which also outlines the aim and objectives of 
the study. It highlights the uses of plants as herbal medicine, a review of mistletoe, its 
importance and uses in Africa. The specific mistletoe of concern, Phragmanthera capitata and 
its host, Hevea brasiliensis (Rubber tree), were discussed and how the study was born. Chapter 
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2 is an evaluation of the quantitative phytochemical and antioxidant activities of the mistletoe. 
The ability of an extract to scavenge free radicals is a determinant of the phytochemicals and 
the quantity present. Evaluation of the phytochemicals and antioxidant potentials of P. capitata 
gives an indication of its ethnomedicinal values. The effects of different solvents were screened 
to find out which solvent is best for the extraction of the phytochemicals and their 
corresponding antioxidant potentials. Chapter 3 is an evaluation of the proximate, mineral and 
anti-nutrient of P. capitata. Highly nutritious diets could boost the immune system in fighting 
and warding off sicknesses and diseases. Hence, this chapter evaluated these parameters in 
relation to medicinal significance. Chapter 4 attempts to look at the chemical profiles of the 
essential oil from the plant. Chapter 5 is a preliminary toxicity assessment of P. capitata. 
According to the WHO specification for medicinal plants, it must be potent against the target 
disease and should not be toxic. Toxicity may be due in part the amount consumed and the 
presence of toxic bio-compounds in the plants. Toxicity information may give an insight into 
the required ingestion dosage while taking note of the effective therapeutic concentration(s). 
There had been reports of toxicity associated with mistletoe most especially the berries. Hence, 
there is a need for this species to be screened for its possible toxicity. Chapter 6 is an evaluation 
of the potential antifungal and antibacterial activities of the plant against some human 
pathogenic organisms. Mistletoe is known as a panacea and therapeutic against all kinds of 
human pathogenic diseases. Chapter 7 is the evaluation of the plant extracts as a possible anti-
mycobacterial agent. Chapter 8 is an in-vitro anti-diabetic evaluation of the sample with 
emphasis on the inhibition of both α- amylase and α- glucosidase inhibition as possible 
mechanisms of action. This is with an attempt to validate one of the ethnopharmacological uses 
of mistletoe. Chapter 9 is the General discussion and conclusion of the study. 
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Background of the study 
Phytochemicals are naturally occurring and biologically active plant compounds that have 
potential disease inhibiting capabilities. These phytochemicals are believed to combat diseases 
due to their antioxidant effect (Afolabi et al., 2007). As a way of responding to environmental 
stress, many plants produce antioxidant compounds such as the polyphenolics. These 
antioxidants are phytochemicals which absorb and neutralise free radicals, quenching singlet 
and triplet oxygen or inducing expression of peroxides and other toxic metabolites. Hence, 
antioxidants have protective ability from damages caused by free radical-induced stress as a 
result of oxidation (Iloki-Assanga et al., 2015). 
Plants are the major source of active chemical constituents against diseases. Most of the world’s 
population still relies on alternative medicines for the treatment of a large number of serious 
diseases (Hussain et al., 2014). Medicinal plants represent a lot of untapped reservoirs of drugs, 
and the structural diversity of their components makes a valuable source of novel compounds. 
Hence, there is a growing interest by natural product scientists in the utilisation of 
phytochemicals and are intensifying efforts towards the evaluation of these valuable medicinal 
plants. 
One of the different families of medicinal plants that have long been exploited in various herbal 
folklores is the Loranthaceae. It is one of the five families in the group of plants called 
“mistletoe”. Species of the Loranthaceae have been extensively used in alternative medicine for 
the treatment and management of several ailments/diseases (Ameer et al., 2015). Chemical and 
pharmacological studies of this family have identified several compounds such as; flavonoids, 
alkaloids, lectins, polypeptides, argenine, glycosides, gallic acid and Loranthin (newly 
identified flavocoumarin) (Ameer et al., 2015). 
Phragmanthera capitata (Sprengel) Balle which is a mistletoe in the Loranthaceae family has 
been used in herbal medicine in Africa. It is the major Loranthaceae species used by the 
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traditional healers in the Logbessou region in Cameroon. It has been used for the management 
and treatment of several ailments as described in the previous chapter (Dibong et al., 2009). 
In Africa, much attention in mistletoe research is in crop protection and little attention has been 
given to its potential role in ethnopharmacology. However, there is the need for scientific 
screening of the African mistletoe for its potential in therapeutics. Different solvents have been 
used in extracting and isolating bio-constituents in plants and the group of compounds extracted 
or isolated is highly solvent dependent (Iloki-Assanga et al., 2015). Prior to this study, no report 
on the quantitative phytochemical evaluation of P. capitata parasitic on rubber trees has been 
investigated. Hence, the aim of this study was to quantitatively examine the phytochemical 
constituents and their corresponding antioxidant activities of Phragmanthera capitata extracted 
with different solvents. 
Methodology 
Location and collection of the sample 
The leaves of Phragmanthera capitata were collected from mature rubber plantations in the 
Rubber Research Institute of Nigeria. The site is located on latitude 6
o 00’- 6o15’ N; longitude 
5
o30’- 5o45’ E and at about 27 m above sea level. The sample was authenticated by Dr 
Emmanuel I. Aigbokhan of the Plant Biology and Biotechnology Department, University of 
Benin, Nigeria. A voucher specimen (UBH10284) was deposited at the UNIBEN herbarium for 
future reference. 
Extraction procedure 
The leaves were removed from the twigs, gently rinsed to remove dust and dirt, air-dried at 
room temperature (mean morning and night temperature of 24
o
C and mean noon temperature of 
27
o
C) in a well-aerated atmosphere and prevented from direct sunlight to avoid denaturation of 
vital phytoconstituents. Dried leaves were pulverised. 300 g each of the ground sample was 
soaked in separate conical flasks with 1.2 L of the organic solvents which include acetone, 
 31 
 
methanol, ethanol and water and shaken in an orbital shaker (Orbital Incubator Shaker, 
Gallenkamp) for 24 hours. The crude extracts were filtered using a Buchner funnel and 
Whatman No. 1 filter paper. The acetone, methanol and ethanol extracts were further 
concentrated to dryness to remove the solvents under reduced pressure using a rotary evaporator 
(Strike 202 Steroglass, Italy) while the aqueous filtrate obtained was concentrated using a 
freeze dryer (Vir Tis benchtop K, Vir Tis Co., Gardiner, NY).  
Reagents and chemicals used 
Solvents and chemicals used include; Folin-Ciocalteu, anhydrous sodium carbonate (Na2CO3), 
Aluminium trichloride (AlCl3), Sodium nitrite (NaNO2), Sodium chloride, 2,2diphenyl-1-
picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), vanillin, 
aluminum chloride (AlCl3), potassium acetate (CH3CO2K), ferric chloride (FeCl2), BHT, 
ascorbic acid, rutin, n-butanol, diethyl ether, ammonia solution, acetone, methanol, ethanol, 
hydrochloric acid, sodium hydroxide, phosphate buffer, potassium ferricyanide [K3Fe(CN)6], 
ammonium molybdate, sodium phosphate, trichloroacetic acid (TCA), glacial acetic acid 
(CH3COOH), sodium nitroprusside (Na2[Fe(CN)5NO]2H2O). These chemicals were purchased 
from Merck and Sigma-Aldrich, Gauteng, South Africa. All the chemicals used in this study 
were of analytical grade. 
In-vitro quantitative phytochemical evaluation 
Phenolic acid determination 
Phenol determination was estimated spectrophotometrically using the Folin-Ciocalteu’s method 
as described by Samatha et al. (2012) with some modifications. 0.5 mL of the plant extracts (1 
mg/mL), standard gallic acid (0.02mg/ mL to 0.1 mg/mL) and the solvent of dissolution 
(control) was pipetted in different test tubes. To this, 2.5 mL of 10% (v/v) Folin-Ciocalteu’s 
reagent was added and the mixture was vortexed. The reaction was allowed to stand at room 
temperature for about 5 mins. After 5 mins, 2 mL of 7.5% (w/v) anhydrous sodium carbonate 
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was added to the solution, vortexed and incubated at 40
o
C for 30 mins. The control solution was 
used as a blank. After incubation, the absorbance was measured at 765 nm using a UV- 3000 
PC spectrophotometer. The experiment was done in triplicate. The phenol content was 
extrapolated from the gallic acid standard/calibration graph equation; y = 8.07 x + 0.1, R
2 
0.9981, and was expressed as mg gallic acid equivalent (GAE)/g from the equation CV/m; 
where “C” is the concentration as derived from the calibration curve equation in mg/mL, “V” is 
the volume of the extract used in the assay in mL and “m” is the mass of the extract used in the 
assay in “g”.  
Flavonoid determination 
The Aluminium chloride colorimetric assay was used to determine the flavonoid content 
according to the method described by Kamtekar et al. (2014) with little modification. This 
method is based on the quantification of the yellow-orange colour produced by the interaction 
of flavonoid with AlCl3. Briefly, 0.5 mL (1 mg/mL) aliquots of the solvent fractions, different 
concentrations (0.2 to 1 mg/mL) of quercetin standard and the solvent of dissolution were 
placed in different test tubes. 2 mL of distilled water was added to the test tubes after which, 
0.15 mL of 5% sodium nitrite was also added to the mixture. The mixture was allowed to stand 
for 6 mins. After 6 mins, 0.15 mL of 10% AlCl3 was added to the solution, allowed to stand for 
5 mins followed by the addition of 1mL of 1 M sodium hydroxide. The solution was made up to 
5 mL with distilled water and measured using a spectrometer at 420 nm. The control solution 
was used as a blank. The experiment was done in triplicate. The flavonoid content was 
calculated using the calibration curve equation, y = 1.064x, R² = 0.9976 and expressed as mg of 
quercetin equivalent (QE)/g using the formula CV/m in the same manner as described in the 
phenolics assay above. 
Proanthocyanidin (Condensed Tannin) determination 
Total proanthocyanidin was determined based on the procedure of Oyedemi et al., (2010). To 
0.5 mL of 1 mg/mL of the extract solution, different concentrations (0.02 mg/mL to 1 mg/mL) 
 33 
 
of the standard catechin and the solvent of dissolution (control), was added 3 mL of vanillin-
methanol (4% w/v) and 1.5 mL of hydrochloric acid and vortexed. The mixture was allowed to 
stand for 15 min at room temperature. The control was used as a blank. The absorbance was 
measured at  500 nm using a UV- 3000 PC spectrophotometer. The experiment was done in 
triplicate. Proanthocyanidin content was evaluated using the calibration curve equation: y = 
0.9038 x + 0.0449, R
2 
0.9951 and was expressed as mg catechin equivalent (CE)/g using the 
formula, CV/m as earlier mentioned in phenol determination. 
In- Vitro anti-oxidant analyses 
The antioxidant activities of P. capitata were determined using DPPH, ABTS, reducing power, 
nitric oxide and phosphomolybdate (Total antioxidant capacity) assays. 
DPPH (2, 2-diphenyl-1-picrylhydrazyl) radical scavenging activity assay  
The method of Kibiti and Afolayan (2015) was used for the determination of DPPH free radical 
scavenging activity. Briefly, a solution of 0.135 mM DPPH radical in methanol was prepared. 
A 1 mL of this solution was mixed with 1 mL (5 µg/mL to 80 µg/mL) each of the plant 
fractions/standard drugs (BHT, vitamin C). The reaction mixture was then vortexed thoroughly 
and left in the dark at room temperature for 30 min. The absorbance of the mixture was 
measured spectrophotometrically at 517 nm. The actual decrease in absorbance was measured 
against that of the control. The scavenging ability of the plant extract was then calculated using 
the equation:  
DPPH Scavenging activity (%) = [(Abs control – Abs sample)/ (Abs control)] ×100;  
Where; Abs control is the absorbance of DPPH + methanol; Abs sample is the absorbance of 
DPPH radical + sample/or standard. 
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ABTS (2, 2’-azino-bis (3-ethylbenzothiazoline)-6-sulfonic acid) radical scavenging activity 
The method described by Wintola and Afolayan (2011) was adopted for the determination of 
ABTS activity of the plant extract. The working solution was prepared by mixing two stock 
solutions of 7 mM ABTS and 2.45 mM potassium persulfate in equal amounts (1:1) and 
allowed to react for 12 to 18 h at room temperature in the dark to form a green-coloured ABTS 
radical (ABTS
+
). The resulting solution was further diluted by mixing 1 mL of the ABTS
+
 
solution with about 50 mL of methanol to obtain an absorbance of 0.700 ± 0.006 at 734 nm (the 
ABTS
+
 + methanol solution is adjusted by either adding the ABTS
+
 if the absorbance were 
lower or adding methanol if the absorbance were higher than the stipulated unit). After 
obtaining the desired absorbance, 1 mL of the resultant solution is then mixed with 1 mL of the 
plant extract/or standard drugs of different concentrations (5 µg/mL to 80 µg/mL). After 7 min, 
the reduction in absorbance was measured at 734 nm using a spectrophotometer. The 
percentage inhibition of ABTS
+
 by the extract was calculated from the following equation:  
% inhibition = [(Abs control – Abs sample)] / (Abs control)] × 100. 
Ferric reducing power of the extracts 
The reducing power was evaluated according to the method described by Aiyegoro and Okoh 
(2010). The mixture containing 2.5 mL of 0.2 M phosphate buffer (pH 6.6) and 2.5 mL 1% 
potassium hexacyanoferrate [K3Fe(CN)6] (w/v) was added to 1.0 mL of the extracts and 
standards (25 µg/mL to 400 µg/mL). The resulting mixture was incubated for 20 min at 50°C, 
followed by the addition of 2.5 mL of 10% Trichloroacetic acid (TCA) (w/v) to terminate the 
reaction. The mixture was centrifuged at 3000 rpm for 10 min. 2.5 ml of the supernatant was 
removed and mixed with 2.5 ml of distilled water and 0.5 ml of 0.1% freshly prepared ferric 
chloride, FeCl3, (w/v) was added. The mixture was allowed to stand for 10 min and the 
absorbance was measured at 700 nm. A mixture with distilled water instead of the sample 
served as the control. Increased absorbance of the reaction mixture indicated higher reducing 
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power of the plant fractions. The percentage inhibition of the sample and the standard drug was 
calculated using the formula: 
% inhibition = [(absorbance of sample – absorbance of control)/ (absorbance of sample)] × 100 
Nitric oxide scavenging activity 
A volume of 2 mL of 10 mM sodium nitroprusside prepared in 0.5 mM phosphate buffer saline 
(pH 7.4) was mixed with 0.5 ml of plant fractions, Vit C and BHT individually at 25 µg/mL to 
400 µg/mL. The mixture was incubated at 25°C for 150 min. 0.5 mL of the incubated solution 
was mixed with 0.5 mL of Griess reagent [1 mL sulfanilic acid reagent (0.33% prepared in 20% 
glacial acetic acid) with 1 mL of naphthalene diamine dichloride (0.1% w/v) at room 
temperature for 5 min]. The mixture was incubated at room temperature for 30 min, followed 
by the measurement of the absorbance at 540 nm. A solution containing water instead of the 
extract/standard was used as a control (Wintola and Afolayan, 2011). The amount of nitric 
oxide radicals inhibited by the extract was calculated using the following equation:  
NO radical scavenging activity (%) = [(Abs control – Abs sample)]/(Abs control)] × 100, where 
Abs control is the absorbance of NO radicals + methanol and Abs sample is the absorbance of 
NO radical + extract or standard. 
Total Antioxidant Capacity (TAC) (Phosphomolybdenum assay) 
The total antioxidant capacity of the plant fractions was determined by phosphomolybdenum 
method according to the protocol described by Olugbami et al., (2015). 0.3 mL of the different 
plant fractions and standard drugs (25 µg/mL to 400 µg/mL) were taken in test tubes and 
dissolved in 3 mL of reagent solution (0.6 M sulphuric acid, 4 mM ammonium molybdate and 
28 mM sodium phosphate). Then the test tubes were covered and incubated in a water bath at 
95°C for 95 min. The mixture was allowed to cool to room temperature and the absorbance was 
measured at 695 nm. A mixture containing distilled water instead of the samples served as 
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control. Ascorbic acid and gallic acid were used as standard drugs. A higher absorbance 
indicates higher total antioxidant potential. The percentage inhibition was calculated thus: 
[(absorbance of sample – absorbance of control)/ (absorbance of sample)] × 100 
All the experiments were carried out in triplicates. 
Statistical analysis 
All data were expressed as mean ± standard deviation (SD) of three replications. Statistical 
analysis was performed by ANOVA. Where the data showed significance (p < 0.05), a mean 
separation was done using the Fischer’s LSD with the aid of GENSTAT 8 statistical package. 
Results  
The resultant percentage yield after extraction with the various solvents were: 21.5% (64.5 g) 
for the methanol extract, 10.8% (32.5 g) for the aqueous extract, 6.87% (20.6 g) for the acetone 
extract and 4.3% (12.9 g) for the ethanol extract. 
Phytochemical evaluation 
Phenol content 
The results of the phenolic content were expressed in mg of gallic acid equivalent per gram (mg 
GAE/g). The acetone extract had the highest phenol content of 218.62 ± 3.38 mg GAE/g while 
the aqueous extract had the lowest amount (175.53 ± 0.32 mg GAE/g). The methanolic and 
ethanolic extracts were 203.78 ±1.95 mg GAE/g and 214.39 ± 4.09 mg GAE/g respectively. 
There was no significant difference between the acetone and ethanol extract (p > 0.05) (Figure 
1). 
Flavonoid content 
The flavonoid content of the crude extracts was determined with reference to the standard 
quercetin and expressed as its equivalent (mg QE/g). The result of the evaluation also showed 
the acetone fraction to be significantly higher (679.82 ± 6.26 mg QE/g) than the other solvent 
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fractions (p < 0.05). Ethanol, methanolic and aqueous fractions had values of 548.87 ± 4.10 mg 
QE/g, 407.90 ± 0.94 mg QE/g and 197.06 ± 3.80 mg QE/mg respectively. All the solvent 
fractions were significantly different from each other (p < 0.05) (Figure 1). 
Proanthocyanidin (condensed tannin) content 
The result of the proanthocyanidin was expressed as mg catechin equivalent per gram (mg 
CE/g). Acetone extract had a significantly higher amount (645.68 ± 6.35 mg CE/g) than the 
other solvent extracts (p < 0.05). The methanol, ethanol and aqueous extracts were 194.00 ± 
6.20 mg CE/g, 402.15 ± 7.55 mg CE/g and 128.83 ± 1.69 mg CE/g respectively. All the solvent 
fractions were significantly different from one another (p < 0.05) (Figure 1). 
 
Figure 1: Phytochemical content of the different solvent fractions of P. capitata in standard 
equivalents. Values are mean ± SD of three replications. Set of bars with different letters are 
significantly different (p < 0.05). 
In-vitro antioxidant compositions 
DPPH free radical scavenging assay 
The DPPH radical scavenging activity of the different solvent extracts in comparison to known 
antioxidants (Vit C and BHT) and their respective concentrations that scavenged 50% (IC50) of 
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the radicals are presented in Figure 2 and Table 1 respectively. The scavenging activity of all 
the solvent fractions and standard drug increased with increase in concentration. At 40 µg/mL, 
almost all the solvent fractions had over 50% inhibitory activity (64.54 ± 2.09% to 82.73 ± 
0.30%) on the DPPH radical except for the aqueous fraction with an activity of 27.59 ± 1.21% 
(Figure 2). The IC50 (the ability of the fractions to scavenge or inhibit 50% of the radicals) 
ranged from 24.5 µg/mL in the acetone fraction to 67.2 µg/mL in the aqueous extract. The 
decreasing scavenging activity of the extracts and the standard drugs based on the IC50 was in 
the order; Vit C > Acetone > Ethanol > Methanol > BHT > Aqueous (Table 1). 
 
Figure 2: DPPH radical scavenging activity of the different solvent fractions of P. capitata. 
Values are mean ± SD of three replications. Set of bars with different letters are significantly 
different (p < 0.05). 
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Table 1: IC50 values of the solvent fractions of P. capitata leaves and standard drugs 
 DPPH ABTS FRAP Nitric Oxide Phosphomolybdenum 
 IC50 
µg/mL 
R
2
 IC50 
µg/mL 
R
2
 IC50 
µg/mL 
R
2
 IC50 
µg/mL 
R
2
 IC50 
µg/mL 
R
2
 
Acetone 24.5 0.9928 1.9* 0.8972 318 0.9677 23* 0.9796 85 0.998 
Methanol 27.4 0.9585 5.7 0.9189 302 0.9748 1* 0.9773 124 0.974 
Ethanol 26.4 0.9594 1.9* 0.7373 308 0.9423 41.9 0.981 87 0.979 
Aqueous 67.2 0.9948 6.8 0.9551 374 0.9887 34 0.9727 144 0.994 
Vit C 18.2 0.928 22 0.959 89 0.9906 10* 0.9999 18* 0.959 
BHT 56 0.9661 4.6* 0.9966 NA 0.8942 27 0.9924 - - 
Gallic acid - - - - - - - - 2* 0.938 
 
IC50 is the concentration (µg/mL) required to scavenge/inhibit 50% of the radical, R
2
: coefficient of determination; values obtained from regression 
lines with 95% confidence level, NA: not active, asterisk (*): values are lower than the least concentration evaluated and dash (-): Values not 
determined. 
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ABTS radical scavenging assay 
There was also a concentration-dependent response in this assay. All the solvent extracts 
showed great ABTS radical scavenging activity at very low concentrations. At the lowest 
concentration (5 µg/mL), the acetone and ethanol extracts had inhibitory activity on the ABTS
+
 
of over 50% (63.18 ± 8.19% and 58.61 ± 1.80% respectively). At 10 µg/mL, all the solvent 
fractions and BHT had exceeded 60% scavenging activity. At 40 µg/mL, there was complete 
inhibition (100%) of all the solvent extracts and standard drugs (Figure 3). The IC50 values 
ranged from < 5 µg/mL in the acetone and ethanol fractions (1.9 µg/mL) and BHT (4.6 µg/mL), 
to 22 µg/mL in Vit C (Table 1). The order of decreasing scavenging activity of the extracts and 
the standard drugs based on the IC50 is in the order; Acetone ≥ Ethanol > BHT > Methanol > 
Aqueous > Vit C. 
 
Figure 3: ABTS radical scavenging activity of the different solvent fractions of P. capitata. 
Values are mean ± SD of three replications. Set of bars with different letters are significantly 
different (p < 0.05). 
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Ferric reducing antioxidant power assay (FRAP) 
The reducing power of the solvent extracts on ferric to ferrous gradually increased with increase 
in concentration. It was at the highest test concentration (400 µg/mL) that all the extracts had 
50% and above reducing power why vit C had 50% reducing power at 100 µg/mL and BHT 
was not active in this assay (Figure 4). The IC50 obtained for the solvent fractions and standard 
ranged from 89 µg/mL in Vit C to >> 400 µg/mL in BHT (Table 1). The increase in the 
reducing power activity of the solvent extracts and standard drugs as obtained from the IC50 is 
in the order; Vit C > Methanol > Ethanol > Acetone > Aqueous > BHT. 
 
Figure 4: Ferric reducing activity of the different solvent fractions of P. capitata. Values are 
mean ± SD of three replications. Set of bars with different letters are significantly different (p < 
0.05). 
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Nitric oxide scavenging assay 
The result of the nitric oxide scavenging activity of the different solvents showed that the 
acetone fraction had a scavenging activity which ranged from 46.41 ± 4.58% at the lowest 
concentration (25 µg/mL) to 73.15 ± 2.79% at 200 µg/mL. The methanol extract scavenging 
activity ranged from 64.99 ± 1.72% at the lowest concentration (25 µg/mL) to 75.26 ± 0.56% at 
200 µg/mL. The ethanol scavenging activity ranged from 49.07 ± 0.43% at the lowest (25 
µg/mL) concentration to 68.73 ± 3.95% at the highest concentration (400 µg/mL). Aqueous 
extract had an activity which ranged from 49.07 ± 2.56% at 25 µg/mL to 68.02 ± 4.32% at 400 
µg/mL. The standard drugs, however, had their highest activities at 50 µg/mL (67.91 ± 2.97%) 
for Vit C and 100 µg/mL (60.292 ± 5.27%) for BHT (Figure 5). The scavenging activity as 
recorded from the IC50 values is in the order; Methanol > Vit C > Acetone > BHT > Aqueous > 
Ethanol (Table 1). 
Figure 5: Nitric oxide scavenging activity of the different solvent fractions of P. capitata. 
Values are mean ± SD of three replications. Set of bars with different letters are significantly 
different (p < 0.05). 
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Total antioxidant capacity (TAC) 
The total antioxidant capacity of P. capitata was measured by phosphomolybdenum method. 
The antioxidant capacity of all the solvent fractions increased with an increase in concentration. 
The acetone fraction ranged from 26.48 ± 2.12% at 25 µg/mL to 78.64 ± 0.77% at 400 µg/mL; 
methenaol extract fraction had a TAC from 19.66 ± 5.82% at 0.025 mg/mL to 75.49 ± 0.79% at 
0.4 mg/mL; ethanol extract TAC was from 30.07 ± 2.47% at 25 µg/mL to 78.46 ± 0.12% at 400 
µg/mL and the aqueous extract TAC ranged from 12.27 ± 5.05% at 25 µg/mL to 70.30 ± 0.60% 
at 400 µg/mL (Figure 6). The IC50 of the solvent fractions and the standard drugs in the order of 
decreasing TAC are; Gallic acid > Vit C > Acetone > Ethanol > Methanol > Aqueous (Table 1). 
 
 
 
Figure 6: Total Antioxidant capacity (TAC) of the different solvent fractions of P. capitata. 
Values are mean ± SD of three replications. Set of bars with different letters are significantly 
different (p < 0.05). 
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The relationship between the phytochemical contents and the IC50 of the antioxidant activities is 
as shown in Figure 7(A-E). The phenol contents had a high linear correlation of R
2
 = 0.9228 
and 0.8658 based on DPPH and TAC assays respectively. Flavonoid also had a high linear 
correlation with TAC (R
2
 = 0.9228) but with DPPH, it showed a high power correlation of R
2
 = 
0.9098. Proanthocyanidin content also had a high exponential correlation of R
2
 = 0.9405 with 
TAC assay. 
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Figure 7: Correlation of the polyphenolic compounds against the IC50 of the antioxidant.  
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Discussion  
Phenols have been recorded to exhibit great antioxidant activities and this has been attributed to 
the presence of the hydrogen group which acts as a hydrogen donor. Consequently, as a result 
of their redox property, they function as a reducing agent and act as radical scavengers (Wintola 
and Afolayan, 2011). The values of the phenol content in this study were evaluated based on the 
amount of Gallic Acid Equivalent (GAE) per gram in the sample. The values of the phenolic 
content obtained confirmed that the solvents had different abilities in extracting the phenols 
from the sample. The acetone fraction, though not significantly different from the ethanol 
fraction (p < 0.05), extracted higher levels of the phenols in P. capitata at the same amount of 
evaluation. It should be noted that phenolic compounds are often associated with diverse 
biomolecules (polysaccharides, proteins, terpenes, chlorophyll, inorganic compounds) and 
therefore, a solvent suitable for the extraction of a particular class/group of compounds must be 
used based on the structural features and related level of solubility of a target molecule 
(Ghasemzadadeh et al., 2011). 
Like phenols, flavonoids are secondary metabolites with polyphenolic structure. They are also 
water soluble and have been reported to exhibit great antioxidant activities than vitamins C, E 
and carotenoids (Ghasemzadadeh and Ghasemzadadeh, 2011). The flavonoid was estimated 
using Quercetin as the reference. It was observed that the effect of the different solvents on the 
flavonoid content was similar to that of the phenol. The acetone fraction was significantly 
higher than the rest of the solvent extracts compared (p < 0.05) (Figure 1); hence, it forms the 
best solvent for the extraction of flavonoid from this P. capitata. However, water (aqueous) 
which is the cheapest solvent and readily available, had the lowest quantity of flavonoid in 
relation to quercetin equivalent. 
Condensed tannin also called proanthocyanidin, are a group of polyphenolic bioflavonoids 
(Wintola and Afolayan, 2011). They are ubiquitous and present as the second most abundant 
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natural phenolic after lignin. Proanthocyanidins are of great interest in nutrition and medicine 
because of their potent antioxidant capacity and possible protective effects on human health 
(Liwei et al., 2004). The result of this study showed that P. capitata is very rich in 
proanthocyanidin content in reference to catechin. Once again, the acetone extracts had a higher 
significant proanthocyanidin content than the other solvent extracts (p < 0.05) and hence a 
solvent of choice for the extraction of proanthocyanidins. 
Different in-vitro methods were also employed to examine the effects of the acetone, methanol, 
ethanol and aqueous on the antioxidant activities of the sample. DPPH radical scavenging 
model is widely employed to evaluate antioxidant activities of natural compounds and plant 
extracts. The degree of discolouration from purple to light yellow indicates the scavenging 
potential of the extract which is a result of the hydrogen donating ability. This assay is very 
sensitive and can detect active ingredients at very low concentrations (Quy Diem et al., 2014). 
The result of this experimentation revealed that all the solvent fractions had high DPPH 
scavenging activities even at very low concentrations (5 µg/mL to 80 µg/mL). IC50 which is the 
concentration of the extract required to scavenge 50% of the radical is an indicator which 
reflects the activity of an extract. The lower the IC50 value, the higher the scavenging activity of 
the extract. In this study, all the solvent fractions exhibited strong DPPH radical scavenging 
abilities. The IC50 values for the acetone (24.5 µg/mL), methanol (27.4 µg/mL) and ethanol 
fractions (26.4 µg/mL), were very close to the standard Vit C (18.2 µg/mL) and lower than 
BHT (56 µg/mL). This result is in conformity with the results of the phytochemical analysis 
with a positive correlation of the polyphenolics (phenol, flavonoid and proanthocyanidin) with 
DPPH and TAC. Solvent fractions with higher polyphenolics contents had lower IC50 values 
hence exhibited higher scavenging activity (Figure 7). 
The ability of the solvent fractions to scavenge the ABTS radical was also evaluated. ABTS 
reacts with persulphate to form a bluish-green colour. When the ABTS radical so formed reacts 
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with an H-donor, it decolourises. All the solvent fractions showed great scavenging activity on 
the ABTS radical at very low concentrations. The IC50 values of all the solvent fractions, which 
ranged from < 5 µg/mL to 6.8 µg/mL, were far lesser than the value for Vit C (22 µg/mL) 
(Table 1). In this study, it was observed that the acetone and the ethanol extract had an IC50 
lesser than the least concentration which indicates their greater effectiveness in scavenging 
ABTS radicals than the methanol and aqueous fractions. 
The ferric reducing power of the solvent fractions was determined by the direct electron 
donation in the reduction of ferric ion (Fe
3+
)
 
to ferrous ion (Fe
2+
). The presence of the different 
solvent fractions caused a reduction of the Fe
3+ 
complex
 
to Fe
2+
 and was monitored at 700 nm. 
The antioxidant activity on FRAP was much lower than DPPH and ABTS as much higher 
concentrations were required to achieve the desired IC50 values for all the solvent extracts and 
standards used. The trend on the effects on FRAP was not directly proportional to the results of 
the polyphenolic contents of the plant as observed in DPPH and ABTS. The methanol fraction 
in this assay, had the strongest FRAP (IC50 = 302 µg/mL) followed by the ethanol (IC50 = 308 
µg/mL), acetone (IC50 = 318 µg/mL) and aqueous (IC50 = 374 µg/mL) in that order (Table 1). 
During the nitric oxide assay, sodium nitroprusside decomposes in aqueous solution at 
physiological pH producing NO, making it an ideal assay to mimic the human body system in 
scavenging the free radical (Pacher et al., 2007). During this assay, nitrite is formed when NO 
generated from sodium nitroprusside reacts with oxygen. So, it can be deduced that the plant 
fractions inhibit nitrite formation by directly competing with oxygen and other nitrogen oxides 
such as NO (Boora et al., 2014). The IC50 values like in the FRAP, does not have a direct 
proportion to the polyphenolic compounds. The methanol fraction gave the best NO scavenging 
ability with an IC50 value lesser than the least concentration evaluated (< 25 µg/mL) (Table 1). 
The total antioxidant capacity (TAC) of the solvent fractions was determined based on the 
reduction of molybdenum (VI) to molybdenum (V) and the subsequent formation of a green 
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phosphate/molybdenum (V) complex at acidic pH. All the solvent fractions had a steady 
increase in TAC as the concentrations increased. At 100 µg/mL, the acetone and ethanol 
fractions had already reduced > 50% molybdenum (VI) to molybdenum (V). Based on the IC50, 
the standard drugs (Vit C and gallic acid) were more potent than the solvent fractions with 
values far lesser than the lowest concentration used for this assay. However, the effect of the 
different solvent showed acetone to be more potent with an IC50 value of 84 µg/mL followed by 
the ethanol fraction with a value of 87 µg/mL. Methanol and aqueous fractions showed lesser 
TAC values with IC50 values of 124 µg/mL and 144 µg/mL respectively. There was a positive 
correlation of the polyphenolic content with the IC50 values of TAC. 
Conclusion  
This study revealed the effect of different solvents on the extraction, phytochemical content and 
antioxidant activities of P. capitata harvested from rubber tree. From the result of this findings, 
if the work were just to extract components for preparatory work only without bioassay, 
methanol would be the solvent of choice as it gave better yield than the rest solvents. If the 
intention were for activity screening, acetone will be preferred as it had the highest polyphenols 
and antioxidant activities.  
Acetone has the ability to dissolve both hydrophilic and lipophilic compounds and is miscible 
with water, less volatile and a very useful extractant in bioassays. It is easy to handle at 
different stages of bioassays and preferred to methanol, ethanol and water even when more 
hydrophilic components are investigated. This is because acetone extracts highly polar 
components and a very useful extractant for dried plant materials (Eloff, 1998). 
The results of this experimentation showed that P. capitata has high amounts of polyphenolic 
compounds and in turn, exhibited great antioxidant activities in all the solvent fractions tested. 
This plant may have great importance in combating oxidative stresses and hence, expanding its 
application in health delivery is recommended.  
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Abstract
Background: Leaves of Phragmanthera capitata (Sprengel) Balle growing on rubber trees were evaluated in order to determine its
nutritional, anti-nutritional and mineral compositions. Materials and Methods: Proximate and anti-nutrient analyses were performed
using standard analytical methods while mineral contents were determined using Inductively Coupled Plasma-Optical Emission
Spectrometer (ICP-OES). Result: The result of the proximate analysis showed that carbohydrate was more with a composition of
57.73±0.33 g/100  g. Protein, fat and fibre compositions were 12.50±0.50, 3.34±0.18 and 11.66±0.54 g/100 g. The total energy
composition was 310.97±2.30  kcal/100  g. The mineral composition revealed that the leaves of the plant were very rich in basic minerals
with high potassium level of 1047.83±34 mg/100 g. Calcium (6.22.58±0.01 mg/100 g), magnesium (361.15±0.01 mg/100 g) and
phosphorous  (115.40±0.01 mg/100  g)  were  also present in appreciable amount. The anti-nutrients evaluated had appreciable amounts
in phytate  (0.15±0.23%),  oxalate  (2.99±0.61%), saponin (3.46±0.01%) and alkaloid (4.20±0.11%). Conclusion:  The study revealed
that Phragmanthera  capitata  could  serve as a source of essential nutrients which can go a long way in ameliorating most nutritional
challenges and may contribute remarkably to the amount of nutrients in human.
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INTRODUCTION
Phragmanthera capitata  (Sprengel) Balle is a mistletoe in
the Loranthaceae family. It is a woody parasitic shrub with
pendent branches of about 2 m long and has a yellow corolla
with  a  pink-red  tip  often  associated with ants’ nests. It
grows on trees in secondary jungles, plantations and bush
Savannah areas, from  Sierra  Leone  to Western Cameroons,
Fernando Po and extending across the Congo basin to Zaïre,
Nigeria, Gabon,  Ivory  Coast  and  Angola1.  As  with  most 
mistletoe, P. capitata is an obligate hemi-parasitic plant which
attaches to and penetrates the stems and branches of its host
tree or shrub by a structure called the haustorium, through
which it absorbs water and mineral nutrients, even though it
can produce its own food through photosynthesis2,3. They are
found parasitizing many economic important tree crops which
include shear butter, neem, cocoa, avocado, kola and rubber
to mention but a few4.
Mistletoes have been widely used in various cultures in
almost every continent to treat various ailments or as a
diuretic  agent5.  It  is  commonly  consumed   in   parts  of
West Africa for the treatment of hypertension, ulcers, epilepsy,
diabetes, weakness of vision and for promoting muscular
relaxation before delivery6. Some rural farmers use the leaves
as feed for their goats and other livestock that have newly
given birth to young ones7,8. In the ecosystem, mistletoe
attracts avian frugivores and other broad array of animals
depend on it for food, consuming the leaves and young
shoots therefore, providing high quality food for a wide range
of animals in forests and woodlands worldwide9.
It is worthwhile to note that consumption of numerous
types  of edible plants as sources of food could be beneficial
to nutritionally marginal population especially in developing
countries where poverty and climate is causing havoc to the
rural populace. In many countries, the supply of minerals is
inadequate to meet the mineral requirements of farm animals
and the growing human population. Minerals cannot be
synthesized by animals/humans and must be provided from
plants or mineral-rich water10 and hence, research is looking
inward to the use of non-conventional leafy plants as possible
sources of cheap nutritional supplement11.
The use of mistletoe in pharmaceuticals as drugs and
other  therapeutic  agents  for  the treatment of divers’ kinds
of ailments are well known. Their phyto-composition and
biological activities which are chiefly dependent on host
species4  are well reported and documented, hence it is widely
known as “cure all”12. Despite its vast medicinal usage, little or
no report is known about its nutritional values hence the aim
of  this study  was  to  determine  the  nutritional and mineral
compositions of P. capitata  that is growing on rubber trees
and also to providing scientific data based on our findings in
relation to its dietary/nutritional and medicinal application(s).
MATERIALS AND METHODS
Leaves of the mistletoe, P. capitata (Fig. 1, 2) were
collected from mature rubber plantations in Rubber Research
Institute of Nigeria, Iyanomo, located on latitude 6E00’-6E15’
N, longitude 5E30’-5E45’ E and on altitude 27 m a.s.l. in Benin
city, which lies on the wet lowland  rainforest  of  Edo State,
Nigeria. Leaves were removed from  the  twigs,  properly 
rinsed  and  air-dried  at room  temperature  (mean  morning 
and night temperature of 24EC and mean noon temperature
of 27EC)  in  a  well  aerated   atmosphere   and   prevented
from   direct    sunlight   to  avoid    denaturation   of    vital
phyto-constituents.  Dried leaves were pulverized  using  an 
electric  motor blender and kept in an air-tight glassware
container and stored at 4EC until when needed. The
pulverized sample was used for all the analyses  and  all  the
analyses were carried out in triplicate.
Nutritive  composition   analysis:   The   moisture  content
was determined  by  the  drying  method  and  ash  content by 
Fig. 1: Phragmanthera capitata (Sprengel) Balle growing on
rubber tree (Hevea brasiliensis  L.)
Fig. 2:  Leaves of Phragmanthera capitata (Sprengel) Balle
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incinerating in a muffle furnace at 550EC as described by
AgriLASA13. Dietary fibre was determined by acid/base
digestion as described by Aina et al.14. Crude fat was extracted
with ether, the nitrogen content of the plant was determined
using the method described by Bvenura and Afolayan15 by
means of the Inductively Coupled Plasma-Optical Emission
Spectrometer (ICP-OES). The value of nitrogen obtained was
multiplied by 6.25 to give the percentage of crude protein16.
The carbohydrate content was determined by weight
difference between 100 and the sum of the percentage of
protein, fat, ash, moisture and dietary fibre.
Energy  content:  The  kilocalorie  (kcal/100  g)  value
estimation  was  done  by  summing  the  multiplied values for
crude protein, crude lipid (excluding crude fibre) and
carbohydrate respectively at Atwater factors (4, 9 and 4 kcal)
as thus:
Energy value (kcal/100 g) = (Crude protein×4)+(Crude fat×9)+
(Total carbohydrate×4)
Anti-nutritive composition
Determination of oxalate content: The modified titration
method of Day and Underwood17 was used to determine the
oxalate content of the plant. One gram of the pulverized
sample was weighed into a conical flask. Seventy five milliliters
of 3 M H2SO4 was added and stirred with a magnetic stirrer for
an hour. This was filtered and 25 mL aliquot of the filtrate was
collected and warm to 80-90EC and kept above 70EC at all
times. The hot aliquot was titrated against 0.05 M of KMnO4
until  an  extremely   faint   pale   pink   colour   persisted  for
15-30 sec. The oxalate content was calculated by taking 1 mL
of 0.05 M of KMnO4 as equivalent to 2.2 mg oxalate.
Determination of phytic acid: Phytic acid was determined as
described by Damilola et al.18. Two grams of the sample was
weighed into a 250 mL conical flask. Hundred  milliliters of 2%
HCl was used to soak the sample for 3 h and then filtered
through What man No. 1 filter paper. Twenty five milliliters
aliquot of the filtrate was placed in a separate 250 mL conical
flask and 5 mL of 0.3% ammonium thiocyanate solution as
indicator. About 53.5 mL of distilled water was added to give
the  desired  acidity.  This  was  then  titrated with standard
iron III chloride solution which contains 0.00195 g iron mLG1
until a brownish yellow colour persisted for 5 min phytic acid
was calculated thus:
Phytic acid (%) = Titre value×0.00195×1.19×100
Determination of saponins: Saponin content was determined
as described by Obadoni and Ochuko19. Briefly, 20 g of the
pulverized plant sample was added to 200 mL of 20% ethanol
and kept on a shaker for 30 min and was then heated in a
water bath at 55EC for 4 h. The resulting mixture was filtered
and the residue re-extracted with another 200 mL of 20%
aqueous ethanol. The filtrate mixture was combined and
reduced to 40 mL in a water bath at 90EC. The concentrate
was transferred into a separatory funnel and 20 mL of diethyl
ether was added, shook vigorously. The ether layer which was
the upper layer was discarded and the aqueous (bottom) layer
retained in a beaker. The retained layer was re-introduced into
the saparatory funnel and 60 mL of n-butanol was added and
shook vigorously. The butanol extract which is the upper layer
was retained while the bottom layer was discarded. The
butanol layer was washed twice with 10 mL of 5% aqueous
sodium chloride.  The   remaining   solution   was  collected
and heated  in  a  water bath and evaporated to dryness to
constant weight at 40EC in an oven. The saponin content was
calculated using the equation:
Weight of residue 100
Weight of 
Saponi
origin
n co
al sa
ntent (%
mple
) = 
Determination of alkaloids: The alkaloid content was
determined  according  to  the  method  of  Omoruyig  et  al.20. 
Briefly, 5 g of plant extract was mixed with 200 mL of 10%
acetic acid in ethanol. The mixture was covered and allowed
to stand for 4 h. This was filtered and the filtrate was
concentrated on a water bath to one-fourth of its original
volume. Concentrated ammonium hydroxide was added in
drops to the extract until precipitation (cloudy fume) was
completed. The whole solution was allowed to settle, the
collected precipitates washed with dilute ammonium
hydroxide and then filtered. The residue collected was dried
and weighed. The alkaloid content was determined using this
equation:
Weight of precipitate 100
Weight of original s
Alkal
ample
oid (%)  
Macro and micro-minerals analysis
Digestion and mineral analysis: The method described by
Bvenura and Afolayan15 was used for the digestion of plant
material. Briefly, a digestion mixture comprising of selenium
powder, sulphuric acid and salicylic acid were prepared. About
0.3 g of  the  ground  plant  material  was  placed  in dry, clean
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digestion tubes. A volume of 2.5 mL of the digestion mixture
was added to each tube and allowed to react at room
temperature  for  2 h. The tubes were heated in a block
digester at 110EC for  60  min.  The  tubes  were allowed to
cool and three successive portions of 1 mL hydrogen peroxide
added at 10 sec intervals due to the volatility of the reaction.
The tubes were returned to the block digester at a
temperature of 330EC and were removed from the block
digester when the digest turned clear in colour. The tubes
were allowed to cool to room temperature, contents
transferred into  50  mL  volumetric  flasks  and  then deionized
water was added to attain volumes of 50 mL. Standards were
prepared for all the individual elements to be analyzed.
The macro-minerals (Calcium, magnesium, potassium,
sodium and phosphorus) and micro-minerals (Iron, zinc,
aluminum,  manganese  and  copper)   were  determined
using the Inductively Coupled Plasma-Optical Emission
Spectrometer (ICP-OES, Varian 710‒ES series, SMM
Instruments, Cape Town, South Africa)15. All analyses were
carried out in triplicates.
Statistical analysis of data: All experiments were done in
triplicates and the results expressed as Mean±SD using the
Microsoft excel 2010 spreadsheet.
RESULTS AND DISCUSSION
Proximate composition: Results of the proximate
composition of P. capitata leaves were shown in Table 1.
Parameters determined include; moisture content, total ash,
fat, dietary fibre, crude protein and carbohydrate. There was
relatively lower moisture content (7.36±0.70 g/100 g) in the
sample  which is comparable to values obtained in five
cowpea verities (6.80±0.22  to 9.10±0.41 g/100 g) as
reported by Owolabi et al.21. This low moisture level indicates
a longer shelf life because moisture content determines the
suitability of food products before consumption because it
affects the physical and chemical aspects of food which relates
to the freshness and stability for storage22.
The   ash    content   (7.41±0.07  g/100   g)  evaluated
from  this  sample   was   relatively  higher  than  all five
varieties  of cowpea (3.38±0.93  to  4.46±0.41 g/100 g),
Indian   spinach    (5.02   g/100     g),    Telfaira  occidentale
(8.54   g/100    g)    and   all    Cissus    populnea   stem 
(6.5±0.7-8.8±0.5 g/100 g) collected from  three   different
locations     as     reported by   Owolabi  et  al.21, Asaolu et al.10
and Adebowale et al.23, respectively. The ash content  of  the 
sample (7.41±0.07 g/100 g) was relatively high indicating its
richness   in   mineral  nutrients. Ash content is  a   measure   of
Table 1: Proximate composition of  Phragmanthera capitata (Sprengel) Balle
Parameters Composition (g/100 g dry weight)
Moisture content 7.36±0.07
Total ash 7.41±0.07
Crude fat 3.34±0.18
Crude fibre 11.66±0.54
Crude protein 12.50±0.50
Carbohydrates 57.73±0.33
Energy value (kcal/100 g) 310.97±2.30
Values are expressed as Mean±SD, n = 3
 the   total  amount of minerals present in the plant. These
minerals act as inorganic co-factors in metabolic processes
which means that without these inorganic co-factors, there
could be impaired metabolism24.
The   dietary   fibre   content   of   the   sample
(11.66±0.54   g/100  g)   is   higher   than   Indian   spinach
(6.05  g/100  g),   bush-buck   (4.02   g/100    g),   scent  leaf
(7.04 g/100 g),  Amaranthus hybidus (8.05 g/100 g) and
Telfaria occidentale (11.05 g/100 g) but slightly lower than
Vernonia  amygdalina   (Bitter leaf) and Hibiscus sabdariffa
with values of 12.08 and 12.04% respectively as reported by
Asaolu et al.10. The  dietary  fibre recorded in the sample is
lower   than   the  Recommended  Daily  Intake   (RDI)  for men
(31.00-38 g dayG1), females (25-26 g dayG1), pregnant women
(28 g dayG1) and lactating mothers (29 g dayG1)25. Nutritionally,
relatively  high  dietary  fibre  evaluated  in  the  sample is
beneficial because it provides the buck necessary for proper
peristaltic action and aids the absorption of trace elements in
the gut and reduces cholesterol absorption23,26.
3The   protein     content    in    the    sample   was
12.50±0.50  g/100  g  and it was the second highest
proximate   composition   of   the   sample.   Though  below
the Recommended  Dietary    Allowance    (RDA)    for   adult 
males   and  females (56 g dayG1)27, it is enough to provide
19.64% dayG1 if 100 g (dry weight) of the sample were
consumed. The protein content of the sample was quiet lower
than reported results for different leafy vegetables consumed
in Africa as reported by Asaolu et al.10 and also lower than the
five cowpea varieties (19.84±0.18-26.61±0.48 g/100 g) as
reported by Owolabi et al. 21 but was higher than Peperomia
pellucida (10.63±0.07 g/100 g) as reported by Ooi et al.28.
Nutritionally, protein is the major component of all cells in the
body and functions in growth, movement and body defense.
It also serves the purpose of enzymatic catalyst and mediates
metabolic and energy regulation25,29.
The result showed that the fat (lipid) content of the
sample was 3.34±0.18 g/100 g and it was the lowest
nutritional  composition  evaluated  in  this study indicating
the low level of fat in the sample which is far below the
recommended percentage calorie requirement for fat per day
which  ranges  from  20-35%  calories  (kcal/100  g).  An  active
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male   requiring    3,000   cal   per   day27   would   need  to
consume 600-1050 cal or 67-117 g of fat dayG1. This sample
could be a good choice for people requiring low fatty food
source.
Carbohydrate had the highest nutritional composition of
57.73±0.33 g/100 g. This value is comparable to the five
varieties of cowpea (56.24±0.51 to 63.30±0.33 g/100 g)
recorded by Owolabi et al.21 and higher than values obtained
for Peperomia pellucida  (46.58±2.74 g/100 g) and stem flour
of Cissus populnea (43.7±2.5 to 48.1±3.5 g/100 g) as
reported by  Ooi  et  al.28  and  Adebowale  et  al.23, 
respectively. The carbohydrate  content  of  the  sample 
(57.73±0.33 g/100 g) is  lower   than   the   DRI   for 
carbohydrate  (130 g dayG1) but can supplement  44.41%  of
the daily requirement for carbohydrate if 100 g were
consumed (Dietary relative intakes)25. Nutritionally, this sample
can provide readily accessible fuel, serve as source of energy
for the body, for physical   performance,   breathing, 
maintaining  body  temperature and for contraction and
relaxation of the heart muscles29, it can also help in breaking
down fatty acids and prevent ketosis, maintaining digestive
health and gives food good flavourings.
The  total  energy derived from this plant as calculated
was 310.97±2.30 kcal/100 g (Table 1) which is below the
recommended daily energy intake of 1,000 kcal for sedentary
children of ages 2-3 years and 1,000-1400 kcal dayG1 for active
children under the same age bracket, sedentary female adults
(19-30 years) would need about 2,000 kcal dayG1 and active
female adults of the same ages would require 2,400 kcal dayG1
to meet their daily intake. For sedentary men (19-30 years) and
active men (14-18 years), their energy requirement per day is
2,800-3,200 kcal, respectively25. The higher the energy value of
a food sample, the lesser the amount required to meet the
required energy intake. This plant on the whole is a good
energy source as all the required energy needed in human is
supplemented from various food products.
Mineral composition of P. capitata: Table 2  shows the result
of  the  mineral  composition of the sample. The results
showed that the sample is a good source of both macro and
micro minerals. The minerals evaluated are in the other;
K>Ca>Mg>P>Fe>Mn>Na>Zn>Cu.
The amount of  K (1047.83±0.01 mg/100  g) in the
sample  is   relatively   lower   than   the   Recommended
Dietary  Allowances  (RDA,  4700  mg  dayG1)  for  K  and also
lower than the values reported in Peperomia pellucida 
(6977±4.24 mg/100 g)28 and Cissus  populnea  stem 
(2679±13 mg/100 g)23 but higher than values recorded in
Cicer arietinum (870 mg/100 g)30, cowpea (15.67±1.17 to
18.69±0.29 mg/100 g)21, Indian spinach   (16.85   mg/100   g), 
Table 2: Mineral composition of Phragmanthera capitata  (Spreng.) Balle
Mineral elements Composition (mg/100 g)
Calcium (Ca) 622.58±0.01
Magnesium (Mg) 361.15±0.01
Potassium (K) 1047.83±0.03
Phosphorous (P) 115.40±0.01
Sodium (Na) 19.23±3.71
Zinc (Zn) 2.49±0.14
Copper (Cu) 1.81±0.07
Manganese (Mn) 27.57±0.60
Iron (Fe) 105.15±8.11
Values are expressed as Mean±SD, n = 3
bitter   leaf   (73.25  mg/100  g), scent  leaf   (86.24  mg/100  g) 
and  Telfaria  occidentalis   (130.24 mg/100 g)10. The Na
content (19.23±3.71 mg/100 g)  in the sample is far lower
than the RDA (1500 g dayG1) and lower than almost all the
traditional vegetables consumed in South Africa as reported
by Odhav et al.31. The K and Na both function for proper fluid
balance, nerve transmission and muscle contraction32.
Calcium  is  the   second   highest   mineral   element  in
the sample with a value of 622.58±0.01 mg/100 g and plays
a  major  role  in  building  and  maintaining   strong  bones
and teeth, it also serves vital roles in nerve transmission,
constriction    and     dilation     of      blood        vessels,   muscle
contraction27, normal functioning of blood coagulation, milk
clotting33, regulation of cell permeability, blood pressure
regulation  and  immune  system health32. Deficiency of
calcium causes  rickets,  osteoporosis,  back pain, indigestion,
irritability, premenstrual tension and cramping of the uterus34.
The daily Recommended Dietary Allowance (RDA) for Ca is
1000 mg dayG1 for males and females aged 19-30 years which
is a bite higher than the 622.58±0.01 mg/100 g obtained in
the sample but it can conveniently supply 62.258% of the daily
allowance hence it is a good supplement for people with Ca
deficiency.
The  presence  of  Mg  in  the  sample  per 100 g was
361.15±0.01 mg which is sufficiently enough to supply the
RDA of Mg per day for most of life stage groups which
requires25  80-420 mg dayG1, hence the sample is a good
source of Mg. Magnesium is important in the formation and
function of bones, muscles and prevents high blood pressure
and depression. It is also needed for making proteins, muscle
contraction, nerve transmission and immune system health
and plays important role in enzyme activity and prevents heart
diseases33. The Mg is vital in strengthening cell membrane
structure and modulates glucose transport across cell
membranes35. Studies have shown that Mg supplementation
improves insulin sensitivity in diabetic patients and it can
improve insulin sensitivity in obese individuals who are at risk
of type 2 diabetes mellitus36.
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The composition of phosphorous in the sample was 
115.40±0.01    mg/100    g   which   is   below   the   RDA  of
700 mg dayG1 for adults and also lower than chickpea seeds
(226  mg/100 g) as reported by Alajaji and El-Adawy30 and
most vegetables consumed in South Africa as reported by
Odhav et al.31, phosphorous is important for healthy bones
and  teeth  and  it  is  found  in  every cell and maintains
normal cell growth and repairs; it maintains blood sugar level,
acid-base balance and normal heart beat level32,33.
The body also needs micro (trace) minerals in very small
amounts. Iron is considered to be a trace mineral, although the
amount needed is somewhat more than for other micro
minerals. The micro minerals assayed for are Zn, Cu, Mn and
Fe. Iren (Fe)  is  the  highest  micro  mineral  produced  by  the
sample with a composition of 105.15±8.11 mg/100 g which
is far above  the  RDA  of 8 mg dayG1 for adult male and up to
28 mg dayG1 for pregnant women. So, about 29.44 g of the
sample is sufficiently enough to supply the RDA of Fe for
pregnant women. The Fe is a major constituent of hemoglobin
and a carrier of oxygen in the blood. The Fe is also important
in tendon and ligament formation, certain chemicals in the
brain are controlled by the presence and absence of iron and
also needed for energy metabolism32,37. The Fe deficiency
causes anaemia, weakness, depression, poor resistance to
infection and in women may cause infertility32 and hence this
sample can be a good source for people with fertility
challenges and other Fe deficiency crisis.
Zinc    (Zn)      content     in     the     sample   was
2.49±0.14 mg/100 g which is lower than the RDA of 8 mg for
adult males, 18 mg for adult females and 27 mg for pregnant
women25. The Zn is in part of many enzymes, needed for
making protein and genetic material has a function in taste
perception, wound healing, normal fetal development,
production of sperm, normal growth and sexual maturation,
immune system health32. This sample therefore can be a good
Zn supplement for people with infertility challenges.
Copper is part of the enzymes such as cytochrome
oxidase, lysyl oxidase and ceruloplasm, needed for iron
metabolism in the blood33. The Cu deficiency can cause
cardiac   abnormalities   in   human   and   animals,  anemia
and neutropenia38. The amount of Cu in the sample
(1.81±0.07 mg/100 g) is above the RDA of 0.9 mg dayG1 for
adult males and females, 1 mg dayG1 for pregnant women and
1.3 mg dayG1 for lactating mothers hence it’s a good source of
Cu and highly recommended for people with Cu deficiency.
Manganese acts as a cofactor and constituents of several
enzymes  involved  in  metabolic  processes necessary for the
Table  3:  Anti-nutrient composition of  Phragmanthera capitata (Sprengel) Balle
Parameters Values (%)
Phytic acid 0.15±0.23
Oxalate 2.99±0.61
Saponins 3.46±0.01
Alkaloids 4.20±0.11
Values are expressed as Mean±SD, n = 3
skeletal  development,  reproductive function and growth. It
is  a  cofactor  of  oxidative  phosphorylation  enzymes  whose
activity increases insulin secretion to improve glucose
tolerance under diabetic condition39. This element is also
involved in urea formation, metabolism of amino acids,
cholesterol  and carbohydrates40. The composition of Mn in
the sample was  27.57  mg/100  g which is above the RDA of
2.3 mg for adult males, 1.8 mg for adult females, 2 mg for
pregnant women and 2.6 mg for lactating mothers25. So, in
providing the daily Mn requirement from the sample, adult
males would need 8.34 g dayG1, adult females 6.53 g dayG1,
pregnant women 7.25g dayG1 and lactating mothers would
need 9.43 g.
Anti-nutritional composition of P.  capitata: The summary of
the anti-nutritional composition of the sample is as shown in
Table 3. Four anti-nutrients were studied, alkaloid was the
most abundant with a percentage value of 4.20±0.11% which
was closely followed by saponin (3.46±0.11%) and oxalate
(2.99±0.61%). Phytic acid was the least with a percentage
value of 0.15±0.23%.
The  anti-nutrient  activities of alkaloid are observed at
high  level  intake/dosage  to  exert toxic and adverse effects
to humans, especially in physiological and neurological
activities. However, dosage differentiates between toxicity and
pharmacological effects of alkaloids41. The percentage of
alkaloid (4.2%) in the sample is higher than Clerodendrum
volubile (0.79%)11, Cissus populnea (0.23%)23, red and white
cocoyam leaves (1.44±0.08 and 1.50±0.05%, respectively)18.
Oxalate composition of 2.99±0.61% in the sample was
higher than 0.583±0.04 and 0.828±0.07% (converted values)
of red and white cocoyam leaves respectively as reported by
Damilola et al.18. The oxalate content of foods is of interest
because consumption of high oxalate diet may result in
hyperoxaluria  thereby increasing the risk of kidney stones.
Iron oxalate crystals cause significant oxidative damage and
diminish  iron  stores needed for red blood cell formation
while  kidney  stones  are caused by calcium oxalate. Oxalate
on the long run, can also act as a chelator and can chelate
toxic  metals  such  as mercury and lead42 and can act as an
antioxidant.
Phytic acid (phytate) though very low (0.15±0.23%) was
also recorded in the sample (Table 2). This value is very small
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to  cause    any   adverse   anti-nutrient   effect   to  phosphorus
absorption in diet. Phytate chelates metal ions such as
calcium, magnesium, zinc, copper, iron and molybdenum to
form insoluble complexes that are not readily absorbed from
the gastrointestinal tract42,43. The greatest effect of phytic acid
on human nutrition is its reduction of zinc bioavailability43. Its
antioxidant ability can be used in the food industry as a
unique and versatile food preservative as it can increase
nutritive value, prolong shelf life and prevent discoloration
when added to fruits, vegetables, cheese, noodle, soy sauces,
juices, bread, alcoholic beverages, meat fishmeal pastes and
canned sea foods. Phytate can also act as an anti-cancer agent
against colon, soft tissue, metastatic lung cancer, breast and
prostate cancer44. It has been reported to reduce blood
glucose and possess health benefits to diabetic patients and
can also prevent kidney stone formation45, hence this plant
has the potential to serve as a remedy for people with the
scare of high oxalate consumption which can lead to kidney
stone formation.
The saponin content of the species was 3.46±0.01 5%.
Saponin is a heterogeneous group of naturally occurring
foam-producing triterpene or steroidal glycosides that occur
in a wide range of plants46. Some biological effects of saponin
in animals include erythrocyte haemolysis, reduction of blot
(ruminant), inhibition of smooth muscles activity, enzyme
inhibition and reduction in nutrient absorption, alteration of
cell wall permeability and therefore produce some toxic
effects when ingested, it also binds with the cell of the small
intestine  thereby  affecting  the  absorption of nutrients
across the intestinal wall42,43. Aside its anti-nutrient effects,
saponin  have  been  reported  to  have various biological
benefits such as, anti-inflammatory, anti-diabetic, anti-HIV,
anti-atherosclerotic and serve as protective functions like
gastro-protective,  hepatoprotective  and  hypolipidemic.
Reports  have  also  shown  saponins  to  be  effective in
maintaining liver  function,  lowering  blood cholesterol,
preventing peptic ulcer, osteoporosis as well as platelet
agglutination42.
CONCLUSION
The study revealed that Phragmanthera capitata, a
mistletoe growing on rubber tree has the potential of
contributing useful amount of nutrients to human and animal
diets. The anti-nutrients present were abite higher than most
found in some conventional vegetables but preparation
techniques   like   soaking,   boiling   and   cooking  reduce
anti-nutrient thereby making their effect negligible. This plant
can  serve  as a supplement to many mineral deficiencies and
also as a source of medicine to a number  of   ailments,   hence,
mistletoe  is  known  as  a  remedy  for  all  kinds of diseases
and  sicknesses.   Instead   of   been   considered  a  pest, it
should  be   seen  as  a  plant  with  great potential in the
food/nutritional   and   pharmaceutical  industries.  Further
studies on its  toxicity  are ongoing to ascertain if any, its
possible adverse effects.
SIGNIFICANT STATEMENTS
This study provides insights into the nutritional
composition of Phragmanthera capitata, a mistletoe widely
exploited in Africa. This study reveals important mineral
compositions even higher than those found in some
conventional vegetables. It is rich in carbohydrate which
serves as a major source of energy and substantial amount of
fibre, protein and fat. The findings of this study revealed that
this species could be used to boast the immune system due to
its rich mineral and nutrient compositions and hence could be
the reason to its therapeutic application in folkloric medicine.
This study also gives a baseline data on its nutritional
composition as most research is on crop protection because
of its parasitic mode of association.
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Background of the study 
Essential oils also called volatile oils, ethereal oils, aetherolea or oil from the named plant, are a 
complex mixture of concentrated hydrophobic liquid containing volatile aromatic compounds. 
It is called “essential” because it contains the essence of the plant's fragrance (Gautam et al., 
2014; Celiktas et al., 2007).  
Essential oils have been known to mankind for hundreds of years and even millennia. Long 
before the utilisation of essential oils as fragrance, its importance as a remedy had been 
identified. It gained recognition in the 9
th
 century and became widespread in the 16
th
 and 17
th
 
centuries when their uses as flavour, aroma and in medicine were known (Lawal and 
Ogunwande, 2013;  Baser and Buchbauer, 2010). 
Interest in essential oils has sky-rocked in recent times because of their perceived biological 
activities: Antioxidative, antimicrobial and antiparasitic properties (Nwiloh, et al., 2014), and 
has now become a part of everyday’s life. They are employed in different biological, physical 
and chemical industries: as food and cigarette flavourings, feed additives, compounding of 
cosmetics and perfumes and as pharmaceuticals. Most recently, they have been employed as 
biocides and insect repellents and currently, it is widely used in aromatherapy (massaging and 
bathing) (Lawal and Ogunwande, 2013; Lee et al., 2012; Baser and Buchbauer, 2010). 
Many novel compounds of biological and pharmacological importance identified, characterised 
and isolated from the essential oils of different plant species from Africa origin have been 
extensively studied. Essential oils have been extracted from different parts of the plant (leaves, 
stem, flowers and roots) and the oils so extracted from different parts of the same plant may 
have completely different compositions. Different methods: distillation, expression, solvent 
extraction, absolute oil extraction, resin tapping, carbon dioxide extraction, cold pressing and 
solvent free microwave extraction, and solvents have been explored in the extraction of 
essential oils in plants (Wikipedia, 2016; Hamid et al., 2011).  
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Despite the wide ethnopharmacological usage and report on the chemical compositions of the 
crude extracts of P. capitata as described in previous chapters, there was no report of the 
essential oil extraction and compositions prior to this study. Hence, this study was aimed at 
evaluating the essential oil compositions of the dried leaves of P. capitata using 
hydrodistillation with two extraction media (water and normal saline) and solvent-free 
microwave extraction (SFME) techniques. 
Methodology 
Plant collection and identification  
Plant collection and identification were carried out as previously described in chapter two 
Essential oil extraction 
Hydro-distillation Technique 
200 g each of the dried leaves were immersed in 2.5 L of distilled water and normal saline and 
hydro-distilled using the Clevenger apparatus fitted with a condenser and connected to a heat-
resistant 5-L round bottom flask. Heat at 50
o
C was supplied to the mantle and the essential oils 
were collected after 3 h of continuous heat.  
Solvent-free microwave extraction (SFME) 
This was done with a Milestone DryDIST (2004) apparatus. The multimode reactor has a twin 
magnetron (2×800 W, 2450 MHz) with a maximum delivered power of 500W in 5W 
increments. A rotating microwave diffuser ensures homogeneous microwave distribution 
throughout the plasma coated PTFE cavity. The temperature was monitored by an external 
infrared sensor. Constant conditions of temperature and water were guaranteed by the reflux of 
condensed water, achieved by a circulating cooling system at 5
o
C. 200 g of the leaves were 
placed into the reactor without the addition of water or solvent. The extraction of the essential 
oil was complete in 40 min. The oils collected in both extraction methods were analysed using 
GC–MS (Ajayi et al., 2016). 
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Gas chromatography-Mass spectrometry (GC-MS) analysis  
GC-MS analyses were performed using an Agilent 7890B GC system coupled with an Agilent 
5977A mass selective detector (MSD) (Chemetrix, Pty, Ltd, Agilent Technologies, DE, 
Germany) and a Zebron-5MS (cross-linked 5% phenylmethyl polysiloxane) column (ZB-5MS 
30m x 0.25 mm x 0.25 µm). GC grade helium was used as carrier gas at a flow rate of 2 ml/min 
and splitless 1 ml injections were used. The injector, source and oven temperatures were set at 
280
o
C, 120 and 70
o
C, respectively. The ramp settings were; 15
o
C/min to 120
o
C, then 10
o
C/min 
to 180
o
C, then 20
o
C/ min to 270
o
C and held for 3 min. The identification of the chemical 
constituents of the essential oil was determined by their GC retention time, and comparison of 
mass spectra obtained with those stored in the NIST11 library. 
Result and Discussion 
This study represents the first report of the chemical composition of the essential oils (EO) 
extracted from the dried leaves of Phragmanthera capitata parasitic on rubber tree. In this 
study, a solvent free microwave (no solvent) and Clevenger apparatus (distilled water and 
normal saline as solvents) extractors were used in the extraction of the essential oils. This is 
with an attempt to ascertain if extraction methods and/or solvents have an effect on the overall 
oil compositions.  
The total number of compounds identified in all three essential oils in this study is shown in 
Table 1. The compounds that are common in all the essential oils are represented in Table 2 
while Table 3 is the percentage compositions of the compounds common only to the oil 
extracted from the solvent-free microwave extractor. In Table 4, the compounds common only 
to the essential oils extracted by hydrodistillation (distilled water and normal saline) are shown. 
The percentage compositions of all the essential oils are in respect to a particular oil and so, in 
Tables 1, 2 and 4, the percentage area (% Area) may not be used to ascertain in terms of exact 
comparison/correlation, the amount or quantity of the compounds, but it speaks best to the 
amount of a particular oil composition. Fifty-six compounds (38 from the solvent-free 
microwave, 28 each from the hydrodistillation) were identified in all the oils as analysed by the 
GC-MS.  Terpenes/terpenoids formed almost 50% of the total classified oils and the 
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monoterpenes/monoterpenoids constituted over 90% of the total EO (Zuzarte and Salgueiro, 
2015). The mass spectra of all the compounds are represented in the GC-MS chromatograms in 
Figure 1.  
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Table 1: Characterization and composition of the essential oils extracted from P. capitata using Solvent-free microwave extractor (SFME) and 
hydrodistillation 
SN RT Compound SFME Hydrodistillation Class of compound Molecular 
Weight 
Formula 
DH2O NS 
(% Area) 
1.  3.169 Heptane, 3,5-dimethyl- 1.44 2.54 2.12 Alkanes  128 C9H20 
2.  3.297 2-Hexenal, (E)- - - 2.43 Aldehydes 98 C6H10O 
3.  3.359 Heptane, 2,4-dimethyl- 4.47 9.36 6.70 Alkanes 128 C9H20 
4.  3.408 Ethylbenzene 4.92 8.68 7.76 Benzene 
(monoterpernoid) 
106 C8H10 
5.  3.457 Xylene  11.15 19.36 17.22 Benzene 318 C24H30 
6.  3.938 2-Nonanone, 9-[(tetrahydro-2H-pyra n-2-
yl)oxy]- 
2.35 - - NA 242 C14H26O3 
7.  4.160 Propanedinitrile, dicyclohexyl- 5.54 - - NA 230 C15H22 N2 
8.  4.169 Benzaldehyde - 1.59 2.94 Aldehyde 106 C7H6O 
9.  4.222 Phenol 0.30 - - Phenols/benzenoids 94 C6H5OH 
10.  4.371 Furan, 2-pentyl - 1.02 0.92 Heteroaromatic 138 C9H14O 
11.  4.357 2-Pentene, 3,4-dimethyl-, (E)- 0.80 - -  98 C7H14 
12.  4.530 2,4-Heptadienal, (E, E)-   0.75 Aldehydes 110 C7H10O 
13.  4.687 Benzene, 1-methyl-3-(1-methylethyl )- 
β-Cymene 
0.14 1.56 1.06 Monoterpene 134 C10H14 
14.  4.726 D-Limonene - 0.81 0.62 Monoterpene 136 C10H16 
15.  4.844 Benzene acetaldehyde - - 1.98 Benzanoid 146 C10H10O 
16.  5.068 Ethyl 2-(5-methyl-5-vinyltetrahydrofuran-2-
yl)propan-2-yl carbonate 
0.32 1.25 1.74 NA 242 C13H22O4 
17.  5.206 2-methoxy Phenol (Guaiacol) 1.23 - - Methoxyphenols 124 C7H8O2 
18.  5.270 Nonanal - 2.03 - Monoterpanoid 142 C9H18O 
19.  5.737 Para-ethylphenol 0.32 - - Monoterpanoid 122 C8H10O 
20.  5.984 4'-Methylacetophenone 0.27 - - Monoterpanoid 134 C9H10O 
21.  6.047 Naphthalene 3.10 17.36 12.61 Benzenoids 128 C10H8 
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22.  6.115 Safranal - 1.32 1.50 Monoterpanoid 150 C10H14O 
23.  6.122 o-Tolualdehyde 0.46 - - Monoterpanoid 120 C8H8O 
24.  6.207 2-Allyl-4-methylphenol (2-Allyl-p-cresol) - 0.85 0.99 Monoterpenoid 148 C10H12O 
25.  6.415 Cumaldehyde 0.48 1.36 1.20 Monoterpenoid 148 C10H12O 
26.  6.488 Acetaldehyde, (3,3-
dimethylcyclohexylidene)-, (E)- 
0.30 - - Monoterpenoid 152 C10H16O 
27.  6.490 2-Cyclohexen-1-one, 5-methyl-2-(1-
methylethyl)- 
- - 1.50 Monoterpenoid 152 C10H16O 
28.  6.659 p-Ethylguaiacol 0.41 - - Monoterpanoid 152 C9H12O2 
29.  6.724 Tridecane - 2.14 3.28 Alkanes 
(sesquiterpene) 
184 C13H28 
30.  6.762 Thiosemicarbazide, 4-(1-adamantylcarbonyl)- - - 1.09 NA 253 C12H19N3OS 
31.  6.863 Benzocycloheptatriene  - 0.61 0.55 Naphthalene 142 C11H10 
32.  6.793 Indole 0.55 - - Indole 117 C8H7N 
33.  6.913 2-Methoxy-4-vinylphenol 0.62 - - Methoxyphenol 150 C9H10O2 
34.  7.149 Phenol, 2,6-dimethoxy- (Syringol) 2.90 - - Methoxyphenol 
(Ether) 
154 C8H10O3 
35.  7.265 1, 1, 5-Trimethyl-1, 2-dihydronaphthalene 0.91 - - Naphthalenes 
(Sesquiterpenoid) 
172 C13H16 
36.  7.405 2-Propenoic acid, 3-phenyl-, methyl ester 
Methyl cinnamate 
0.57 - - Monoterpenoids 162 C10H10O2 
37.  7.523 2',3',4' Trimethoxyacetophenone 0.64 - - NA 210 C11H14O4 
38.  7.626 Naphthalene, 2,6-dimethyl- 0.23 1.19 - Naphthalene 156 C12H12 
39.  7.754 Naphthalene, 2,7-dimethyl- - 2.95 - Naphthalene 156 C12H12 
40.  7.835 Isoeugenol 1.21 -  Monoterpenoids 164 C10H12O2 
41.  8.059 Pentadecane 1.03 2.68 2.08 Sesquiterpenoid 212 C15H32 
42.  8.095 β-ionone 1.05 2.85 4.03 Sesquiterpenoid 192 C13H20O 
43.  9.248 Pentadecane 2.03 - - Alkanes 
(sesquiterpenoid) 
212 C15H32 
44.  9.288 (4-Acetylphenyl) phenylmethane - 1.25 - Sesquiterpenoid 210 C15H14O 
45.  9.353 Tetradecanal 3.58 3.80 5.91 Alkanes 212 C14H28O 
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 (sesquiterpenoid) 
46.  9.422 Acorenone 1  2.47 4.24 Sesquiterpenoid 220 C15H24O 
47.  9.423 Methyl eudesmate 4.99 - - Ester 226 C11H14O5 
48.  9.789 Octadecane 0.21 - - Acyclic alkane 254 C18H38 
49.  9.816 2-Iodoadamantane 0.50 1.05 1.30  262 C10H15I 
50.  10.017 cis-Pinane 22.82 - - Monoterpenoids 138 C10H18 
51.  10.052 (±)-Phytone 3.08 1.08 1.64 Sesquiterpenoid 268 C18H36O 
52.  10.232 Diheptyl Phthalate - 0.51 0.82 Ester 362 C22H34O4 
53.  10.349 α-Linolenic acid 6.73 7.69 11.00 Polyunsaturated fatty 
acids (Fatty Acyls) 
278 C18H30O2 
54.  10.447 Methyl hexadecanoic acid 3.08 - - Esters 270 C17H34O2 
55.  10.468 Pyridine-3-carboxamide, oxime, N-(2-
trifluoromethylphenyl)- 
- 0.64 - NA 281 C13H10F3N3O 
56.  11.387 Phytol 5.31 - - Diterpenoid 296 C20H40O 
RT: Retention time, DH2O: Distilled water, NS: Normal Saline, NA: Not Available in library. 
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Figure 1: GC-MS total-ion chromatograms overlay of the essential oils of P. capitata extracted with the Solvent-Free Microwave Extractor (SFME) 
and hydrodistillation techniques using Distilled Water (DH2O) and Normal Saline (NS) as solvents. 
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Fourteen compounds as shown in Table 2 were present in all three essential oils of the plant: 
Compounds extracted with the solvent-free microwave formed 41.97% while compounds 
extracted with the hydrodistillation formed 80.61% (distilled water) and 76.38% (normal 
saline).  
Table 2: Compounds common to all the essential oils of P. capitata 
SN Compound SFME Hydrodistillation 
DH2O NS 
(% Area) 
1.  Heptane, 3,5-dimethyl- 1.44 2.54 2.12 
2.  Heptane, 2,4-dimethyl- 4.47 9.36 6.70 
3.  Ethylbenzene 4.92 8.68 7.76 
4.  Xylene  11.15 19.36 17.22 
5.  Benzene, 1-methyl-3-(1-methylethyl )- 
β-Cymene 
0.14 1.56 1.06 
6.  Ethyl 2-(5-methyl-5-vinyltetrahydrofuran-2-
yl)propan-2-yl carbonate 
0.32 1.25 1.74 
7.  Naphthalene 3.10 17.36 12.61 
8.  Cumaldehyde 0.48 1.36 1.20 
9.  Pentadecane 1.03 2.68 2.08 
10.  β-ionone 1.05 2.85 4.03 
11.  Tetradecanal 3.58 3.80 5.91 
12.  2-Iodoadamantane 0.50 1.05 1.30 
13.  2-Pentadecanone, 6,10,14-trimethyl 
(±)-Phytone 
3.08 1.08 1.64 
14.  α-Linolenic acid 6.73 7.69 11.00 
 Total (%) 41.97 80.61 76.38 
SFME: Solvent–Free Microwave Extraction, DH2O: Distilled water, NS: Normal Saline 
Among the compounds present in all the essential oils, Xylene was the most abundant with 
compositions of 11.15 %, 19.36% and 17.22%  for solvent-free, distilled water and normal 
saline respectively (Table 2 and Figure 2). It is an aromatic hydrocarbon mostly used in 
industry and medical laboratories as a solvent. It is found naturally in petroleum, coal, and 
wood tar. It is a colourless, flammable liquid, often used as a solvent in printing, paint, leather 
and rubber industries (Kandyala et al., 2010). The high content of xylene and some other 
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compounds: Heptane, 3, 5-dimethyl-, Heptane, 2, 4-dimethyl- and Ethylbenzene, could have 
been influenced by the host species, Hevea brasiliensis; the world’s natural source of rubber 
and also may be responsible for fire outbreak most especially in the dryer seasons in the tropics 
(Mathiasen et al., 2008).  
Alpha (α) linolenic acid is the second highest abundant compound common to all the EOs with 
compositions of 6.73%, 7.69% and 11.00% respectively for solvent-free, distilled water and 
normal saline (Table 2). It  is a polyunsaturated omega-3-fatty acid found in fish and plant 
sources (vegetable oils, seeds and nuts). It is an essential fatty acid needed by humans but 
cannot be synthesised in the body and as such, must be acquired through diet. It is used for the 
treatment of cardiovascular diseases (coronary heart disease, ischemic heart disease, myocardial 
infarction, cardiac arrest, heart failure and stroke), reduces cholesterol levels and acts as an anti-
inflammatory agent (Rajaram, 2014; Pan, et al 2012). It is also believed to have a reducing 
effect on hip bone fracture (Orchard et al., 2013; Farina et al., 2011). It plays a role in the 
reduction of type-2-diabetes with the suggestion that it improves insulin sensitivity (Wu et al., 
2012; Muramatsu et al., 2010; Bloedon et al., 2008). One of its notable mechanisms of action in 
combating cardiovascular diseases is by reduction of blood pressure and improving endothelial 
function (Rajaram et al., 2014).  
The compounds found only in the essential oil extracted with the solvent-free microwave 
(SFM) extractor are depicted in Table 3. Twenty-three compounds making 57.80% of the total 
oil from SFME was exclusive to it. Cis-Pinane (22.82%) (Figure 2) was the most abundant 
compound in all the three essential oils composition (Table 1). Its major use is as an ingredient 
of fragrance.  
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Table 3: Compounds exclusive to the essential oils extracted with the Solvent-Free Microwave 
Extractor 
SN Compound % Area  
1.  2-Nonanone, 9-[(tetrahydro-2H-pyra n-2-yl)oxy]- 2.35 
2.  Propanedinitrile, dicyclohexyl- 5.54 
3.  Phenol 0.30 
4.  2-Pentene, 3,4-dimethyl-, (E)- 0.80 
5.  2-methoxy Phenol (Guaiacol) 1.23 
6.  Para-ethylphenol 0.32 
7.  4'-Methylacetophenone 0.27 
8.  o-Tolualdehyde 0.46 
9.  Acetaldehyde, (3,3-dimethylcyclohexylidene)-, (E)- 0.30 
10.  p-Ethylguaiacol 0.41 
11.  Indole 0.55 
12.  2-Methoxy-4-vinylphenol 0.62 
13.  Phenol, 2,6-dimethoxy- (Syringol) 2.90 
14.  1, 1, 5-Trimethyl-1, 2-dihydronaphthalene 0.91 
15.  2-Propenoic acid, 3-phenyl-, methyl ester 
Methyl cinnamate 
0.57 
16.  2',3',4' Trimethoxyacetophenone 0.64 
17.  Isoeugenol 1.21 
18.  Pentadecane 2.03 
19.  Benzoic acid, 3,4,5-trimethoxy-, methyl ester 4.99 
20.  Octadecane 0.21 
21.  cis-Pinane 22.82 
22.  Methyl hexadecanoic acid 3.08 
23.  Phytol 5.31 
Total (%) 57.80 
 
Syringol and guaiacol with the percentage compositions of 1.23% and 2.90% respectively are 
closely related and derived from the pyrolysis of lignin. They are the components of wood and 
charcoal smoke. They form the main aroma of smoked and grilled foods. Syringol is 
responsible for the smoky aroma while guaiacol gives the taste (ACS, 2015). While syringol is 
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mainly a flavourant, guaiacol on the other hand, aside being a flavourant, is used medically as 
an expectorant, local anaesthetic, antiseptic (ACS, 2011) and for the treatment of pulmonary 
tuberculosis (Nammack and Tiber, 1937; Coghill, 1896). The presence of guaiacol could 
contribute to the anti-Mycobacterium tuberculosis activity observed in the crude extracts of P. 
capitata in chapter seven of this study. Isoeugenol is a monoterpenoid which is used as 
flavourant and storage agent in cosmetics and food products. It also possesses some medicinal 
properties as a prooxidant and antioxidant agent (Atsumi et al., 2005). It acts as an anti-
inflammatory agent by modulating ionomycin-induced cytokine release (Galbiati et al., 2012). 
Different studies have shown its antioxidant activities by inhibiting the lipopolysaccharide-
dependent production of nitric oxide and also have an anti-microbial activity (Sharifi-Rad et al., 
2015; Li et al., 2006).  
Another compound of interest with considerable percentage composition (3.08%) in the 
essential oil extracted from the solvent-free microwave is the Methyl hexadecanoic acid. It acts 
as an antioxidant, nematicide, hypocholesterolemic, pesticide, hemolytic-5-alpha reductase 
inhibitor (Rajeswari et al., 2012). One compound which has elicited interest and extensively 
used in medicinal application is phytol. Its composition in the SFME was 5.31%. It is a 
diterpenoid with an inhibitory effect on Staphylococcus aureus (Inoue et al., 2005); a causative 
agent of some skin infections, urinary tract infection, pneumonia, osteomyelitis and mastitis, 
etc. Phytol is an oxidant which reduces hydroxyl radical and nitric oxide production in the body 
(Santos et al., 2013). It also has an anti-rheumatic/arthritis, anti-diuretic effects and it is known 
to be a good anti-cancer agent (Rajeswari et al., 2012), it reduces cytokine production and 
oxidative stress (Silva et al., 2013). Other compounds common only to the SFME in substantial 
amounts are; 2-Nonanone, 9-[(tetrahydro-2H-pyra n-2-yl) oxy] - (2.35%), Propanedinitrile, 
dicyclohexyl- (5.54%), Pentadecane (2.03%) and Benzoic acid, 3, 4, 5-trimethoxy-, methyl 
ester (4.99%). 
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Cis-Pinane 
 
Figure 2: A: The compound with the highest composition (present only in the solvent-free 
microwave extraction) and B: compound with the second highest composition (present in all the 
essential oils of P. capitata)  
 
The percentage composition of compounds common only to the essential oils (Distilled water 
and Normal saline) extracted using hydrodistillation are shown in Table 4. Cumulatively, 18 
compounds were identified in the oils while nine compounds were found common in the oils. 
Table 4: Compounds found only in the hydrodistillation extraction using distilled water 
(DH2O) and Normal saline (NS) as solvents 
SN Compound DH2O NS 
% Area 
1.  2-Hexenal, (E)-  2.43 
2.  Benzaldehyde 1.59 2.94 
3.  Furan, 2-pentyl 1.02 0.92 
4.  2,4-Heptadienal, (E, E)-  0.75 
5.  D-Limonene 0.81 0.62 
6.  Benzene acetaldehyde  1.98 
7.  Nonanal 2.03  
8.  Safranal 1.32 1.50 
9.  2-Allyl-4-methylphenol (2-Allyl-p-cresol) 0.85 0.99 
10.  2-Cyclohexen-1-one, 5-methyl-2-(1 methylethyl)-  1.50 
11.  Tridecane 2.14 3.28 
12.  Thiosemicarbazide, 4-(1-adamantylcarbonyl)-  1.09 
13.  Benzocycloheptatriene  0.61 0.55 
14.  Naphthalene, 2,7-dimethyl- 2.95  
15.  (4-Acetylphenyl) phenylmethane 1.25  
16.   Acorenone 1 2.47 4.24 
 
Xylene 
 
A B 
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17.  Diheptyl Phthalate 0.51 0.82 
18.  Pyridine-3-carboxamide, oxime, N-(2-
trifluoromethylphenyl)- 
0.64  
 Total (%) 18.20 23.62 
 Number of compounds 13 14 
 
Benzaldehyde with the percentage composition of 1.59% and 2.94% for distilled and normal 
saline respectively is the simplest representative of the aromatic aldehydes. It is a colourless 
liquid with a characteristic almond odour. It is used as a flavourant in food and scented products 
like cosmetics. It is a precursor to other organic compounds used in pharmaceuticals and plastic 
industries. (Anderson, 2006). It is also used in beekeeping as a bee repellent during honey 
harvest. (Evans and Butler, 2010). The percentage compositions of D-Limonene in the oils were 
0.81% and 0.62% respectively for distilled and normal saline. It is a natural monoterpene which 
had been extensively studied for its chemotherapeutic and minimal toxicity activities. Its wide 
application has been in cancer therapy. It has shown great anti-cancer activity in in-vitro, in-
vivo and clinical trials. It has also shown promise in gallstone dissolution and Heartburn relief 
(Sun, 2007; Vigushin et al., 1998; Elegbede et al., 1984). The composition of Acorenone 1 was 
2.47% and 4.24% in the distilled water and normal saline solvents respectively. This compound 
has not been extensively studied and hence, little is known about its medicinal application but 
the report of Bader et al. (2003) mentioned its activity against Bacillus subtilis and cytotoxic 
effect on monkey kidney cell-line.  
Safranal with the composition of 1.32% and 1.50% in the distilled and normal saline solvents, is 
famous for its saffron odour and flavour. It has been used as an antimicrobial agent. It has a 
protective effect against indomethin-induced gastric ulcers and effective against specific cancer 
cell-lines. Its effects on the Central Nervous System have been widely investigated.  It has 
shown anticonvulsive, antidepressant, antianxiety and hypnotic effects. It also has shown anti-
ischemia and antihypertensive effect (Rezaee and Hosseinzadeh, 2013). Other compounds 
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common to both distilled and normal saline respectively are Benzaldehyde 1.59% and 2.94%, 
Furan, 2-pentyl 1.02% and 0.92%, Tridecane 2.14% and 3.28%, Benzocycloheptatriene 0.61% 
and 0.55% and Diheptyl Phthalate 0.51% and 0.82%. 
Conclusion  
This study being the first account of the essential oils extracted from Phragmanthera capitata, 
was able to reveal some compounds with reported biological activities and industrial usage. In 
recent days, mistletoe study is geared towards cancer research in Europe and extensively used 
as an antihypertensive agent in traditional medicine in Africa. The presence of some of the 
compounds in the essential oils of this plant could contribute to its wide reported 
ethnopharmacological applications; most especially in cancer and hypertension management. 
This study also revealed that different extraction methods and solvents could influence the 
composition of essential oils of P. capitata.  
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Abstract
Background: There has been a surge in the use of medicinal plants in the past decades; hence, the screening of potential cytotoxic
compounds is of utmost importance to guarantee their safe use in alternative medicine. Different solvent extracts of the leaves of
Phragmanthera  capitata  (Sprengel)  Balle,  a  parasitic  mistletoe  growing  on  rubber  tree  were  evaluated  for  possible  toxicity.
Methodology:  Brine shrimp (Artemia salina) hatchability (based on the Minimum Inhibitory Concentration (MIC50) of the extracts to inhibit
50% hatching of the cysts) and lethality (based on the Lethal Concentration (LC50) of the extracts to kill 50% of the hatched cysts (nauplii))
assays were employed to evaluate the possible toxicity of the species.  Results: Lowest hatching percentage was recorded in the ethanolic
extract (34.40%) with an MIC50 value of 0.14 mg mLG1 and the highest hatching success was observed in the aqueous extract (59.33%)
with an MIC50 value of 0.59 mg mLG1. All the extracts hatching success were significantly higher than the positive control (Amoxicillin)
(p<0.05). The LC50 for the lethality assay in all the solvent extracts was greater than 1 mg mLG1. Conclusion: Based on Meyer’s toxicity
index, LC50>1 mg mLG1 were considered non-toxic hence, all the solvent extracts tested showed that they were not toxic and can be
further explored for the development of plant-based pharmaceuticals drugs. Further in vivo  and cell lines cytotoxicity test is
recommended to substantiate these findings.
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INTRODUCTION
There has been a surge in public interest in herbal
therapies both in developing and developed countries with
herbal remedies being available not only in drug stores, but
now also in food stores and supermarkets. It is estimated that
upto four billion people (representing 80% of the world’s
population) living in the developing world rely on herbal
medicinal products as a primary source of healthcare.
Medicinal plants have provided a source of inspiration for
novel therapeutic drugs, as plant derived medicines have
immensely contributed to the health and well being of
humans1. The medicinal value of plants is chiefly due to the
phytochemicals like alkaloids, essential oils, tannins, resins and
many others that are present in them which produce a
physiological action on the human body2.
In spite of the positive perception of patients on the use
of herbal medicines, their alleged satisfaction with therapeutic
outcomes as well as their disappointment with conventional
allopathic or orthodox medicines in terms of effectiveness
and/or safety, the problem of safety of herbal remedies
continues to remain a major issue of concern. The general
perception that herbal remedies or drugs are very safe and
devoid of adverse effects is not only untrue, but also
misleading. Herbs have been reported to produce a wide
range  of  undesirable  or  adverse  reactions  some  of  which
could cause serious injuries, abortion of pregnancy, dizziness,
vomiting,  diarrhoea,  abdominal  pain,  fast  heart  beat,  ulcer,
loss of appetite, life-threatening conditions and even death1.
Much of the information on medicinal herbs made
available to consumers is not backed by credible scientific
data. For this reason, study is carried out to determine the
toxicity of medicinal plants3 and in recommendation from the
World Health Organization (WHO)4,  in order to reduce adverse
effects from the consumption of herbal medicines, there is
need for a thorough scientific validation on the toxicity of
these plants.
There had been a number of toxicity tests in which the
responses have been measured in invertebrates. These tests
have the advantages of being cost effective, reproducible,
easy to experiment and environmentally relevant5. A general
bioassay that appears capable of detecting a broad spectrum
of bioactivity present in plant crude extracts is the brine
shrimp (Artemia salina) lethality assay. Brine shrimp is used as
an indicator for the detection of anti-tumor, fungi toxins, plant
extract toxicity, heavy metals, cyanobacteria toxins, pesticidal
compounds and cytotoxicity of dental materials2,6. This assay
has also been noted as a useful tool for the isolation of
bioactive compounds from plants extracts7. Most study is
based on Brine Shrimp Lethality Assay (BSLA) on the hatched
cysts (nauplii) for toxicity analysis of natural products but a few
other researchers have used the assay on the inhibition of
hatching of the cysts5,6,8.
Phragmanthera capitata (Spreng) Balle is an obligate
hemi-parasitic plant which attaches to and penetrates the
stems and branches of its host tree or shrub by a structure
called the haustorium. It is a mistletoe in the Loranthaceae
family. It is a woody parasitic shrub with pendent branches of
about 2 m long. It has a yellow corolla with a pink-red tip and
often associated with ant’s nests. It grows on trees in
secondary  jungles,  plantations  and  bush  savannah  areas;
from Sierra Leone to Western Cameroons, Fernando Po and
extending across the Congo basin to Zaïre, Nigeria, Gabon,
Ivory Coast and Angola9,10. As with most mistletoe, it is a
medicinal plant utilized in the treatment of a wide range of
ailments across Africa and the world at large. The leaves, twig
(stem) and/or combination of both parts have been used in
different  preparations  and  doses  in  folklore  medicine  to
treat diverse ailments ranging from insomnia, diabetes,
hypertension, infertility, gastrointestinal disorders, anxiety,
bacteria/fungi infections, arthritis, epilepsy, cancer, etc.10,11.
However, based on literatures, there had been no report on
the possible toxicity of P. capitata despite its numerous
folkloric applications.
From the foregoing therefore, the objectives of this study
was to evaluate the potential toxicity of the acetone,
methanol,  ethanol  and  aqueous  extracts  of  P.  capitata
using  the  brine  shrimp  hatchability  and  lethality  assays
(BSH and BSLA) in order to ascertain/validate its numerous
ethno-pharmacological safe use and provide data base for the
preliminary toxicity of P. capitata  growing on rubber tree.
MATERIALS AND METHODS
Location and collection of sample: Leaves of mistletoe were
collected from mature rubber plantations in Rubber Research
Institute of Nigeria, Iyanomo, located on latitude 6E00’-6E15’
N;  longitude 5E30’-5E45’E and on altitude 27 ma.s.l., in Benin
City, which lies on the wet lowland rainforest of Edo State,
Nigeria.
Extraction procedure: Leaves were removed from the twigs,
gently rinsed to remove dust and dirt, air-dried at room
temperature (mean morning and night temperature of 24EC
and mean noon temperature of 27EC) in a well aerated
atmosphere and prevented from direct sunlight to avoid
denaturation of vital phyto-constituents. Dried leaves were
pulverized.  The ground sample was put into separate conical
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flasks containing acetone, methanol, ethanol and water,
shaken in an orbital shaker (Orbital Incubator Shaker,
Gallenkamp) for 24 h. The crude extracts were filtered using a
Buchner funnel and Whatman No. 1 filter paper. The acetone,
methanol and ethanol extracts were further concentrated to
dryness to remove the solvents under reduced pressure using
a rotary evaporator (Strike 202 Steroglass, Italy) while the
aqueous filtrate obtained was concentrated using a freeze
dryer (Vir Tis benchtop K, Vir Tis Co., Gardiner, NY). The
acetone, methanol and ethanol extracts were reconstituted in
their parent solvents to yield a 100 mg mLG1 stock solution
while  the  aqueous  extract  was  directly  prepared  in  filtered
sea water.
Preparation of the assay: The method described by Kibiti and
Afolayan12 was employed with little modifications. Five petri
dishes containing 30 mL of the extracts were prepared in
filtered sea water by first dissolving them in an infinitesimal
amount   of   the   parent   solvents   to   yield   a   two-fold
dilution  series  of  concentrations  (1,  0.5,  0.25,  0.125  and
0.0625 mg mLG1). A positive control was also prepared by
dissolving amoxicillin in sea water in the same concentrations
as the plant extracts. Sea water only served as the negative
control. The set up was allowed to stand for 30 min to allow
the solvents to evaporate.
Artemia  salina   hatching  assay:  This  assay  was  evaluated
as described by Kibiti and Afolayan12. A density of ten A. salina
cysts was stocked in each of the petri dishes containing 30 mL
of the prepared two-fold concentrations (1-0.0625 mg mLG1)
of the plant fractions and positive control. The petri dishes
were partly covered, incubated at 30EC and under constant
illumination for 72 h. The number of free nauplii in each petri
dish was counted after every 12 h till end of 72 h. The
percentage of hatchability was assessed by comparing the
number of hatched nauplii with the total number of cysts
stocked.
Artemia salina lethality assay: Artemia salina cysts were
hatched in sea water and 10 nauplii were pipetted into each
petri dish containing the two-fold concentrations of the
extracts and control as in the hatchability above. The petri
dishes were then examined and the number of living nauplii
(that   exhibited   movement   during   several   seconds   of
observation) was counted after every 12 h and the set up was
allowed to stand for 72 h under constant illumination. The
percentage of mortality was calculated as:
Total nauplii-Alive naupliiMortality (%) = ×100
Total nauplii
Data  analysis:  The  percentage  hatchability  success  and
mortality data obtained from the 5 different concentrations of
each fraction and control experiments were used to construct
the dose-response curves. These were used to determine their
corresponding MIC50 and LC50 values. The minimum inhibitory
concentration 50 (MIC50) was determined as the concentration
of the plant extract/control drug that inhibited hatching of
50% of the cysts. The LC50 was taken as the concentration
required for producing 50% mortality of the nauplii. The MIC50
and LC50 values were determined from the best-fit line
obtained by regression analysis of the percentage hatchability
and lethality versus the concentration. The statistical analysis
was done on GENSTAT 8. A two-way analysis of variance
(ANOVA)   followed   by   Fischer’s   least   significant   different
(for means separation) was used to test the effect of
concentration and time of exposure of the plant extracts on
the  hatchability  success  of  the  cysts  and  mortality  of  the
larvae, respectively.
RESULTS
Brine  shrimp  hatchability  assay:  The  hatching  success  of
A. salina  incubated with different plant extracts and control is
as shown in Fig. 1 with the aqueous extract having a
significantly higher hatching success (59.33%) than the rest of
the solvent extracts including both the positive control
(amoxicillin) (23.47%) and sea water (46.67%) (p<0.05). The
hatching success of the cysts in the acetone (37.87%) and
methanol (35.47%) extracts showed non-significant difference
from each other but the acetonic extract was significantly
higher   than   the   ethanolic   extract   (34.40%)   which   had
non-significant difference from the methanol extract (p>0.05).
The effect of different solvent concentrations on the
hatching success of the cyst was also evaluated and the result
is depicted in Fig. 2a and b. Figure 2a shows the activities of
the different plant extracts/positive control at varying
concentrations to the hatching success of the cysts. The
percentage hatching success of cysts incubated with the
acetone extract showed significant differences at varying
concentrations. The lowest concentration (0.0625 mg mLG1)
had  the  highest  hatching  percentage  (67.33%)  and  it  was
not   significantly   different   from   the   cysts   incubated   at
0.25   mg   mLG1   with   a   hatching   success   of   59.33%.
There   was   zero   percent  (0%)  hatchability  at  the  highest
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Fig. 1: Percentage hatching success of Artemia salina cysts incubated in different solvent extracts and controls. The values are
means of five concentrations for each plant extract/control±SD of three replicates. Bars with different letters are
significantly different (p<0.05)
Fig. 2(a-b): Percentage hatching success of Artemia salina cysts incubated in different concentrations of the plant extracts and
control. The values are means of the replicates (at different hours) for the concentrations for each plant
extract/control±SD of three replicates. Set of bars with different letters is significantly different (p<0.05), (a) Set of bars
represents the effect of the solvent extracts/positive control at varying concentrations on the hatching success of the
cysts and (b) Set of bars represents the effect of the solvent extracts/positive control to a particular concentration on
the hatching success of the cysts
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concentration of 1 mg mLG1. The methanol, ethanol and
aqueous extracts had significant higher hatching percentage
of the cysts at 0.125 mg mLG1 (66, 62 and 64%, respectively).
There  was also 0% hatchability at the highest concentration
of  1  mg  mLG1  in  the  methanol  and  ethanolic  extracts.
While,  there  was  non-significant  difference  at  0.25  and
0.0625 mg mLG1 in the methanolic extract but the same was
not true in the ethanolic extract that showed significant
difference at all concentrations tested (p<0.05). The aqueous
extract  had  non-significant  difference  at  0.5,  0.125  and
0.0625 mg mLG1. There was a dose-dependent response in the
positive control with an anomalous significantly higher
hatchability at 0.5 mg mLG1.
Figure    2b   is   an   expression   of   the   percentage
hatchability of the solvent extracts in response to particular
concentrations.  At  1  mg  mLG1,  acetone,  methanol  and
ethanol  extracts  had  0%  hatchability   while   the   aqueous
extract had a significant higher percentage hatchability of
33.33%, all the extracts were significantly different from the
positive control. The aqueous extract also had significant
higher  hatching  success  (61.33  and  76%,  respectively)  at
0.5 and 0.25 mg mLG1. There  was  non-significant  hatchability 
success between acetone and ethanol extracts at 0.5 mg mLG1 
while at 0.25 mg mLG1, methanol and ethanol was not
different significantly from each other. At 0.125 mg mLG1,
methanol,     ethanol     and     aqueous     extracts     showed
non-significant difference and at 0.0625 mg mLG1, acetone
and aqueous extracts were not significantly different from
each other (p<0.05).
The  effect  of  exposure time on the hatching success on
A. salina is shown in Fig. 3a and b. Figure 3a showed the
response  of  the cysts in each solvent extract to varying time
of exposure. The same trend was observed in all the extracts
and controls tested. There was a lower significant hatching
success at 24 h in all the extracts and controls.  There were no
Fig. 3(a-b): Percentage hatching success of Artemia salina cysts incubated at different durations in the plant extracts/controls.
The values are means of replicates (of all the concentrations) for each plant extract/control±SD of three replicates.
Set of bars with different letters are significantly different (p<0.05), (a) Set of bars represents the effect of the solvent
extracts/positive control at varying time of exposure on the hatching success of the cysts and (b) Set of bars represents
the effect of the solvent extracts/positive control to a particular time of exposure on the hatching success of the cysts
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Fig. 4: Percentage mortality of Artemia salina nauplii incubated in different plant extracts and controls. Means are values of five
concentrations for each plant fraction/control±SD of three replicates. Bars with different letters are significantly different
(p<0.05)
Table 1: Hatchability and Lethality of Artemia salina  in different plant extracts
as shown by their MIC50  and LC50  values, respectively
Hatchability assay Lethality assay
------------------------------------ ---------------------------------
MIC50  (mg mLG1) R2 LC50  (mg mLG1) R2
Acetone extract 0.15 0.8314 >1 0.9398
Methanol extract 0.21 0.9985 >1 0.9398
Ethanol extract 0.14 0.8995 >1 0.9778
Aqueous extract 0.59 0.8325 >1 0.8068
Amoxicillin <0.0625 0.7971 0.89 0.9604
MIC50 and LC50 are defined as the concentration (mg mLG1) of the plant extracts
and positive control (Amoxicillin) sufficient to obtain 50% of hatching inhibition
of the cysts and nauplii mortality of Artemia salina, respectively. The R2 is the
coefficient of determination from the regression equation
significant differences in hatching success from 36-72 h in
most of the extracts (p>0.05) and controls except in the
aqueous extract where there was a lower significant difference
at 36 h from both 60 and 72 h (p<0.05).
In Fig. 3b, the response of the cyst in different solvent
extract to a particular time exposure was shown. The aqueous
extract had a higher hatching success at all levels of exposure
but was not significantly different from sea water at all levels
of exposure (p>0.05). The acetone, methanol and ethanol
extracts showed non-significant difference from one another
at all levels of exposure (p>0.05). Though the test drug had
the lowest hatching success in all the levels of exposure time,
the same was not significantly different from the acetone,
methanol and ethanol extracts (p>0.05). The test drug was
significantly lower than the aqueous extract and sea water at
all the levels of exposure to time (p<0.05) except at 72 h
where it was not significantly different from the sea water
hatching success (p>0.05).
The inhibitory effects of the different solvent extracts and
positive control on the hatchability success were expressed as
MIC50 (Table 1) which represents the potential of the extracts
to inhibit hatching of the cysts by 50% (that is 50% hatching
success). The positive control exhibited more potent inhibitory
activity  (76.53%)  with  a  MIC50  value  of  <0.0625  mg  mLG1
while the extracts had inhibitory effect in the other:
Ethanol>acetone>methanol>aqueous.
Brine shrimp lethality assay (BSLA): The percentage
lethality/mortality of A. salina larvae (nauplii) incubated in
different solvent extracts of P. capitata  and controls are
shown in Fig. 4. There was a significantly higher mortality
percentage (22.33%) of the nauplii incubated with the test
drug than the extracts and sea water (p<0.05). Although, there
was non-significant difference (p>0.05) between the extracts
and the sea water, the aqueous extract had the least mortality
of 0.50% while the ethanolic extract had the highest mortality
of 9.50%.
The  effect  of  varying  concentrations  of  the  plant
fractions on the mortality of larvae is shown in Fig. 5a and b.
The degree of mortality of nauplii was in a concentration
dependent fashion. The highest mortality was observed in all
the extracts at 1 mg mLG1 while the control had a maximum
mortality (100%) at 1 mg mLG1. There was 0% mortality of the
nauplii at concentrations of 0.0625-0.5 mg mLG1 in the
methanolic   and   aqueous   extracts.   There   was   also   0%
mortality at concentrations of 0.125 and 0.0625 mg mLG1 in
the acetone extract while the ethanolic extract had 0% only at
0.0625 mg mLG1 (Fig. 5a).
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Fig. 5(a-b): Percentage mortality of Artemia salina  cysts incubated in different concentrations of the plant extracts and control.
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Figure 5b illustrates the relationship of the solvent
extracts and control in respect  of  a particular concentration.
At 1 mg mLG1, the positive control had a higher significant
mortality   (100%)   from   the  extracts  (p<0.05).  Though  the
ethanolic extract had the highest mortality of the nauplii
(30%)  but  it  was  not  significantly  different  from  the
acetone  (6.17%)  and  methanolic  (3.33%)  extracts  (p>0.05)
but significantly higher than the aqueous extract (2.5%)
(p<0.05). At 0.5-0.0625 mg mLG1, all the plant extracts and
control had no significant difference from one another
(p>0.05).
The percentage mortality due to exposure time is
captured in Fig. 6a and b. The result showed that the
percentage mortality was time dependent as the longer the
nauplii were exposed to the plant extracts, the higher the
mortality (Fig. 6a). Exposure of the nauplii from 12-48 h in the
acetone and methanol extracts showed no mortality but
further exposure gave a non-significant mortality at 60 h and
significant mortality at 72 h (Fig. 6a). Significant mortality in
the  ethanol  extract  was  only  recorded  after  72  h  while the
aqueous extract had non-significant mortality although,
(p<0.05). The test drugs showed a higher significant mortality
of   the   nauplii   at   12-60   h   (p<0.05).   The   extracts   gave
non-significant  different  mortality  from  one  another  and
sea water at 12-60 h (p<0.05) (Fig. 6b).
The   expected   dose/concentration   expected   to   kill
50%   nauplii   was   calculated   and   presented   in   Table 1.
The     test     drug     had     the     highest     lethal     dose     of
0.89  mg  mLG1  while,  all  the  plant  extracts  had  lethal 
doses >1 mg mLG1.
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Fig. 6(a-b): Percentage mortality of Artemia salina  cysts incubated in different time durations in the plant extracts/controls. The
values are means of replicates (of all the concentrations) for each plant extract/control±SD. Set of bars with different
letters are significantly different (p<0.05), (a) Set of bars represents the effect of the solvent extracts/positive control
at varying time of exposure on the mortality of the nauplii and (b) Set of bars represents the effect of the solvent
extracts/positive control to a particular time of exposure on the mortality of the nauplii
DISCUSSION
For  the  past  30  years,  A. salina  (brine  shrimp)  nauplii
have been used as the first line of preliminary evaluation of
the general toxicity of herbal remedies6. In this study, the
toxicity of P. capitata  was evaluated using both the inhibition
of hatching of the cysts and mortality of the hatched cysts
(nauplii) in different concentrations of plant extracts and
controls.  The  hatching  success  of  A.  salina  cysts  incubated
with aqueous extracts had the highest hatching success which
means it had the least inhibitory hatching activity (40.67%)
and  presumably  less  toxic  than  the  rest  solvent  extracts
(Fig. 1). This could explain why most traditional herbal
medicines are prepared using water as a solvent because it is
not or less toxic8.
There was an increase in hatching success of the cysts
incubated   in   the   plant   extracts   as   the   concentration
decreases, but a maximum hatching success was achieved at
0.25 mg mLG1 and a further decrease in concentration resulted
in decrease in hatching success (Fig. 2a, b). Artemia salina  has
a resistant cyst stage which is tolerant of a wide range of
salinity from saturated saline to almost fresh water5,13 and until
the  dormancy  is  broken,  hatching  will  not  occur  hence,  at
0.25 mg mLG1, the plant extracts exhibited an optimum
breaking of the dormancy of the cysts and further increase or
decrease in the concentration exhibited an inhibitory action
on the cysts. From the results, it is observed that the extracts
at 1 mg mLG1 exhibited a toxic/inhibitory effect therefore
preventing the cysts from hatching.
The hatching success of the cysts in response to exposure
time as shown in Fig. 3a suggests that after 36 h of incubation
in the various plant extracts, no further significant hatching
success was observed (p<0.05) suggesting that 36-48 h is the
best hatching time for brine shrimp which is also in agreement
with the reports of Meyer et al.14. There was a fairly low
hatching success  of  the plant extracts on the cysts except for
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the aqueous extract which had a hatching success of over 50%
at 36 h and above. The low hatchability success observed with
this plant species could be attributed to the presence of
chemical metabolites which probably may cause the eggs to
further encyst in response to the chemical toxins.
According to Otang et al.5 the resistance of the brine
shrimp cysts to unfavourable environmental conditions makes
the hatchability assay less desirable hence the lethality assay
is a more appropriate test for the preliminary screening of
herbal toxicity because it has the advantage of circumventing
the toxin tolerance of the cyst stage as the nauplii that are very
sensitive to toxins are used13.
In accordance to Meyer et al.14 and Bastos et al.15 with
respect to brine shrimp lethality test, the criterion of toxicity
for plant remedies is as follows;  the plant extract showing LC50
values greater than 1000 µg mLG1 (1 mg mLG1) are considered
non-toxic,   LC50   values   equal/greater   than   500   µg   mLG1
(0.5 mg mLG1) but not greater than 1000 µg mLG1 are
considered to have weak toxicity while those having LC50
values less than 500 µg mLG1 are considered toxic. The BSLA
result of all the solvent extracts of P. capitata  leaf showed that
the extracts were not toxic with LC50>1 mg mLG1 (Table 1)
hence, these extracts may be considered safe for consumption
as a herbal medicine. On the other hand, this non-toxic result
could be discouraging as an alternative for the treatment and
management  of  cancer/tumor,  as  brine  shrimp  lethality
test is usually an indicator for the preliminary screening of
bioactivity including for anticancer16. This result is in
agreement with the results obtained from Indonesian
mistletoe,     Dendrophthoe     pentandra,     growing     on
different   host   plants   and   Macrosolen   cochinchinensis
growing  on  Artocarpus  heterophyllus16  which  had  LC50
values >1000 µg mLG1.
There was a proportionate relationship of the
concentration   to   the   degree   of   lethality   of   the   nauplii
(Fig. 5a, b). The degree of mortality increased with increase in
concentration as the maximum mortality of 17.5, 16.7, 30 and
2.5% occurred at the highest concentration of 1 mg mLG1
incubations  of  acetone,  ethanol,  ethanol  and  aqueous
extracts, respectively while the test drug had a 100% mortality
of the nauplii. Conversely, least mortality of 0% was observed
in  all  the  solvent  extracts  at  the  least  concentration  of
0.0625 mg mLG1 (Fig. 5a, b). The percentage mortality of the
nauplii  in  all  the  extracts  at  concentration  range  from
0.0625-0.5  mg  mLG1  was  non-significant  (p>0.05)  except  at
1 mg mLG1 where there was significance between the aqueous
extract (2.5%) and the ethanolic extract (30%) (Fig. 5b). The
administration of different concentration range was to set a
baseline between safe and lethal limits in order to prevent the
effect of acute overdose in future in vivo trials as simple
zoological invertebrates are used for convenient toxicological
screening system of medicinal plants5.
The effect of the plant extracts on the nauplii over
duration of time was done to ascertain the maximum
sensitivity of nauplii on the toxic metabolites/chemical
compounds present in the different solvent extracts.  Mortality
of the nauplii was first observed at 60 h of exposure to the
extracts and an exponential significant lethality at 72 h
(p<0.05)  in  the  extracts  except  for  the  aqueous  extract.
Lewis17 sited by Carballo et al.6 reported that maximum
sensitivity of the nauplii to test compounds is reached at the
second and third instar stages and this is after 48 h of
incubation,  this is in agreement with this present findings that
mortality was hardly noticed before 48 h in the plant extracts.
According to Otang et al.5,  toxic effects of plant toxins can be
delayed and thus suggesting that long exposure time is
advisable for the evaluation of toxicological risks of plant
extracts with brine shrimp lethality assay. The delayed
mortality effect observed at 72 h suggests that the different
plant extracts may have some nutritive values that may have
acted as food and also the presence of less toxic compounds
to brine shrimp.
CONCLUSION
This  study  showed  that  the  different  solvent  extracts 
of   P.   capitata   growing   on   rubber   tree   are   not   toxic
(LC50>1 mg mLG1) in the brine shrimp lethality assay hence, it
may be considered safe for use in traditional/alternative
medicine. However, further in vivo, in vitro and cancer cell
lines toxicity tests are required to further substantiate these
claims and also to ascertain if it has anticancer potentials
because there had been a report on Macrosolen
cochinchinensis (a mistletoe) which had no toxicity on brine
shrimp but showed cytotoxicity in cell lines. The indication
being that the cytotoxic compounds in the extracts might be
selectively toxic on cancer cells and hopefully less toxic to
normal cells16.
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Background of the study 
The advent of antibiotics has proved to be the main tool in combating microbial infections and 
have greatly improved the health-related qualities of human life. Since the discovery of 
antibiotics and their uses in chemotherapy, there has been a notion in the health sector that this 
would lead to the eventual eradication of infectious diseases. However, over the past decades, 
over-reliance and use of antibiotics have led to the emergence and dissemination of multi-drug 
resistant strains of several groups of microorganisms (Bhalodia and Shukla, 2011; Khan et al., 
2009). 
Due to the increase in resistant clinical isolates, there is a paramount need to develop new and 
innovative antimicrobial agents (Djeussi et al., 2013). Coates et al., (2002) cited by Khan et al. 
(2009), stated that even new families of antimicrobial agents may result in short life expectancy 
due to the rapid and widespread of the emergence of resistance to newly introduced antibiotics. 
Therefore, researchers are looking for new leads in the discovery of better alternatives against 
multi-drug resistant microbial strains. Among the potential sources of new agents, plants have 
long been investigated owing to their popular use as remedies for diverse infectious diseases 
because they contain many bioactive compounds that could be of interest in therapeutics 
(Djeussi et al., 2013). Herbal drugs research is increasing on a daily basis not only because they 
serve as lead to the formulation of new preventive or curative drugs, but because they are 
affordable and believed to be safer than orthodox drugs (Balouiri et al., 2016; Ogunmefun et 
al., 2015; Olajuyigbe and Afolayan, 2012). 
One of the groups of plants popular for its folkloric usage and for the treatments of all kinds of 
ailments is the mistletoe. They are also commonly called as “heal all” because of the belief that 
they can cure all diseases (Adodo, 2004). Amongst know families of the mistletoe, 
Loranthaceae is widely distributed and extensively exploited in Africa for its diverse 
therapeutic values. Some of the recognised therapeutic applications include; antitumor, cough, 
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headache, tightening of the uterus after childbirth, antiviral, anticancer, antinociception and 
antimicrobial etc. (Ameer et al., 2015; Moghadamtousi et al., 2013).  
Prior to this study, there had been a dearth or no information on the antimicrobial activities of 
Phragmanthera capitata growing on rubber tree save the report of Ogunmefun et al. (2015) on 
Phragmanhera incana growing on Kolanut and Cocoa. This may be due to the fact that most 
studies on mistletoe are focused on its parasitic habit on host plants. This chapter, therefore, is 
aimed at investigating the anti-bacterial and anti-fungal activities of P. capitata on different 
human and animal pathogenic strains of microorganisms using the agar and 96-well broth 
dilution techniques. 
Materials and Methods 
Collection and extraction of the Phragmanther capitata 
Collection and extraction of the P. capitata were done as previously described in chapter two. 
 
Rationale for the selection of the microorganisms 
The bacteria and fungi used for this work were selected based on their roles as opportunistic 
pathogens to humans and animals and their association with stomach disorders, diarrhoea, 
dysentery, wound and other infections and primarily to validate the ethnopharmacological 
claims of P. capitata as a remedy to these diseases (Ogunmefun et al., 2015) 
Microbial strains 
Five gram-positive strains: Enterococcus faecalis (ATCC 29212), Staphylococcus aureus (OK), 
Bacillus subtilis KZN, Bacillus cereus, Streptococcus pyogenes  and 5 gram negative strains: 
Vibrio cholera, Klebsiella pneumonia (ATCC 4352), Pseudomonas aeruginosa (ATCC 19582), 
Salmonella typhi (OK) and Escherichia coli (ATCC 8739) were used for the antibacterial 
activity. The fungi isolates used were Trichophyton mucoides ATCC 201382, Trichophyton 
tonsurans ATCC 28942, Candida albicans (ATCC 10231) and Aspergillus niger ATCC 16888. 
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All the organisms used were obtained from the Medicinal Plants and Economic Development 
(MPED) Research Centre, Botany Department, University of Fort Hare, South Africa. 
Preparation of bacterial inoculum 
Direct colony suspension method was used in preparing the inoculum. Three to five 
morphologically similar colonies from fresh Müller Hinton Agar plates were transferred with a 
loop into about 5 mL of normal saline in a capped test tube and vortex. The suspension formed 
was adjusted to give a turbidity equivalent to that of a 0.5 McFarland standard (BaSO4 prepared 
spectrophotometrically) to give an approximate 1.5 × 10
8
 CFU/mL. The adjusted colony was 
then diluted in a ratio 1:100 in Müller Hinton Broth to give a colony suspension of 1 × 10
6
 
CFU/mL. Final suspensions of 1 × 10
4
 CFU/spot and 3-7 × 10
5
 CFU/mL were used for the agar 
and broth dilutions respectively. 
Preparation of fungal inoculum 
Fungal strains were freshly sub-cultured on sterile Sabouraud Dextrose Agar and incubated at 
30
o
C for 2-5 days. The resultant cells and spores were washed into sterile Normal Saline and 
the turbidity adjusted to a 0.5 McFarland standard equivalent. This resulted in a 1 × 10
6
 
CFU/mL. The suspension is further diluted in a 1:10 ratio in Sabouraud Dextrose Broth to give 
a turbidity of 5 × 10
5
 CFU/mL. 
Dilution assays 
Agar dilution and broth microdilution assays as described by Wiegand et al. (2008) and the 
European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2003) which are 
modifications from the guidelines of the Clinical and Laboratory Standard Institute (NCLI), 
were used for this study.  
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Preparation of the plant extract 
A 10 mL stock solution of 500 mg/mL was prepared by first dissolving the crude extract in 1 
mL of DMSO and made up with either Müller Hinton or Sabouraud Dextrose Broth for anti-
bacterial and anti-fungal respectively was prepared. Two-fold serial dilutions of the stock (250, 
125, 62.5, 31.23, 15.625 and 7.8125 mg/mL) were also prepared in broth. Standard drugs 
(ciprofloxacin and nystatin for antibacterial and antifungal respectively) were also prepared in 
2-fold serial dilutions according to guidelines of the Clinical and Laboratory Standard Institute 
(CLSI). 
Resazurin (Alamar Blue) Preparation 
Resazurin was obtained as a tablet and prepared according to the manufacturer’s specification. 
A tablet was dissolved in 50 mL of sterilised distilled water and vortex. A ratio 1:10 final 
volume was used for the assay. 
Agar dilution assay 
Müller Hinton and Sabouraud Dextrose Agar were separately prepared according to the 
manufacturer’s description for antibacterial and fungi screening respectively. The agar was 
autoclaved at 121
o 
C for 15 min and allowed to cool to 50
o
C in a water bath. About 0.5 mL of 
the 2-fold serial dilutions were added to the molten agar (24.5 mL) in the water bath, swirled 
and poured into petri dishes and allowed to cool and solidify. 10 µL each from both the 
prepared bacterial and fungal inoculum was delivered on the solidified agar surface to give the 
desired final inoculum of 1 × 10
4
 CFU/spot and 1 × 10
3
 CFU/mL respectively.  The extract 
concentrations for the antibacterial ranged from 5 mg/mL to 0.1563 mg/mL while for the 
antifungal, a range of 10 mg/mL to 0.3125 mg/mL was used. The concentration of 
Ciprofloxacin (antibacterial standard) ranged from 64 µg/mL to 2 µg/mL while Nystatin 
(antifungal standard) ranged from 16 µg/mL to 0.5 µg/mL. Bacteria plates were incubated at 
37
o
C and readings were taken between 16-20 hrs and after 3 days of incubation; fungi plates 
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were incubated at 30
o
C and initial readings were taken after 2 to 3 days and the second readings 
were taken after 5 days. 
Broth microdilution assay 
Müller Hinton Broth for antibacterial screening was also tested using the 96-well microtitre 
plate with lid. The extracts and the standard drug were prepared in a concentration twice the 
desired final concentration as it will be diluted with an equal amount of bacteria in broth. 
Briefly, 200 µL of the prepared extracts and standard drug in broth was introduced into the first 
wells in columns 1-10 (in row A). Rows B-H in columns 1-10 had 100 µL of broth alone while 
rows A-H in column 11 had 200 µL of broth and 100 µL of broth was in A-H in column 12. 
Two-fold serial dilutions using a multi-channelled micropipette was done systematically down 
the columns 1-10 (from rows B-H). 100 µL was removed from the starting concentrations 
(Columns 1-10 in Row A) and taken to the next row with the 100 µL broth, mix well and 100 
µL taken from it to the next well until the last row (H) where it was discarded. This brings the 
final volume in all the test wells with the extracts and the standard drugs to 100 µL except the 
11
th
 column which had 200 µL of the broth that served as sterility control. An equal volume 
(100 µL) of the 1 × 10
6
 CFU/mL bacterial inoculum was transferred into all the wells except the 
11
th
 column to give the desired final inoculum load of 5 × 10
5
 CFU/mL. Column 12 served as 
growth control (drug-free). The extracts concentrations ranged from 10 mg/mL to 0.078 mg/mL 
while ciprofloxacin ranged from 2 µg/mL to 0.0156 µg/mL. Microtiter plates were incubated at 
37
o
C for 18-20 hrs. After incubation, 20 µL of Alamar blue (resazurin) was added to all the 
wells and incubation for few minutes to observe any colour changes.  
Minimum Inhibitory/Bactericidal Concentrations (MIC/MBC) 
The Minimum Inhibitory Concentrations were determined visually in the agar and broth 
dilutions as the lowest concentrations of the extracts at which no bacterial/fungal growth was 
visible (or greatly reduced in comparison to the controlled growth in the antifungal assay) or 
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colour changed from blue to pink in the case of the resazurin broth assay. Minimum 
Bactericidal Concentrations were determined by sub-culturing wells with no colour change on 
fresh agar plates and incubated at 37
o
C for 16 to 20 hrs. After the incubation, the lowest 
concentration that did not show any visible growth was taken as the MBC. 
Result 
The results of the antibacterial Minimum Inhibitory Concentration (MIC) using agar dilution 
and resazurin broth microdilution assays (Figure 1) are shown in Table 1. The result revealed 
that both gram-positive (+ve) and negative (-ve) bacteria tested were susceptible to the crude 
extracts of P. capitata. The gram-negative bacteria were more susceptible to the crude extracts 
in both methods assayed for but more defined in the agar dilution. The MIC values in the agar 
dilution ranged from 1.25 mg/mL to 2.5 mg/mL for all the gram-negative bacteria except for K. 
pneumonia (in the methanol and ethanol extracts) and S. typhi (in the methanol extract) which 
had MIC values of 5 mg/mL. The aqueous extract had the lowest activity compared to the 
organic solvent extracts but also exhibited better gram –ve activity in the agar dilution method 
with a MIC value of 5 mg/mL in E. coli, S. typhi and V. cholera. However, there was no activity 
recorded for the aqueous extract in the broth dilution technique. The standard drug 
(Ciprofloxacin) showed great antibacterial activity with a MIC value ranging from 0.0625 
µg/mL to 0.25 µg/mL in the broth dilution and ≤ 2 µg/mL (lest concentration tested) in the agar 
dilution.  
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Table 1: Minimum Inhibitory Concentrations (MICs) of the different solvent extracts of P. capitata on selected gram-negative and gram-
positive bacteria using the agar and Resazurin broth dilution assays 
 Agar Dilution (16-20 hrs) Resazurin Broth Microdilution   
Act Met Eth Aqu Cip Act Met Eth Aqu Cip 
mg/mL µg/mL mg/mL µg/mL 
Enterococcus faecalis (+ve) 2.5 2.5 5 > 5 ≤ 2 2.5 2.5 5 > 10 0.25 
Staphylococcus aureus (+ve) 5 5 5 > 5 ≤ 2 5 5 5 > 10 0.0625 
Bacillus subtilis (+ve) 5 5 5 > 5 ≤ 2 2.5 2.5 2.5 > 10 0.0625 
Bacillus cereus (+ve) 2.5 2.5 2.5 > 5 ≤ 2 2.5 2.5 5 > 10 0.125 
Streptococcus pyogenes(+ve) 5  5 5 > 5 ≤ 2 5 5 5 > 10 0.0625 
Vibrio cholera (-ve) 2.5 2.5 2.5 5 ≤ 2 2.5 2.5 5 > 10 0.0625 
Klebsiella pneumonia (-ve) 2.5 5 5 > 5 ≤ 2 2.5 2.5 2.5 > 10 0.25 
Pseudomonas aeruginosa (-ve) 2.5 2.5 2.5 > 5 ≤ 2 2.5 2.5 2.5 > 10 0.25 
Salmonella typhi (-ve) 2.5 5 1.25 5 ≤ 2 5 5 5 > 10 0.0625 
Escherichia coli (-ve) 2.5 2.5 1.25 5 ≤ 2 2.5 1.25 2.5 > 10 0.0625 
 
Annotations: Act (acetone extract), Met (methanol extract), Eth (ethanol extract), Aqu (aqueous extract), Cip (ciprofloxacin), “>” (value greater than 
the highest concentration tested) and “≤” (value lesser than or equal to the lowest concentration tested). 
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Figure 1: A schematic representation of the 96-Well Resazurin Broth Microdilution Model 
Annotations: The blue colouration indicates inhibition of growth; Pink indicates organisms are 
active.  
 
Table 2 is the result of the bactericidal activity of the extracts and agar dilution MIC after three 
days of incubation. The organic solvent extracts of Phragmanthera capitata showed more 
bactericidal activity on Escherichia coli with a MBC value of 2.5 mg/mL while there was no 
bactericidal activity on P. aeruginosa. The MBC for the organic extracts ranged from 2.5 
mg/mL to 10 mg/mL with acetone having the best activity. The result of the agar dilution 
technique incubated for a prolonged time (3 days) showed a comparable result to the MBC with 
a range of 2.5 mg/mL to values greater than the highest concentration tested (> 5 mg/mL) for 
the crude extracts. Ciprofloxacin also showed a great lethal activity on almost all the organisms 
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at the concentrations tested except for E. faecalis that survived the highest dosage for this test. 
However, variation was observed in the organisms incubated for a prolonged period of time 
with ciprofloxacin in the agar. While at 4 mg/mL, V. cholera and K. pneumonia continued to 
grow, the same organisms were killed in the bactericidal test. 
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Table 2: Minimum Bactericidal Concentrations (MBCs) and MIC of the Agar dilution after 3 days of incubation of the different solvent 
extracts of P. capitata on selected gram-negative and gram-positive bacteria  
 MBC Agar Dilution (After 3 Days) 
Act Met Eth Aqu Cip Act Met Eth Aqu Cip 
mg/mL µg/mL mg/mL µg/mL 
Enterococcus faecalis (+ve) 5 5 5 > 10 > 2 5 5 5 > 5 4 
Staphylococcus aureus (+ve) 5 10 10 > 10 0.0625 5 > 5 > 5 > 5 ≤ 2 
Bacillus subtilis (+ve) 5 10 10 > 10 0.125 5 > 5 > 5 > 5 ≤ 2 
Bacillus cereus (+ve) 5 5 10 > 10 > 2 5 5 > 5 > 5 ≤ 2 
Streptococcus pyogenes(+ve) 5 10 10 > 10 0.0625 5 > 5 > 5 > 5 ≤ 2 
Vibrio cholera (-ve) 5 5 5 > 10 0.0625 5 5 5 > 5 4 
Klebsiella pneumonia (-ve) 5 5 5 > 10 1 5 5 5 > 5 4 
Pseudomonas aeruginosa (-ve) 10 10 10 > 10 0.25 > 5 > 5 > 5 > 5 ≤ 2 
Salmonella typhi (-ve) 5 10 10 > 10 0.0625 5 > 5 > 5 > 5 ≤ 2 
Escherichia coli (-ve) 2.5 2.5 2.5 > 10 0.0625 2.5 2.5 2.5 > 5 ≤ 2 
 
Annotations: Act (acetone extract), Met (methanol extract), Eth (ethanol extract), Aqu (aqueous extract), Cip (ciprofloxacin), “>” (value greater than 
the highest concentration tested) and “≤” (value lesser than or equal to the lowest concentration tested) 
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The antifungal activities of the solvent extracts of P. capitata on some selected human 
pathogenic fungi are as shown in Table 3. The MICs were read twice; between 2-3 days and 
after 5 days of incubation. The MIC for C. albicans and A. niger were taken as the 
concentrations which showed little spot to no growth in comparison to the control (Figure 2). 
The result revealed that T. mucoides and C. albicans were resistant to the organic solvent 
extracts of the plant. Trichophyton tonsurans and A. niger were, however, susceptible to the 
organic solvent extracts. The MICs for acetone, methanol and ethanol extracts on T. tonsurans 
were 1.25 mg/mL, 10 mg/mL and 5 mg/mL respectively. Acetone and ethanol extracts had a 
MIC of 5 mg/mL while methanol extract had MIC value of 10 mg/mL on A. niger. The result 
after 5 days of incubation was similar to the first observation except in the ethanol extract 
where the MIC increased to 10 mg/mL in both T. tonsurans and A. niger. However, a very high 
susceptibility was observed in the aqueous extract in all the fungi assayed for and remained 
unchanged after 5 days of incubation. The MIC of the aqueous extract was 1.25 mg/mL on T. 
mucoides and ≤ 0.3125 mg/mL (lowest concentration tested) on T. tonsurans, C. albicans and 
A. niger. Nystatin also showed a high MIC on the tested organisms with MIC which ranged 
from 4 µg/mL to 8 µg/mL after 2-3 days of incubation and greater than 16 mg/mL in C. 
albicans after 5 days of incubation. 
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Table 3: Minimum Inhibitory Concentrations (MIC) of the different solvent extracts of P. capitata on selected human pathogenic fungi 
 2-3days after incubation 5days after incubation 
Act Met Eth Aqu Nys Act Met Eth Aqu Nys 
mg/mL µg/mL mg/mL µg/mL 
Trichophyton mucoides >10 >10 >10 1.25 4 >10 >10 >10 1.25 4 
Trichophyton tonsurans 1.25 10 5 ≤0.3125 4 1.25 10 10 ≤0.3125 4 
Candida albicans >10 >10 > 10 ≤0.3125 4 >10 >10 >10 ≤0.3125 >16 
Aspergillus niger 5 10 5 ≤0.3125 8 5 10 10 ≤0.3125 8 
 
Annotations: Act (acetone extract), Met (methanol extract), Eth (ethanol extract), Aqu (aqueous extract), Nys (nystatin), “>” (value greater than the 
highest concentration tested) and “≤” (value lesser than or equal to the lowest concentration tested). 
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Figure 2: Representation of the anti-fungal MIC determination of P. capitata against the tested 
fungi using the Agar Dilution technique. 
Annotations: values 1-4 are the fungal used which are; 1= Trichophyton mucoides; 2= 
Trichophyton tonsurans; 3= Candida albicans and 4= Aspergillus niger. A1, A2 & A4, M1& 
M2, E1 & E2 and H4, H5 & H6, are the different concentrations used with the highest 
concentration being 1 (10 mg/ml) and the least was 6 (0.3125 mg/mL). Spots on plates are fungi 
growth indicating resistance of the organism(s) at that concentration. 
 
Discussion 
In ethnopharmacological research, antimicrobial susceptibility tests are carried out to determine 
how effective potential anti-microbial agents from biological extracts could be against different 
pathogenic microorganisms. These tests are used to screen plant extracts for antimicrobial 
activities and also used to determine or ascertain the usefulness of antimicrobial agents in 
fighting infections by determining their MIC (Ncube et al., 2007). According to the EUCAST 
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document (2003), in-vitro susceptibility tests are carried out on pathogenic microorganisms 
with suspicion of belonging to species that have displayed resistance to commonly used 
antimicrobial agents. These tests are also very useful for the surveillance of resistance, 
epidemiology of susceptibility and to compare new and existing antimicrobial agents. These 
parameters are very vital in clinical practice in classifying the tested microorganisms as 
clinically susceptible, intermediate or resistant to the test antimicrobial agents (Wiegand et al., 
2008). 
Different standard methods have been used to evaluate the antimicrobial activities of plants 
crude extracts. However, dilution methods have been favoured over others for the determination 
of MIC (broth and agar dilutions) and MBC (broth dilution) (Wiegand et al., 2008). Presently, a 
new method using the oxidation–reduction colorimetric indicator resazurin is been used for the 
determination of drug resistance and MICs of antimicrobial agents against Pathogenic 
organisms (Ncube et al., 2007; Nateche et al., 2006). Resazurin, which is blue in its oxidised 
state, turns pink when reduced by viable cells (Figure 1) and can easily be detected with the 
naked eyes and the MIC determined even without the aid of a spectrophotometer. This work 
explores the use of resazurin for the broth microdilution method for the antibacterial MIC 
determination 
Antibacterial assay 
The agar and broth dilution techniques used in this study revealed that they are both effective 
antibacterial techniques for the determination of MIC. However, the resazurin broth 
microdilution technique proved to be more sensitive as it could detect the slightest activity of 
the organisms where the agar dilution could not; this was evidently observed in the aqueous 
extract (V. cholera, S. typhi and E. coli) in the antibacterial assay (Table 1 and Figure 1). 
According to early works on parasitic plants, Hawksworth (1996) reported that parasitic plants 
scarcely utilise their photosynthate and depends mostly on the nutrient absorbed from the host. 
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Hence, the bio-compounds are chiefly dependent on its host. This was evident in the 
antimicrobial works of Ogunmefun et al. (2015), Deeni and Sadiq (2002) and Efuntoye et al. 
(2010) which showed different antimicrobial activities of the same plant on different hosts. This 
study in comparison to the works of Ogunmefun et al., (2015), showed that Phragmanthera 
capitata of rubber tree (Hevea brasiliensis) have greater promise for its anti-bacteria potential 
(MIC of 1.25 mg/mL to 5 mg/mL in the organic solvents) than the ones harvested from kolanut 
and cocoa (MIC of 100 mg/mL to 200 mg/mL). While Bacillus sp, K. pneumonia and E. coli 
were resistant in P. capitata from kolanut and cocoa (Ogunmefun et al., 2015), these bacteria 
were highly susceptible to the same species collected from rubber trees in this work.  
The bactericidal ability of P. capitata parasitic on rubber tree was also assayed for and the 
result revealed that this plant will not only inhibit these bacteria but also has the potential to kill 
them at appreciable concentrations (Table 2). Hence, P. capitata parasitic on rubber tree has 
potential as an antibiotic in the pharmaceutical industry and can serve as an alternative remedy 
to the diseases caused by these bacteria.  
In evaluating the effect of the extract on the bacteria in the agar dilution method, incubation was 
further prolonged for 3 days and the results obtained were in comparison with the MBC. Some 
organisms that were initially inhibited by the extracts after 20 hrs however recovered and 
continued growth (Table 2). This could be as a result of the antibacterial bio-compounds in the 
extract(s) becoming weak and less active and therefore bacteria that were still alive recovered 
and continued to grow. This observed outcome could give some insights into the shelf life or 
duration of action of the extracts against microorganisms. This simply explains that where 
organisms continued growth, the extracts at those concentrations were not bactericidal to them. 
Alternatively, organisms that continued growth may not have been properly dissolved in the 
agar and hence when the activity of the extract reduced beyond their threshold, they re-grew. 
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This could be a major advantage of the broth over the agar dilution method as the organism is 
highly soluble or mixes very well with the broth as they are both liquids. 
Antifungal assay 
 The activity of the crude extracts of P. capitata was also tested against pathogenic fungi using 
the agar dilution technique. Four pathogenic fungi were tested but only two viz; T. tonsurans 
and A. niger were susceptible to the organic extracts. While A. niger was susceptible in this 
work, the same was resistant in the reports of Ogunmefun et al., (2015) suggesting that P. 
capitata from rubber tree may be more potent than the ones collected from kolanut and cocoa as 
an anti-fungal agent. The result on C. albicans from this work is in support of Ogunmefun et 
al., (2015) which did not show any activity on the organic solvents used.  Interestingly, while 
the aqueous extract seldom showed anti-bacterial activity, the same had a very high anti-fungal 
activity as it inhibited all four tested fungi (Table 3 and Figure 2, H4). This could suggest that 
water was able to extract the anti-fungal agent in the plant than the organic solvent extracts. 
There were no marked changes observed after prolonged incubation of the plates for 5 days and 
where changes occurred, the same reason as above could justify it. 
Conclusion 
The outcome of this work clearly revealed that P. capitata harvested from rubber trees has the 
ability to inhibit both gram-positive and negative bacteria effectively and also exhibited anti-
fungi ability and with great promise for use as an anti-microbial agent in folklore medicine. 
While it was recorded that water was a weak anti-bacterial extractant in this study, contrarily, 
water would be recommended if the target were fungi. This work further supported the claimed 
ethnopharmacological uses of P. capitata against gastrointestinal infections and other 
opportunistic diseases of humans and animals. Also worth noting is the potential of P. capitata 
to could serve as an alternative remedy in therapeutics as most of the organisms used for this 
work have had some reports of resistance to conventional drugs.   
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Background of the study 
Tuberculosis (TB), an infectious disease usually caused by the bacterium, Mycobacterium 
tuberculosis, is one of the leading causes of human morbidity and mortality (Nguta et al., 2016; 
Sánchez and Kouznetsov 2010). According to the 2016 Factsheet on TB by the World Health 
Organization (WHO), TB is one of the top ten causes of death worldwide. The report stated 
that, of the 10.4 million people who took ill with TB, 1.4 million died from the disease 
(excluding those with HIV) in 2015. An estimated 1 million children (0 to 14 years) were 
infected with TB and 170,000 excluding those with HIV died of the infection in 2015 (WHO, 
2016).   
Tuberculosis is prevalent in every part of the world. Currently, a reported one-third of the 
world’s population has latent TB (infected but asymptomatic) and a 10% lifetime risk of 
developing into an active TB. Active TB is transmitted from an infected person through the air 
when they cough, sneeze or spit, to about 10 to 15 other people within a year. The Asian 
continent accounts for 61% while Africa accounts for 26% of the world TB cases. Six countries 
in the order of prevalence: India, Indonesia, China, Nigeria, Pakistan and South Africa, account 
for 60% of the new TB cases (WHO, 2016; Gupta et al., 2014).  
Rifampicin, Isoniazid, Streptomycin and Ethambutol were introduced almost three decades ago 
in TB control programme for the treatment of TB. The indiscriminate use: inappropriate, 
incorrect prescription by healthcare providers, poor quality drugs and patients stopping 
treatment prematurely had led to the alarming rise in the  development of multidrug resistance 
(MDR-TB), the more severely extensive-resistant (XDR-TD) and currently, totally drug-
resistant (TDR-TB) TB strains (WHO, 2016; Nguta et al., 2016; Proksch et al., 2015; Singh et 
al., 2013). No new anti-TB drug had been released for decades now and MDR-TB, XDR-TB 
and TDR-TB are on the increase, hence, there is an urgent need for new leads in the 
development of novel, effective, safe and affordable drugs against all forms of resistant TB 
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strains. Amongst different natural products used in ethnopharmacology, plant-based products 
have been extensively utilised because of its vast reservoir of phytochemicals explored for a 
wide range of infections and anti-mycobacterium compounds have been derived from them 
(Nguta et al., 2015). 
Phragmanthera capitata (Sprengel) Balle has been used in herbal medicine for the treatment 
and management of TB related ailments and different infections and diseases in Africa (Takem 
et al., 2015). Arising from the foregoing, this chapter was aimed at investing the possible anti-
Mycobacterium tuberculosis potential of P. capitata using the automated BACTEC MGIT 960 
system. 
Methodology 
Collection and extraction of Phragmanthera capitata 
Collection and extraction of P. capitata were carried out as previously described in chapter two 
Microbial strain, culture and assay 
The American Type Culture Collection of Mycobacterium tuberculosis strain H37RV (ATCC 
25618) was used for this assay. Suspension of virulent M. tuberculosis (H37Rv) strain was 
grown using mycobacterial growth indicator tubes (MGIT). The inoculum was prepared in 
Lowenstein–Jensen slants. An inoculum of less than 15 days old was prepared from the culture 
grown on Lowenstein-Jensen medium in normal saline and adjusted to a 1.0 McFarland 
standard. The suspension was then vortexed and allowed to stand for about 20 min for larger 
particles to settle to the bottom of the tube. After settling, the supernatant was transferred to a 
fresh sterile tube and adjusted to a 0.5 McFarland standard. The adjusted inoculum was further 
diluted in a ratio 1:5. 0.5 mL of the diluted suspension was inoculated in Middlebrook 7H12 
(MGIT 960 system, Becton Dickinson, Sparks, USA) tubes containing aliquots (100 µl) of the 
test and control compounds. Final DMSO concentration was ≤ 1.2%. The tubes were incubated 
at 37
o
C in MGIT system. The growth units (GU) were monitored for six days. The growth was 
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monitored through fluorescent changes due to oxygen consumption in the medium during active 
growth.  
For the determination of the Minimal Inhibitory Concentration, 1% mycobacterial control 
culture was prepared in a drug-free; with 1.2% DMSO; isoniazid (INH) and extracts in MGIT 
tubes and the MIC of the compound determined relative to the growth units of the control (GU). 
The MIC was determined as the lowest test compound concentration that equals or lower than 
GU of the 1% mycobacterial culture. All the extracts were tested at two-fold decreasing 
concentrations (50, 25, 12.5, 6.25, 3.125 and 1.5625 µg/mL). 
Result and Discussion 
Ethnobotanical studies on the use of P. capitata and other mistletoe of the Loranthaceae have 
reported their pharmacological application on a variety of ailments but most have been silent on 
their use for the treatment of tuberculosis except for the report of Ibekwe et al. (2014), which 
identified a mistletoe species (Tapinanthus sessilifolia Polh. & Wiens) with anti-tuberculosis 
activity. Yet, they are known as a panacea or “cure-all” (National Institute of Health, 2015; 
Ogunmefun et al., 2013; Adodo, 2004). This study is the first evaluation of the anti-tuberculosis 
potential of P. capitata irrespective of the host and amongst the reported few on mistletoes 
generally.  
There is no clear-cut reference for crude plant extract activity on tuberculosis. The sensitivity is 
subject to the methodology employed in the test. Different researchers have used various 
standards for the interpretation of anti-mycobacterial activity of herbal drugs. There is not really 
an explicatory reason to these set standards in most of these cases (Mohamad et al., 2011). 
According to Borges-Argáeza et al. (2007) and Gautam et al. (2007), MIC of ≤ 100 µg/mL 
were considered active against M. tuberculosis and other Mycobacterium spp. Luo et al. (2011), 
set activity at MIC ≤ 125 µg/mL. Tosun et al. (2005) and Camacho-Corona et al. (2008) set a 
MIC value of ≤ 200 µg/mL while a value of ≤ 500 µg/mL and ≤ 1600 µg/mL were considered 
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as active by Newton et al. (2002); Ibekwe et al. (2014) and Mohamad et al. (2011) respectively. 
In this present study, the highest tested concentration was 50 µg/mL and comparison was done 
in respect to MIC values by previous works.  
Different methods have been employed for the evaluation of anti-tuberculosis screening of 
medicinal plants. Franzblau
 
et al. (2012), Sánchez and  Kouznetsov
 
(2010), Khalifa
 
(2013) and 
many other researchers have reported different methodologies for the anti-tuberculosis 
screening of different compounds. The BACTEC 460 which uses the radioisotope was 
considered a gold-standard for measuring the growth of intracellular mycobacteria in 
macrophages. However, the use of BACTEC 460 was discontinued by the manufacturer due to 
safety issues involved in the handling of radioactive elements. As an alternative to the 
BACTEC 460 system, a BACTEC Mycobacteria Growth Indicator Tube (MGIT) 960 system 
was used for this assay (Jhamb et al., 2014). Its performance is equivalent to the Radiometric 
BACTEC 460, plating and other methods (Jhamb et al., 2014; Adjers-Koskela and Katila, 
2003; Bemer et al., 2002). This system is fully automated, safe (not radioactive), not labour 
intensive, higher throughput, not invasive and highly efficient in M. tuberculosis screening 
(http://www.bd.com/ds/productCenter/MT-BactecMgit960.asp). 
The result of the in-vitro anti-Mycobacterium tuberculosis screening of the different fractions of 
P. capitata is as shown in Table 1. The MIC values of the solvent fractions ranged from 25 
µg/mL to 50 µg/mL. The acetone and the aqueous extracts had the best activity with a MIC 
value of 25 µg/mL, while the ethanol extract had a MIC value of 50 µg/mL. The methanol 
extract did not show any activity at the highest concentration evaluated (Table 1). The result 
from this study is an indication that P. capitata harvested from rubber tree has the potential as 
an anti-mycobacterial agent. With comparison to the different ranges of MIC values set above 
by different researchers on crude plant extracts on Mycobacterium tuberculosis, this species 
activity can be termed as highly active (Mohamad et al., 2011). The result also revealed that 
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extraction solvent has an effect on the mycobacterial bioactivity of the extracts. It can be 
deduced that acetone and water extracted more of the active bio-compounds against M. 
tuberculosis than ethanol and methanol. This solvent effect also supports our earlier antifungal 
study where the aqueous extract had a lower MIC (better antifungal properties) than the other 
solvents. 
Table 1: MIC determination against M. tb H37Rv growth using BACTEC MGIT 960 system 
Extract MIC in μg/mL 
Acetone  25 
Methanol  > 50 
Ethanol  50 
Aqueous  25 
Isoniazid 0.05  
 
This study revealed the potential of P. capitata against the virulent M. tuberculosis strain. In 
comparison to other established anti-tuberculosis medicinal plants in Malaysia (Mohamad et al., 
2011), Turkey (Askun et al., 2013; Tosun et al., 2005), Cameroon (Nkenfou et al., 2015), South 
Africa (Mativandlela et al., 2008) and Nigeria (Ibekwe et al., 2014), P. capitata has shown to 
be more effective than most of the enumerated species. Notably, in one of these evaluations, a 
mistletoe species, Tapinanthus sessilifolia, (host could not be ascertained) of the Loranthaceae 
family, used in Nigeria for the treatment of tuberculosis by herbal practitioners, a high activity 
against the H37Rv strain (MIC 128 µg/mL) (Ibekwe et al., 2014) was recorded. This high 
activity may suggest the potential of the African mistletoe (Loranthaceae) for the treatment of 
tuberculosis. Hence, further anti-tuberculosis screening on the African Mistletoe to evaluate 
their potentials in the fight against tuberculosis is of the essence as Africa is highly ladened 
with the TB scourge (WHO, 2016) 
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Conclusion 
This study highlights the results of P. capitata harvested from rubber tree plantation against the 
virulent strain of Mycobacterium tuberculosis. It provides a preliminary scientific validation of 
the use of this species against some tuberculosis associated symptoms like cough, respiratory 
dysfunctions, fever and headaches (Ogunmefun et al., 2013; Dibong et al., 2009). Further 
screening of P. capitata parasitic in different host plants and other African mistletoe for 
possible use in the development of anti-mycobacterial drugs is needed in the fight against TB. 
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Background of the study 
Diabetes mellitus which is a complex disease characterized by hyperglycemia (Lee and Jeon, 
2013) is an abnormal metabolism of carbohydrate, protein and fat (Kazeem et al., 2013). This 
progressive disorder of glucose metabolism eventually leads to different severe vascular 
changes with secondary complications that may be hard to manage and threat (Rayar and 
Manivannan, 2015). The inadequate synthesis of insulin and the insulin resistance or 
dysfunction by the pancreas β- cells result in type I and II diabetes respectively (Kazeem et al., 
2013). 
Alpha-amylase and glucosidase are gastrointestinal digestive enzymes found in the pancreatic 
juice and saliva and in the mucosal brush border of the small intestine respectively. While α- 
amylase catalyzes the initial breakdown of large insoluble starch molecules into absorbable 
smaller oligosaccharides, α- glucosidase on the other hand, initiates the end of the digestion by 
further degrading the smaller molecules into glucose which enters the bloodstream on 
absorption leading to post-prandial hyperglycemia (elevated blood glucose levels) (Kazeem et 
al., 2013; Mohamed et al., 2012). Therefore, the inhibition of both α- amylase and glucosidase 
delays digestion of carbohydrate in the small intestine and reduces post-prandial 
hyperglycemia. 
Anti-diabetic mechanisms of action act by lowering the blood glucose levels by inhibiting 
glucose digestion and/or absorption in/from the small intestine, increment of the secretion of 
insulin from the pancreas β- cells, elevation of the insulin activities in the peripheral tissues, 
inhibition of gluconeogenesis by reducing the hepatic glucose production and improvement of 
glucose utilization by adipose and skeletal muscle tissues (Agnaniet et al., 2016; El-Abhar and 
Schlaalan, 2014). 
Different synthetic anti-diabetic drugs have been developed (Derosa and Maffioli, 2012) and 
though they are effective, but side effects and cost have been their major concern and setbacks.  
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Hence, the use of plant-based pharmaceuticals has been sought as alternatives with increased 
potency, easily available and with less side effects than existing synthetic drugs (Mallare et al., 
2005). Although different researchers have reported different anti-diabetic activities in some 
mistletoes in-vivo (Takem et al., 2015; Osadebe et al., 2010, 2004), none has investigated the 
possible mode of action. Therefore, this present study was aimed at investigating the effect of 
Phragmanthera capitata activities on α- amylase and glucosidase in an attempt to validate its 
ethnomedicinal usage as an anti-diabetic agent (Ogunmefun et al., 2015; Dibong et al., 2009) 
and its possible mechanism of action. 
Methodology 
Plant collection and extraction 
Collection and extraction of the sample were carried out as previously described in chapter two.  
Alpha-amylase inhibition assay 
Assay Principle: Alpha-amylase activity was measured by the amount of starch hydrolyzed into 
monosaccharides in the presence of the enzyme. The reaction incorporates an iodine reagent 
which gives a blue colour in the presence of starch. In the presence of an enzyme inhibitor, the 
intensity of the colour measured spectrophotometrically indicates the amount of starch 
remaining in the reaction mixture, and hence, the extent of alpha-amylase inhibition. 
Reagents  
i. Starch solution (2%): 0.2 g of starch in 100 mL distilled water. Proper dissolution was 
initiated by boiling the solution in a glass beaker directly on a stirring plate for about 15 
minutes.  
ii. Phosphate buffer: 100 mM pH 6.8  
iii. 1M Hydrochloric acid (stock solution = 37%): 8.212 mL HCl (1N) was slowly added to 25 
mL distilled water and made up to 100 mL with the same.  
iv. Iodine reagent: 0.127 g I2 and 0.083 KI were mixed together in 100 mL of distilled water.  
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v. Alpha-amylase enzyme: 10 mg porcine pancreatic amylase was dissolved in 100 mL 
phosphate buffer. The preparation was made just before use and kept in ice pack.  
vi. Acarbose stock solution (positive control): A 500 μM solution was initially prepared fresh 
immediately before the assay by dissolving 3.2 mg acarbose in 10 mL phosphate buffer. 
Aliquots of 1 mL were made into eppendorf tubes and placed in ice pack. The aliquots were 
diluted five-fold to give a working concentration of 100 μM which is 64 μg/mL. 
vii. Plant extracts: Different concentrations (50, 100, 500 and 1000 μg/mL) of the acetone, 
methanol, ethanol and aqueous crude extracts were prepared in phosphate buffer. 
Procedure:  
10 μL of the enzyme solution was pipetted into appropriate wells of a 96-well plate. Thereafter, 
30 μL of test samples, phosphate buffer (the control, enzyme without inhibitor) or positive 
control (acarbose, 64 μg/mL) were added to the enzyme in respective wells. The mixture was 
pre-incubated for 10 minutes at 37ºC to allow interaction of the enzyme with the different 
compounds. The reaction was started by the addition of 40 μL starch solution to the wells and 
was incubated again for 30 minutes at 37ºC. The reaction was terminated by adding 20 μL of 
1M HCl to each well, followed by 75 μL iodine reagent. Absorbance was measured at 580 nm 
using a microplate reader (Diagnostic Automation, Inc, USA, DAR 800). Controls without 
enzyme and without starch were also included in the assay to be certain that no reaction 
occurred when one of either the enzyme or substrate was absent. This was done to eliminate 
false positive results because some plants extracts have been reported to contain traces of α-
amylase or starch.  
Alpha-amylase inhibition was measured as a percentage of the enzyme control using the 
formula:  
% α-amylase inhibition = [(Abs control – Abs sample)/ (Abs control)] X 100. 
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Alpha-glucosidase inhibition assay  
Assay Principle: The assay is based on the hydrolysis of p-nitrophenyl-α-D-glucopyranoside 
(PNP-GLUC) specifically by α-glucosidase into a yellow coloured product, p-nitrophenol 
(PNP) and D-glucose, with an absorbance maximum at 405 nm. Inhibition of α-glucosidase 
results in reduced formation of PNP.  
Reagents  
i. Potassium phosphate buffer (100 mM; pH 6.8)  
ii. p-Nitrophenyl-α-D-glucopyranoside (PNP-GLUC) solution (10 mM)  
iii. Sodium carbonate solution (100 mM)  
iv. α-glucosidase solution (50 µg/mL) 
v. Epigallocatechin gallate (positive control); EGCG (10 μg/mL)  
Procedure  
Briefly, 10 μL of plant extract (50, 100, 500 and 1000 μg/mL) or the positive control (EGCG) 
was mix with 40 μL of α-glucosidase solution. The mixture was pre-incubated at 37ºC for 5 
minutes and initial background absorbance was read at 405 nm. Thereafter, 10 μL of PNP-
GLUC was added and the reaction mixture was incubated again for 20 minutes at 37ºC. The 
reaction was terminated by the addition of 50 μL of sodium carbonate solution. The absorbance 
was measured again at 405 nm using a microplate reader (Diagnostic Automation, Inc, USA, 
DAR 800). Controls without the enzyme inhibitor (phosphate buffer) and without the substrate 
(PNP-GLUC) were also included in the assay.  
The percentage inhibition of α-glucosidase was calculated as follows:  
% α-glucosidase inhibition = [(Abs control – Abs sample)/ (Abs control)] X 100.  
Statistical analysis 
All data in triplicates were subjected to one-way analysis of variance (ANOVA) using 
GENSTAT 8 statistical package. Where the data showed significance (P ≤ 0.05), mean 
separation was done by Fisher’s Least Significant Differences (LSD). 
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Result  
The ability of the crude extracts of P. capitata to inhibit α- amylase was shown in Figure 1. All 
the extracts exhibited weak α- amylase inhibition at the concentrations (50, 100, 500 and 1000 
µg/mL) tested in a concentration-dependent manner. While the percentage inhibition of the 
positive control (acarbose) was 94.58 ± 2.32% at a concentration of 64 µg/mL, it ranged from -
0.22 ± 0.39 to 14.05 ± 0.24% in the acetone extract, 1.71± 0.34 to 13.96 ± 0.28% in the 
methanol extract, 0.80 ±  0.71 to 11.96 ± 1.24% and -2.66 ±  0.54 to 1.18 ±  0.46% for the 
ethanol and aqueous extracts respectively. The concentration of the extracts that inhibited 50% 
of α- amylase could not be determined in this study (Table 1).  
 
Figure 1: Alpha-amylase inhibitory activity of the different solvent extracts of Phragmanthera 
capitata. Values are mean ± SD (n=3). Set of bars (the same concentration) with different 
alphabets are significantly different (p <0.05). ‘*’ significantly lower than acarbose (positive 
control) (p<0.05). 
The same concentration range used for the α-amylase assay was also used in evaluating the α- 
glucosidase inhibition of P. capitata and the result was shown in Figure 2. A concentration-
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dependent inhibition was also observed in α- glucosidase investigation. In contrast to the low α- 
amylase inhibition by the different solvent extracts of P. capitata, a stronger inhibition was 
observed with α- glucosidase activity. The percentage α- glucosidase inhibition ranged from 
41.44 ± 2.20 to 94.05 ± 0.08% in the acetone extract and from 14.31± 0.69 to 50.96 ± 2.17% in 
the aqueous extract. The concentration of the extract that inhibited 50% (IC50) of α- glucosidase 
enzyme was shown in Table 1. The acetone followed by the methanol extract had the best α- 
glucosidase inhibitory activities with IC50 values of 71.89 ± 3.48 µg/mL and 91.98 ± 2.24 
µg/mL
 
respectively. The aqueous extract had the least activity with an IC50 value of 952.87 ± 
9.87 µg/mL. Though the inhibition of α- glucosidase at lower concentrations (50 and 100 
µg/mL) assayed for in this study was significantly lower than the positive control (EGCG at 10 
µg/mL), higher concentrations of 500 and 1000 µg/mL of all the solvent except the aqueous 
extract, had significantly higher inhibitions (89.95 ± 7.06 to 94.05 ± 0.08%) than the EGCG 
with 64.57 ± 1.03% inhibitory activity (p <0.05). 
 
Figure 2: Alpha-glucosidase inhibitory activity of the different solvent extracts of 
Phragmanthera capitata. Values are mean ± SD (n=3).  Set of bars (the same concentration) 
with different alphabets are significantly different (p <0.05). #: significantly higher than the 
positive control (EGCG: Epigallocatechin gallate) while ‘*’ is significantly lower than EGCG 
(p <0.05).  
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Table 1: IC50 of α-amylase and α- glucosidase inhibitory activity of the different solvent 
extracts of P. capitata 
 
 IC50 µg/mL 
α- Glucosidase  α- Amylase 
Acetone 71.89 ± 3.48 
a
 ND 
Methanol 91.98 ± 2.24
 a
 ND 
Ethanol 178.71 ± 6.82 
b
 ND 
Aqueous 953.87 ± 9.87 
c
 ND 
Acarbose - < 64 
Epigallocatechin gallate < 10
 d
 - 
Values are means ± SD (n=3). Figures with different superscript are significantly different at p 
< 0.05. ND: not determined. 
Discussion 
Diabetes had been a global health issue with an estimated 3% of the world’s population been 
diabetic and the prevalence had been postulated to increase to 6.3% by the year 2025. The 
management of diabetes still posed a challenge in the health sector because of the complications 
and secondary failure rates associated with the use of synthetic anti-diabetic medications 
(Kumaresan et al., 20i3; Kwon et al., 2007). This had led to the continuous search for natural 
anti-diabetic products which are effective, cheap and less toxic. Phragmanthera capitata had 
been used extensively for the management and treatment of a wide range of ailments including 
diabetes in folklore medicine in Africa (16, 15; 4). This present study was carried out to 
investigate the anti-diabetic properties of P. capitata.  
Crude extracts prepared from different solvents (acetone, methanol, ethanol and aqueous) were 
used for this investigation and the concentration range (50 µg/mL to 1000 µg/mL) for the 
evaluation was however within the safe limit (LD50 ˃ 1000 µg/mL) earlier established in 
chapter five of this study.  From the results of the investigation, all the solvent extracts 
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exhibited weak α- amylase inhibition (Figure 1) and this may give the impression that the anti-
diabetic mechanism of action of P. capitata may not probably be by the inhibition of pancreatic 
α-amylase. The stronger α-glucosidase inhibition (Figure 2) could be one of the best possible 
mechanisms whereby this plant exerts its antihyperglycemic activity.  
Contrary to the results of this study, Channabasava and Sadananda (2013) investigation on 
Dendrophthoe falcate, a mistletoe in the Loranthaceae family that was harvested from neem 
plant, reported a very high α-amylase inhibition of 84 to 88% in the methanol and aqueous 
extracts respectively (concentrations used were not well defined). The weak α-amylase and 
strong α-glucosidase inhibitory activity observed in this study were in consonance with an 
earlier report by Kwon et al (2007) that most phytochemicals are weak α-amylase but stronger 
α-glucosidase inhibitors. This also agreed with the reports of Oboh et al (2012) on Telfaria 
occidentalis, Kazeem et al (2013) on Morinda lucida and Kazeem and Ashafa (2015) on 
Dianthus basuticus who observed weak α-amylase and stronger α-glucosidase inhibitions. 
However, weak α-amylase inhibition by medicinal plants confers an advantage over synthetic 
anti-diabetic medications: with high α- amylase inhibition in the management of postprandial 
blood glucose. The excessive pancreatic α-amylase inhibition by synthetic anti-diabetic drugs 
could result in the accumulation of undigested carbohydrates in the colon which may promote 
abnormal bacterial fermentation on them. This abnormal bacterial fermentation is believed to be 
responsible for most of the gastrointestinal side effects observed by synthetic anti-diabetic 
drugs (Apostolidis et al., 2007; Kwon et al., 2007). Therefore, mild α-amylase inhibitory 
activity is desirable. Hence, the low α-amylase and high α- glucosidase inhibition exhibited by 
P. capitata could serve as a therapeutic pathway for the treatment of postprandial 
hyperglycemia with little or no side effects. The use of crude extracts for the management of 
diabetes may confer a further advantage over synthetic drugs because the purer an extract 
becomes the synergistic interactions of the compounds may diminish and eventually the thinner 
the safety may be (Osadebe et al., 2010b).  
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There was no positive correlation of extraction yield to inhibitory activities in this study. 
Though the methanol and aqueous had more extraction yield, the acetone extract exhibited the 
best α-glucosidase [Table 1] and α- amylase (500 µg/mL – 1000 µg/mL [Figure 1]) inhibitory 
activity while the aqueous extract had the least activity. Channabasava and Sadananda (2013) 
reported a contrary finding with the aqueous extract of D. falcata been more potent that the 
methanol extract. The best activity observed in the acetone extract in this study could be due to 
the ability of acetone to extract both hydrophilic and lipophilic compounds from the sample 
(Eloff, 1998). This also supports earlier findings in this study (Chapter two) where the acetone 
extract had better polyphenolic compounds than the other solvent extracts tested with 
corresponding higher anti-oxidant activity.  
Conclusion 
This study is the first in-vitro anti-diabetic report of P. capitata harvested from rubber trees.. 
This study suggests that the inhibition of carbohydrate-hydrolyzing enzymes (weak α-amylase 
and strong α-glucosidase inhibition) could be one of the possible mechanisms of action by 
which P. capitata exerts its anti-diabetic activity hence, supports its reported ethnomedicinal 
application in the management of diabetes in African folklore.The low α- amylase inhibition 
observed in this study may suggest that the anti-diabetic mechanism of action of P. capitata 
may not probably be by the inhibition of pancreatic α- amylase. The stronger α- glucosidase 
inhibition could be one of the best possible mechanisms whereby this plant exerts its anti- 
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GENERAL DISCUSSION AND CONCLUSION  
 
Discussion 
The increase in the use of herbal medicine has simultaneously resulted in a rapid demand for 
medicinal plants globally (Chen et al., 2016). However, in accordance with the reports of the 
International Union for Conservation of Nature and the World Wildlife Fund, a vast number of 
medicinal plants are threatened with extinction due to overexploitation and habitat destruction 
(Bentley, 2010). Another factor which could lead to the deliberate destruction of medicinal 
plants is ignorance of importance or use. Many plants are threatened with extinction because 
their uses are either undocumented and/or unknown and hence, they are considered as weeds 
and destroyed with prejudice. This is the case with mistletoe. Mistletoes are globally seen as 
pests of gardens and plantations that reduce the quality of produce or even kill the crops 
(Adesina et al., 2013). Hence, there is a deliberate attempt by plantation and garden owners to 
eradicate them; an act which has left some species of mistletoe now at the risk of extinction 
(IUCN, 2015). It is believed that proper documentation of plants’ uses and importance will 
serve as a key in sustainable conservation for future purposes. This study, therefore, sought to 
evaluate, validate and document the medicinal potentials of Phragmanthera capitata (Sprengel) 
Balle, a mistletoe commonly found in rubber plantations in Africa (Dibong et al., 2010; 
EngoneObiang et al., 2009) and faced with the scourge of unwholesome destruction from 
rubber plantations across Africa. 
Studies in phytopharmacology involve multidisciplinary sciences and the research is almost 
unlimited. In this thesis, the phytochemical, anti-oxidative, nutritive, essential oil and toxicity 
evaluations of P. capitata were reported. Biological activities of the extracts on some human 
pathogenic micro-organisms most especially Mycobacterium tuberculosis; and its effect on 
diabetes were also discussed. 
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The presence of polyphenolics like phenols, flavonoids and proanthocyanidins etc have been 
reported to be responsible for the anti-oxidative properties in medicinal plants extracts. 
Antioxidants are substances with protective abilities from damages caused by free radical-
induced stresses as a result of oxidation (Iloki-Assanga et al., 2015). In this study, different 
solvents (methanol, acetone, ethanol and water) were used for the extraction of the mistletoe to 
determine their effects on the total yield and activities. From the result, all the solvent extracts 
had high polyphenolic content with correlated anti-oxidant activities. Methanol had the highest 
extract yield while ethanol had the lowest yield. However, the acetone followed by the ethanol 
extracts had higher amounts of polyphenolic assayed for with corresponding higher antioxidant 
activities as reported in chapter two of this thesis. Hence, this plant may be effective in the 
management of oxidative related stresses or inflammations. 
This study also evaluated the potential nutritional and mineral compositions of the sample. This 
research revealed important mineral compositions even higher than those found in some 
conventional vegetables. It is rich in carbohydrate which is the major source of energy and a 
substantial amount of fibre, protein and fat. The findings of this work suggest that this species 
could have the potential to boost the immune system due to its rich mineral and nutrient 
compositions. The nutritional and mineral potentials of P. capitata could be a contributing 
factor to its wide therapeutic applications in herbal medicine.  
The use of essential oils in healthcare is topical in recent times most especially in aromatherapy 
(Lawal and Ogunwande, 2013; Baser and Buchbaur, 2010; Lee et al., 2010). The essential oils 
from P. capitata revealed the presence of some pharmacological important compounds like 
Alpha-linolenic acid, Isoeugenol, Methyl hexadecanoic acid, Phytol and D-limonene. The 
presence of these and other compounds in the plant could also be a contributing factor to its 
pharmacological activities.  
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The general perception that herbal remedies are safe and devoid of adverse effects may not be 
entirely true and misleading. In fact, there had been several reports of toxicity in herbal 
remedies which had led to serious damages to the consumers (Ekor, 2014). Arising from these 
contraindications, the different solvent extracts were screened for possible toxicity using the 
brine shrimp assay. The outcome of the evaluation revealed all extracts of P. capitata to be non-
toxic based; hence, could be explored for further plant-based pharmaceuticals.  
The increase in multidrug resistance (MDR), total drug resistance (TDR) and extensive drug 
resistance (XDR) in most human pathogenic microorganisms to conventional drugs has 
necessitated the screening of plant-based products as possible anti-microbial agents (Djeussi et 
al., 2013; Coates et al., 2002). Hence, the assessment of the extracts of P. capitata on some 
human pathogenic bacteria and fungi was carried out. The outcome of the assessment showed 
that P. capitata has a better potential as an anti-bacterial agent than as an anti-fungi agent 
except for the aqueous extract which proved otherwise (with better antifungal activity). Most 
notable of its bacterial activity is the high inhibitory effect on Mycobacterium tuberculosis, the 
major causative agent of tuberculosis. Hence, this plant may be said to have potential to confer 
some immunity against the dreaded TB and other pathogenic diseases in general. 
The anti-diabetic screening of the P. capitata revealed that the potential mechanism of action 
could be by the inhibition of pancreatic α- amylase and α- glucosidase. The use of phytotherapy 
for the management of diabetes could eradicate the side effects associated with the use of 
synthetic anti-diabetic medications. This study supports the ethnopharmacological application 
of P. capitata in the management of diabetes (Ogunmefun et al., 2015; Dibong et al., 2009). 
Conclusion  
The outcome of this study revealed the potential of P. capitata in phytotherapeutics. The high 
polyphenolic contents with correlative antioxidative activities of the extracts are an indication 
of the possible anti-inflammation activity of P. capitata against cellular oxidative stresses 
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caused by free radicals. The nutrient value and mineral contents in the sample could suggest its 
immune boosting potentials and even supplement for most nutrient deficiency syndromes. The 
compounds identified in the essential oils of the sample could have a significant contribution to 
the total pharmacological activities observed in this study and will also pave way for further 
studies in this line as it is the first ever report of the chemical constituents of the essential oils of 
the sample. As one of the WHO criterion for the use of phytotherapy, the non-toxic outcome of 
this study could alleviate the scare of the reported toxicity of most mistletoe. The outcome of 
this study further validated some ethnomedicinal uses of P. capitata against infectious diseases, 
diabetes and hence, may serve as an important herb in the management of the infections caused 
by microorganisms. 
From the foregoing, P. capitata has exhibited potentials in phytotherapy.  Therefore, instead of 
its total destruction from rubber trees and other crop plantations, a sustainable conservation 
approach should be implemented to have the full benefits of this plant now and in the future 
(because the destruction of a plant could result to the permanent loss of a potential tomorrow’s 
lifesaving drug).  
References 
Adesina, S.K., Illoh, H.C., Imoh, I.J., Imoh, E.J., 2013. African Mistletoes (Loranthaceae); 
Ethnopharmacology, Chemistry and Medicinal Values: An Update. African Journal of 
Traditional, Complementary and Alternative Medicines 10(4), 161–170. PMCID: 
PMC3794408. 
Baser, K.H.C. Buchbauer, G., 2010. Handbook of Essential Oils: Science, Technology and 
Applications. CRC Press, Boca Raton, London, New York.  
Bentley, R., editor. Medicinal plants. London: Domville-Fife Press; 2010. p. 23–46. 
Chen, S-L., Yu, H., Luo, H-M., Wu, Q., Li, C-F., Steinmetz, A., 2016. Conservation and 
sustainable use of medicinal plants: problems, progress, and prospects. BMC Chinese 
Medicine 11, 37. DOI: 10.1186/s13020-016-0108-7.  
Coates, A., Hu, Y., Bax, R. Page, C., 2002. The future challenges facing the development of 
new antimicrobial drugs. Nature Reviews Drug Discovery. 1, 895-910. 
 144 
 
Dibong, S.D., EngoneObiang, N.L., Ndongo, D., Priso, R.J., Taffouo, V., Fankem, H., Salle, 
G., Missoup, A.D., Boussim, I.J., Amougou, A., 2009. An assessment on the uses of 
Loranthaceae in ethnopharmacology in Cameroon: A case study made in Logbessou, 
North of Douala. Journal of Medicinal Plants Research 3(8), 592-595.  
Dibong, S.D., Mony, R., Ndiang, Z., Ondoua, J.M., Boussim, I.J., Bilong, B., Amougou, A., 
2010. The struggle against Phragmanthera capitata (Sprengel) S. Balle (Loranthaceae) 
parasite of agroecosystems’ fruit trees in Cameroon. Journal of Agricultural 
Biotechnology and Sustainable Development 2(5), 76-81. 
Djeussi, D.E., Noumedem, J.A., Seukep. J.A., Fankam, A.G., Voukeng, I.K., Tankeo, S.B., 
Nkuete, A.H., Kuete, V., 2013. Antibacterial activities of selected edible plants extracts 
against multidrug-resistant Gram-negative bacteria. BMC Complementary and 
Alternative Medicine 3,164. DOI: 10.1186/1472-6882-13-164 
Ekor, M., 2014. The growing use of herbal medicines: issues relating to adverse reactions and 
challenges in monitoring safety. Frontiers in Pharmacology 4, 177.  
EngoneObiang, N.L., Sallé, G., Eschbach, J.M., Salomon, M., 2009. Susceptibility of rubber 
trees to Loranthaceae in Gabon. Journal of Plant Interactions 4 (3), 233-240. DOI: 
10.1080/17429140902962613. 
Iloki-Assanga, S.B., Lewis-Lujan, L.M., Lara-Espinoza, C.L., Gill-Salido, A.A., Fernandez-
Angulo, D., Rubio-Pino, J.L., Haines, D.D., 2015. Solvent effects on the phytochemical 
constituent profiles and antioxidant activities, using four different extraction formulations 
for analysis of Bucida buceras L. and Phoradendron californicum. BMC Research Notes 
8, 396. DOI 10.1186/s13104-015-1388-1. 
International Union for the Conservation of Nature. 2015. Red List of Threatened Species. 
Version 2015.1. <www.iucnredlist.org>. Downloaded on 04 June 2015 
Lawal, O.A. Ogunwande, I.A., 2013. Essential Oils from the Medicinal Plants of Africa. In 
book: Medicinal Plant Research in Afric, 203-224. DOI: 10.1016/B978-0-12-405927-
6.00005-9.  
Lee, M.S., Choi, J., Posadzki, P., Ernst, E., 2012. Aromatherapy for healthcare: An overview of 
systematic reviews. Maturitas 71 (3), 257–260. PMID 22285469. 
Ogunmefun, O.T., Olatunji, B.P., Adarabioyo, M.I., 2015. Ethnomedicinal survey on the uses 
of mistletoe in South-western Nigeria.  European Journal of Medicinal Plants. 8 (4), 
224-230. DOI: 10.9734/EJMP/2015/11048. 
 
